id	sid	tid	token	lemma	pos
aiua-5550	1	1	stesura	stesura	PROPN
aiua-5550	1	2	seveso	seveso	PROPN
aiua-5550	1	3	archivio	archivio	PROPN
aiua-5550	1	4	italiano	italiano	X
aiua-5550	1	5	di	di	X
aiua-5550	1	6	urologia	urologia	PROPN
aiua-5550	1	7	e	e	PROPN
aiua-5550	1	8	andrologia	andrologia	NOUN
aiua-5550	1	9	2015	2015	NUM
aiua-5550	1	10	;	;	PUNCT
aiua-5550	1	11	87	87	NUM
aiua-5550	1	12	,	,	PUNCT
aiua-5550	1	13	3238	3238	NUM
aiua-5550	1	14	original	original	ADJ
aiua-5550	1	15	paper	paper	NOUN
aiua-5550	1	16	clinical	clinical	ADJ
aiua-5550	1	17	significance	significance	NOUN
aiua-5550	1	18	of	of	ADP
aiua-5550	1	19	prostatic	prostatic	ADJ
aiua-5550	1	20	-	-	PUNCT
aiua-5550	1	21	urethral	urethral	ADJ
aiua-5550	1	22	angulation	angulation	NOUN
aiua-5550	1	23	on	on	ADP
aiua-5550	1	24	the	the	DET
aiua-5550	1	25	treatment	treatment	NOUN
aiua-5550	1	26	outcome	outcome	NOUN
aiua-5550	1	27	of	of	ADP
aiua-5550	1	28	patients	patient	NOUN
aiua-5550	1	29	with	with	ADP
aiua-5550	1	30	symptomatic	symptomatic	ADJ
aiua-5550	1	31	benign	benign	ADJ
aiua-5550	1	32	prostatic	prostatic	ADJ
aiua-5550	1	33	hyperplasia	hyperplasia	NOUN
aiua-5550	1	34	treated	treat	VERB
aiua-5550	1	35	with	with	ADP
aiua-5550	1	36	tamsulosin	tamsulosin	NOUN
aiua-5550	1	37	hydrochloride	hydrochloride	NOUN
aiua-5550	1	38	hassan	hassan	PROPN
aiua-5550	1	39	el	el	PROPN
aiua-5550	1	40	-	-	PUNCT
aiua-5550	1	41	tatawy	tatawy	ADJ
aiua-5550	1	42	1	1	NUM
aiua-5550	1	43	,	,	PUNCT
aiua-5550	1	44	tarek	tarek	PROPN
aiua-5550	1	45	gameel	gameel	PROPN
aiua-5550	1	46	1	1	NUM
aiua-5550	1	47	,	,	PUNCT
aiua-5550	1	48	mohammed	mohammed	PROPN
aiua-5550	1	49	abo	abo	PROPN
aiua-5550	1	50	el	el	PROPN
aiua-5550	1	51	-	-	PROPN
aiua-5550	1	52	enen	enen	PROPN
aiua-5550	1	53	1	1	NUM
aiua-5550	1	54	,	,	PUNCT
aiua-5550	1	55	ayman	ayman	NOUN
aiua-5550	1	56	hagras	hagras	PROPN
aiua-5550	1	57	1	1	NUM
aiua-5550	1	58	,	,	PUNCT
aiua-5550	1	59	ayman	ayman	PROPN
aiua-5550	1	60	mousa	mousa	PROPN
aiua-5550	1	61	1	1	NUM
aiua-5550	1	62	,	,	PUNCT
aiua-5550	1	63	abdel	abdel	PROPN
aiua-5550	1	64	hamid	hamid	PROPN
aiua-5550	1	65	el	el	PROPN
aiua-5550	1	66	-	-	PROPN
aiua-5550	1	67	bahnasy	bahnasy	PROPN
aiua-5550	1	68	1	1	NUM
aiua-5550	1	69	,	,	PUNCT
aiua-5550	1	70	ali	ali	PROPN
aiua-5550	1	71	abdel	abdel	PROPN
aiua-5550	1	72	raheem	raheem	PROPN
aiua-5550	1	73	1	1	NUM
aiua-5550	1	74	,	,	PUNCT
aiua-5550	1	75	khaled	khaled	PROPN
aiua-5550	1	76	abu	abu	PROPN
aiua-5550	1	77	-	-	PUNCT
aiua-5550	1	78	dewan	dewan	PROPN
aiua-5550	1	79	2	2	NUM
aiua-5550	1	80	1	1	NUM
aiua-5550	1	81	urology	urology	NOUN
aiua-5550	1	82	department	department	NOUN
aiua-5550	1	83	,	,	PUNCT
aiua-5550	1	84	tanta	tanta	PROPN
aiua-5550	1	85	university	university	PROPN
aiua-5550	1	86	hospital	hospital	NOUN
aiua-5550	1	87	,	,	PUNCT
aiua-5550	1	88	egypt	egypt	PROPN
aiua-5550	1	89	.	.	PROPN
aiua-5550	1	90	2	2	NUM
aiua-5550	1	91	radiology	radiology	NOUN
aiua-5550	1	92	department	department	NOUN
aiua-5550	1	93	,	,	PUNCT
aiua-5550	1	94	tanta	tanta	PROPN
aiua-5550	1	95	university	university	PROPN
aiua-5550	1	96	hospital	hospital	NOUN
aiua-5550	1	97	,	,	PUNCT
aiua-5550	1	98	egypt	egypt	PROPN
aiua-5550	1	99	.	.	PUNCT
aiua-5550	2	1	objectives	objective	NOUN
aiua-5550	2	2	:	:	PUNCT
aiua-5550	2	3	to	to	PART
aiua-5550	2	4	evaluate	evaluate	VERB
aiua-5550	2	5	the	the	DET
aiua-5550	2	6	impact	impact	NOUN
aiua-5550	2	7	of	of	ADP
aiua-5550	2	8	the	the	DET
aiua-5550	2	9	prostatic	prostatic	ADJ
aiua-5550	2	10	-	-	PUNCT
aiua-5550	2	11	urethral	urethral	ADJ
aiua-5550	2	12	angulation	angulation	NOUN
aiua-5550	2	13	(	(	PUNCT
aiua-5550	2	14	pua	pua	PROPN
aiua-5550	2	15	)	)	PUNCT
aiua-5550	2	16	on	on	ADP
aiua-5550	2	17	the	the	DET
aiua-5550	2	18	treatment	treatment	NOUN
aiua-5550	2	19	efficacy	efficacy	NOUN
aiua-5550	2	20	of	of	ADP
aiua-5550	2	21	selective	selective	ADJ
aiua-5550	2	22	alpha-1a	alpha-1a	PRON
aiua-5550	2	23	receptor	receptor	NOUN
aiua-5550	2	24	blocker	blocker	NOUN
aiua-5550	2	25	in	in	ADP
aiua-5550	2	26	male	male	ADJ
aiua-5550	2	27	patients	patient	NOUN
aiua-5550	2	28	with	with	ADP
aiua-5550	2	29	lower	low	ADJ
aiua-5550	2	30	urinary	urinary	ADJ
aiua-5550	2	31	tract	tract	NOUN
aiua-5550	2	32	symptoms	symptom	NOUN
aiua-5550	2	33	secondary	secondary	ADJ
aiua-5550	2	34	to	to	ADP
aiua-5550	2	35	benign	benign	ADJ
aiua-5550	2	36	prostatic	prostatic	ADJ
aiua-5550	2	37	hyperplasia	hyperplasia	NOUN
aiua-5550	2	38	(	(	PUNCT
aiua-5550	2	39	luts	luts	PROPN
aiua-5550	2	40	/	/	SYM
aiua-5550	2	41	bph	bph	NOUN
aiua-5550	2	42	)	)	PUNCT
aiua-5550	2	43	.	.	PUNCT
aiua-5550	3	1	materials	material	NOUN
aiua-5550	3	2	and	and	CCONJ
aiua-5550	3	3	methods	method	NOUN
aiua-5550	3	4	:	:	PUNCT
aiua-5550	3	5	a	a	DET
aiua-5550	3	6	total	total	NOUN
aiua-5550	3	7	of	of	ADP
aiua-5550	3	8	80	80	NUM
aiua-5550	3	9	patients	patient	NOUN
aiua-5550	3	10	with	with	ADP
aiua-5550	3	11	luts	luts	PROPN
aiua-5550	3	12	/	/	SYM
aiua-5550	3	13	bph	bph	NOUN
aiua-5550	3	14	and	and	CCONJ
aiua-5550	3	15	with	with	ADP
aiua-5550	3	16	mean	mean	ADJ
aiua-5550	3	17	age	age	NOUN
aiua-5550	3	18	53.3	53.3	NUM
aiua-5550	3	19	±	±	NUM
aiua-5550	3	20	6.3	6.3	NUM
aiua-5550	3	21	(	(	PUNCT
aiua-5550	3	22	range	range	NOUN
aiua-5550	3	23	47	47	NUM
aiua-5550	3	24	-	-	SYM
aiua-5550	3	25	70	70	NUM
aiua-5550	3	26	)	)	PUNCT
aiua-5550	3	27	were	be	AUX
aiua-5550	3	28	included	include	VERB
aiua-5550	3	29	in	in	ADP
aiua-5550	3	30	our	our	PRON
aiua-5550	3	31	prospective	prospective	ADJ
aiua-5550	3	32	comparative	comparative	ADJ
aiua-5550	3	33	study	study	NOUN
aiua-5550	3	34	.	.	PUNCT
aiua-5550	4	1	the	the	DET
aiua-5550	4	2	patients	patient	NOUN
aiua-5550	4	3	were	be	AUX
aiua-5550	4	4	classified	classify	VERB
aiua-5550	4	5	into	into	ADP
aiua-5550	4	6	2	2	NUM
aiua-5550	4	7	groups	group	NOUN
aiua-5550	4	8	as	as	ADP
aiua-5550	4	9	a	a	DET
aiua-5550	4	10	consecutive	consecutive	ADJ
aiua-5550	4	11	cases	case	NOUN
aiua-5550	4	12	40	40	NUM
aiua-5550	4	13	in	in	ADP
aiua-5550	4	14	each	each	DET
aiua-5550	4	15	one	one	NUM
aiua-5550	4	16	depending	depend	VERB
aiua-5550	4	17	on	on	ADP
aiua-5550	4	18	the	the	DET
aiua-5550	4	19	pua	pua	NOUN
aiua-5550	4	20	either	either	CCONJ
aiua-5550	4	21	≤	≤	PROPN
aiua-5550	4	22	35˚	35˚	NUM
aiua-5550	4	23	(	(	PUNCT
aiua-5550	4	24	group	group	NOUN
aiua-5550	4	25	a	a	NOUN
aiua-5550	4	26	)	)	PUNCT
aiua-5550	4	27	or	or	CCONJ
aiua-5550	4	28	>	>	X
aiua-5550	4	29	35˚	35˚	X
aiua-5550	4	30	(	(	PUNCT
aiua-5550	4	31	group	group	NOUN
aiua-5550	4	32	b	b	PROPN
aiua-5550	4	33	)	)	PUNCT
aiua-5550	4	34	.	.	PUNCT
aiua-5550	5	1	pua	pua	PROPN
aiua-5550	5	2	and	and	CCONJ
aiua-5550	5	3	different	different	ADJ
aiua-5550	5	4	prostatic	prostatic	ADJ
aiua-5550	5	5	parameters	parameter	NOUN
aiua-5550	5	6	were	be	AUX
aiua-5550	5	7	measured	measure	VERB
aiua-5550	5	8	using	use	VERB
aiua-5550	5	9	transrectal	transrectal	ADJ
aiua-5550	5	10	ultrasound	ultrasound	NOUN
aiua-5550	5	11	.	.	PUNCT
aiua-5550	6	1	prostate	prostate	NOUN
aiua-5550	6	2	-	-	PUNCT
aiua-5550	6	3	specific	specific	ADJ
aiua-5550	6	4	antigen	antigen	NOUN
aiua-5550	6	5	(	(	PUNCT
aiua-5550	6	6	psa	psa	NOUN
aiua-5550	6	7	)	)	PUNCT
aiua-5550	6	8	,	,	PUNCT
aiua-5550	6	9	the	the	DET
aiua-5550	6	10	international	international	ADJ
aiua-5550	6	11	prostate	prostate	NOUN
aiua-5550	6	12	symptom	symptom	NOUN
aiua-5550	6	13	score	score	NOUN
aiua-5550	6	14	and	and	CCONJ
aiua-5550	6	15	quality	quality	NOUN
aiua-5550	6	16	of	of	ADP
aiua-5550	6	17	life	life	NOUN
aiua-5550	6	18	score	score	NOUN
aiua-5550	6	19	(	(	PUNCT
aiua-5550	6	20	ipss	ipss	PROPN
aiua-5550	6	21	/	/	SYM
aiua-5550	6	22	qol	qol	PROPN
aiua-5550	6	23	score	score	NOUN
aiua-5550	6	24	)	)	PUNCT
aiua-5550	6	25	,	,	PUNCT
aiua-5550	7	1	maximum	maximum	ADJ
aiua-5550	7	2	flow	flow	NOUN
aiua-5550	7	3	rate	rate	NOUN
aiua-5550	7	4	(	(	PUNCT
aiua-5550	7	5	qmax	qmax	PROPN
aiua-5550	7	6	)	)	PUNCT
aiua-5550	7	7	,	,	PUNCT
aiua-5550	7	8	and	and	CCONJ
aiua-5550	7	9	postvoid	postvoid	VERB
aiua-5550	7	10	residual	residual	ADJ
aiua-5550	7	11	(	(	PUNCT
aiua-5550	7	12	pvr	pvr	NOUN
aiua-5550	7	13	)	)	PUNCT
aiua-5550	7	14	volume	volume	NOUN
aiua-5550	7	15	were	be	AUX
aiua-5550	7	16	compared	compare	VERB
aiua-5550	7	17	between	between	ADP
aiua-5550	7	18	the	the	DET
aiua-5550	7	19	groups	group	NOUN
aiua-5550	7	20	.	.	PUNCT
aiua-5550	8	1	the	the	DET
aiua-5550	8	2	clinical	clinical	ADJ
aiua-5550	8	3	significance	significance	NOUN
aiua-5550	8	4	of	of	ADP
aiua-5550	8	5	pua	pua	PROPN
aiua-5550	8	6	was	be	AUX
aiua-5550	8	7	evaluated	evaluate	VERB
aiua-5550	8	8	after	after	ADP
aiua-5550	8	9	8	8	NUM
aiua-5550	8	10	weeks	week	NOUN
aiua-5550	8	11	of	of	ADP
aiua-5550	8	12	medical	medical	ADJ
aiua-5550	8	13	treatment	treatment	NOUN
aiua-5550	8	14	with	with	ADP
aiua-5550	8	15	tamsulosin	tamsulosin	NOUN
aiua-5550	8	16	hydrochloride	hydrochloride	NOUN
aiua-5550	8	17	0.4	0.4	NUM
aiua-5550	8	18	mg	mg	PROPN
aiua-5550	8	19	daily	daily	PROPN
aiua-5550	8	20	.	.	PUNCT
aiua-5550	9	1	results	result	NOUN
aiua-5550	9	2	:	:	PUNCT
aiua-5550	9	3	baseline	baseline	NOUN
aiua-5550	9	4	evaluation	evaluation	NOUN
aiua-5550	9	5	(	(	PUNCT
aiua-5550	9	6	pre	pre	ADJ
aiua-5550	9	7	-	-	NOUN
aiua-5550	9	8	treatment	treatment	NOUN
aiua-5550	9	9	)	)	PUNCT
aiua-5550	9	10	for	for	ADP
aiua-5550	9	11	both	both	DET
aiua-5550	9	12	groups	group	NOUN
aiua-5550	9	13	were	be	AUX
aiua-5550	9	14	comparable	comparable	ADJ
aiua-5550	9	15	to	to	ADP
aiua-5550	9	16	each	each	DET
aiua-5550	9	17	other	other	ADJ
aiua-5550	9	18	with	with	ADP
aiua-5550	9	19	no	no	DET
aiua-5550	9	20	clinically	clinically	ADV
aiua-5550	9	21	significant	significant	ADJ
aiua-5550	9	22	difference	difference	NOUN
aiua-5550	9	23	regarding	regard	VERB
aiua-5550	9	24	age	age	NOUN
aiua-5550	9	25	,	,	PUNCT
aiua-5550	9	26	psa	psa	NOUN
aiua-5550	9	27	,	,	PUNCT
aiua-5550	9	28	ipss	ipss	PROPN
aiua-5550	9	29	/	/	SYM
aiua-5550	9	30	qol	qol	PROPN
aiua-5550	9	31	score	score	NOUN
aiua-5550	9	32	,	,	PUNCT
aiua-5550	9	33	qmax	qmax	PROPN
aiua-5550	9	34	and	and	CCONJ
aiua-5550	9	35	pvr	pvr	PROPN
aiua-5550	9	36	volume	volume	NOUN
aiua-5550	9	37	(	(	PUNCT
aiua-5550	9	38	p	p	NOUN
aiua-5550	9	39	-	-	PUNCT
aiua-5550	9	40	value	value	NOUN
aiua-5550	9	41	>	>	NOUN
aiua-5550	9	42	0.05	0.05	NUM
aiua-5550	9	43	)	)	PUNCT
aiua-5550	9	44	.	.	PUNCT
aiua-5550	10	1	comparison	comparison	NOUN
aiua-5550	10	2	of	of	ADP
aiua-5550	10	3	parameters	parameter	NOUN
aiua-5550	10	4	after	after	ADP
aiua-5550	10	5	8	8	NUM
aiua-5550	10	6	weeks	week	NOUN
aiua-5550	10	7	showed	show	VERB
aiua-5550	10	8	that	that	SCONJ
aiua-5550	10	9	tamsulosin	tamsulosin	NOUN
aiua-5550	10	10	hydrochloride	hydrochloride	NOUN
aiua-5550	10	11	improved	improve	VERB
aiua-5550	10	12	the	the	DET
aiua-5550	10	13	total	total	ADJ
aiua-5550	10	14	ipss	ipss	PROPN
aiua-5550	10	15	and	and	CCONJ
aiua-5550	10	16	all	all	DET
aiua-5550	10	17	subscores	subscore	NOUN
aiua-5550	10	18	(	(	PUNCT
aiua-5550	10	19	p	p	X
aiua-5550	10	20	<	<	X
aiua-5550	10	21	0.001	0.001	NUM
aiua-5550	10	22	)	)	PUNCT
aiua-5550	10	23	,	,	PUNCT
aiua-5550	10	24	qol	qol	INTJ
aiua-5550	10	25	(	(	PUNCT
aiua-5550	10	26	p	p	NOUN
aiua-5550	10	27	=	=	NOUN
aiua-5550	10	28	0.001	0.001	NUM
aiua-5550	10	29	)	)	PUNCT
aiua-5550	10	30	,	,	PUNCT
aiua-5550	10	31	qmax	qmax	PROPN
aiua-5550	10	32	(	(	PUNCT
aiua-5550	10	33	p	p	X
aiua-5550	10	34	=	=	NOUN
aiua-5550	10	35	0.002	0.002	NUM
aiua-5550	10	36	)	)	PUNCT
aiua-5550	10	37	,	,	PUNCT
aiua-5550	10	38	and	and	CCONJ
aiua-5550	10	39	pvr	pvr	NOUN
aiua-5550	10	40	(	(	PUNCT
aiua-5550	10	41	p	p	X
aiua-5550	10	42	=	=	NOUN
aiua-5550	10	43	0.04	0.04	NUM
aiua-5550	10	44	)	)	PUNCT
aiua-5550	10	45	in	in	ADP
aiua-5550	10	46	group	group	PROPN
aiua-5550	10	47	a	a	PRON
aiua-5550	10	48	(	(	PUNCT
aiua-5550	10	49	table	table	NOUN
aiua-5550	10	50	1	1	NUM
aiua-5550	10	51	)	)	PUNCT
aiua-5550	10	52	.	.	PUNCT
aiua-5550	11	1	conclusion	conclusion	NOUN
aiua-5550	11	2	:	:	PUNCT
aiua-5550	11	3	tamsulosin	tamsulosin	NOUN
aiua-5550	11	4	hydrochloride	hydrochloride	NOUN
aiua-5550	11	5	appears	appear	VERB
aiua-5550	11	6	to	to	PART
aiua-5550	11	7	be	be	AUX
aiua-5550	11	8	less	less	ADV
aiua-5550	11	9	effective	effective	ADJ
aiua-5550	11	10	in	in	ADP
aiua-5550	11	11	improving	improve	VERB
aiua-5550	11	12	ipss	ipss	PROPN
aiua-5550	11	13	/	/	SYM
aiua-5550	11	14	qol	qol	PROPN
aiua-5550	11	15	score	score	NOUN
aiua-5550	11	16	,	,	PUNCT
aiua-5550	11	17	qmax	qmax	PROPN
aiua-5550	11	18	and	and	CCONJ
aiua-5550	11	19	pvr	pvr	NOUN
aiua-5550	11	20	in	in	ADP
aiua-5550	11	21	patients	patient	NOUN
aiua-5550	11	22	with	with	ADP
aiua-5550	11	23	lager	lag	ADJ
aiua-5550	11	24	pua	pua	NOUN
aiua-5550	11	25	.	.	PUNCT
aiua-5550	12	1	the	the	DET
aiua-5550	12	2	pua	pua	PROPN
aiua-5550	12	3	might	might	AUX
aiua-5550	12	4	be	be	AUX
aiua-5550	12	5	a	a	DET
aiua-5550	12	6	predictor	predictor	NOUN
aiua-5550	12	7	for	for	ADP
aiua-5550	12	8	the	the	DET
aiua-5550	12	9	treatment	treatment	NOUN
aiua-5550	12	10	efficacy	efficacy	NOUN
aiua-5550	12	11	of	of	ADP
aiua-5550	12	12	α	α	NOUN
aiua-5550	12	13	-	-	PUNCT
aiua-5550	12	14	blockers	blocker	NOUN
aiua-5550	12	15	and	and	CCONJ
aiua-5550	12	16	more	more	ADJ
aiua-5550	12	17	studies	study	NOUN
aiua-5550	12	18	are	be	AUX
aiua-5550	12	19	warranted	warrant	VERB
aiua-5550	12	20	in	in	ADP
aiua-5550	12	21	the	the	DET
aiua-5550	12	22	future	future	NOUN
aiua-5550	12	23	before	before	ADP
aiua-5550	12	24	the	the	DET
aiua-5550	12	25	final	final	ADJ
aiua-5550	12	26	conclusion	conclusion	NOUN
aiua-5550	12	27	.	.	PUNCT
aiua-5550	13	1	key	key	ADJ
aiua-5550	13	2	words	word	NOUN
aiua-5550	13	3	:	:	PUNCT
aiua-5550	13	4	prostatic	prostatic	ADJ
aiua-5550	13	5	-	-	PUNCT
aiua-5550	13	6	urethral	urethral	ADJ
aiua-5550	13	7	angulation	angulation	NOUN
aiua-5550	13	8	,	,	PUNCT
aiua-5550	13	9	benign	benign	ADJ
aiua-5550	13	10	prostatic	prostatic	ADJ
aiua-5550	13	11	hyperplasia	hyperplasia	NOUN
aiua-5550	13	12	and	and	CCONJ
aiua-5550	13	13	tamsulosin	tamsulosin	NOUN
aiua-5550	13	14	hydrochloride	hydrochloride	NOUN
aiua-5550	13	15	.	.	PUNCT
aiua-5550	13	16	submitted	submit	VERB
aiua-5550	13	17	20	20	NUM
aiua-5550	13	18	february	february	NOUN
aiua-5550	13	19	2015	2015	NUM
aiua-5550	13	20	;	;	PUNCT
aiua-5550	13	21	accepted	accept	VERB
aiua-5550	13	22	30	30	NUM
aiua-5550	13	23	april	april	PROPN
aiua-5550	13	24	2015	2015	NUM
aiua-5550	13	25	summary	summary	NOUN
aiua-5550	13	26	no	no	DET
aiua-5550	13	27	conflict	conflict	NOUN
aiua-5550	13	28	of	of	ADP
aiua-5550	13	29	interest	interest	NOUN
aiua-5550	13	30	declared	declare	VERB
aiua-5550	13	31	.	.	PUNCT
aiua-5550	14	1	up	up	ADP
aiua-5550	14	2	till	till	SCONJ
aiua-5550	14	3	now	now	ADV
aiua-5550	14	4	the	the	DET
aiua-5550	14	5	exact	exact	ADJ
aiua-5550	14	6	pathophysiology	pathophysiology	NOUN
aiua-5550	14	7	of	of	ADP
aiua-5550	14	8	bph	bph	NOUN
aiua-5550	14	9	is	be	AUX
aiua-5550	14	10	still	still	ADV
aiua-5550	14	11	poorly	poorly	ADV
aiua-5550	14	12	understood	understand	VERB
aiua-5550	14	13	and	and	CCONJ
aiua-5550	14	14	different	different	ADJ
aiua-5550	14	15	theories	theory	NOUN
aiua-5550	14	16	have	have	AUX
aiua-5550	14	17	emerged	emerge	VERB
aiua-5550	14	18	and	and	CCONJ
aiua-5550	14	19	changed	change	VERB
aiua-5550	14	20	over	over	ADP
aiua-5550	14	21	the	the	DET
aiua-5550	14	22	past	past	ADJ
aiua-5550	14	23	years	year	NOUN
aiua-5550	14	24	.	.	PUNCT
aiua-5550	15	1	some	some	DET
aiua-5550	15	2	studies	study	NOUN
aiua-5550	15	3	reported	report	VERB
aiua-5550	15	4	that	that	SCONJ
aiua-5550	15	5	the	the	DET
aiua-5550	15	6	prostate	prostate	NOUN
aiua-5550	15	7	volume	volume	NOUN
aiua-5550	15	8	does	do	AUX
aiua-5550	15	9	not	not	PART
aiua-5550	15	10	correlate	correlate	VERB
aiua-5550	15	11	with	with	ADP
aiua-5550	15	12	the	the	DET
aiua-5550	15	13	clinical	clinical	ADJ
aiua-5550	15	14	luts	lut	NOUN
aiua-5550	15	15	and/or	and/or	CCONJ
aiua-5550	15	16	the	the	DET
aiua-5550	15	17	degree	degree	NOUN
aiua-5550	15	18	of	of	ADP
aiua-5550	15	19	bladder	bladder	NOUN
aiua-5550	15	20	outlet	outlet	NOUN
aiua-5550	15	21	obstruction	obstruction	NOUN
aiua-5550	15	22	(	(	PUNCT
aiua-5550	15	23	boo	boo	NOUN
aiua-5550	15	24	)	)	PUNCT
aiua-5550	15	25	(	(	PUNCT
aiua-5550	15	26	2	2	NUM
aiua-5550	15	27	,	,	PUNCT
aiua-5550	15	28	3	3	NUM
aiua-5550	15	29	)	)	PUNCT
aiua-5550	15	30	,	,	PUNCT
aiua-5550	15	31	and	and	CCONJ
aiua-5550	15	32	other	other	ADJ
aiua-5550	15	33	studies	study	NOUN
aiua-5550	15	34	discussed	discuss	VERB
aiua-5550	15	35	several	several	ADJ
aiua-5550	15	36	anatomical	anatomical	ADJ
aiua-5550	15	37	factors	factor	NOUN
aiua-5550	15	38	that	that	PRON
aiua-5550	15	39	may	may	AUX
aiua-5550	15	40	explain	explain	VERB
aiua-5550	15	41	the	the	DET
aiua-5550	15	42	clinical	clinical	ADJ
aiua-5550	15	43	effect	effect	NOUN
aiua-5550	15	44	of	of	ADP
aiua-5550	15	45	bph	bph	NOUN
aiua-5550	15	46	such	such	ADJ
aiua-5550	15	47	as	as	ADP
aiua-5550	15	48	intravesical	intravesical	ADJ
aiua-5550	15	49	prostatic	prostatic	ADJ
aiua-5550	15	50	protrusion	protrusion	NOUN
aiua-5550	15	51	(	(	PUNCT
aiua-5550	15	52	ipp	ipp	PROPN
aiua-5550	15	53	)	)	PUNCT
aiua-5550	15	54	,	,	PUNCT
aiua-5550	15	55	transition	transition	NOUN
aiua-5550	15	56	zone	zone	NOUN
aiua-5550	15	57	volume	volume	NOUN
aiua-5550	15	58	(	(	PUNCT
aiua-5550	15	59	tzv	tzv	NOUN
aiua-5550	15	60	)	)	PUNCT
aiua-5550	15	61	,	,	PUNCT
aiua-5550	15	62	transition	transition	NOUN
aiua-5550	15	63	zone	zone	NOUN
aiua-5550	15	64	index	index	NOUN
aiua-5550	15	65	(	(	PUNCT
aiua-5550	15	66	tzi	tzi	PROPN
aiua-5550	15	67	)	)	PUNCT
aiua-5550	15	68	and	and	CCONJ
aiua-5550	15	69	presumed	presume	VERB
aiua-5550	15	70	circle	circle	NOUN
aiua-5550	15	71	area	area	NOUN
aiua-5550	15	72	ratio	ratio	NOUN
aiua-5550	15	73	(	(	PUNCT
aiua-5550	15	74	4	4	NUM
aiua-5550	15	75	-	-	SYM
aiua-5550	15	76	9	9	NUM
aiua-5550	15	77	)	)	PUNCT
aiua-5550	15	78	.	.	PUNCT
aiua-5550	16	1	recently	recently	ADV
aiua-5550	16	2	,	,	PUNCT
aiua-5550	16	3	cho	cho	PROPN
aiua-5550	16	4	et	et	PROPN
aiua-5550	16	5	al	al	PROPN
aiua-5550	16	6	.	.	PROPN
aiua-5550	16	7	introduced	introduce	VERB
aiua-5550	16	8	the	the	DET
aiua-5550	16	9	term	term	NOUN
aiua-5550	16	10	prostatic	prostatic	ADJ
aiua-5550	16	11	-	-	PUNCT
aiua-5550	16	12	urethral	urethral	ADJ
aiua-5550	16	13	angulation	angulation	NOUN
aiua-5550	16	14	(	(	PUNCT
aiua-5550	16	15	pua	pua	PROPN
aiua-5550	16	16	)	)	PUNCT
aiua-5550	16	17	as	as	ADP
aiua-5550	16	18	a	a	DET
aiua-5550	16	19	new	new	ADJ
aiua-5550	16	20	measurement	measurement	NOUN
aiua-5550	16	21	that	that	PRON
aiua-5550	16	22	could	could	AUX
aiua-5550	16	23	be	be	AUX
aiua-5550	16	24	a	a	DET
aiua-5550	16	25	causal	causal	ADJ
aiua-5550	16	26	factor	factor	NOUN
aiua-5550	16	27	for	for	ADP
aiua-5550	16	28	bph	bph	NOUN
aiua-5550	16	29	(	(	PUNCT
aiua-5550	16	30	10	10	NUM
aiua-5550	16	31	)	)	PUNCT
aiua-5550	16	32	,	,	PUNCT
aiua-5550	16	33	and	and	CCONJ
aiua-5550	16	34	in	in	ADP
aiua-5550	16	35	their	their	PRON
aiua-5550	16	36	subsequent	subsequent	ADJ
aiua-5550	16	37	preliminary	preliminary	ADJ
aiua-5550	16	38	clinical	clinical	ADJ
aiua-5550	16	39	study	study	NOUN
aiua-5550	16	40	using	use	VERB
aiua-5550	16	41	the	the	DET
aiua-5550	16	42	fluid	fluid	ADJ
aiua-5550	16	43	dynamic	dynamic	ADJ
aiua-5550	16	44	model	model	NOUN
aiua-5550	16	45	,	,	PUNCT
aiua-5550	16	46	they	they	PRON
aiua-5550	16	47	reported	report	VERB
aiua-5550	16	48	that	that	SCONJ
aiua-5550	16	49	the	the	DET
aiua-5550	16	50	urinary	urinary	ADJ
aiua-5550	16	51	flow	flow	NOUN
aiua-5550	16	52	rate	rate	NOUN
aiua-5550	16	53	decreased	decrease	VERB
aiua-5550	16	54	by	by	ADP
aiua-5550	16	55	more	more	ADJ
aiua-5550	16	56	than	than	ADP
aiua-5550	16	57	27	27	NUM
aiua-5550	16	58	%	%	NOUN
aiua-5550	16	59	as	as	SCONJ
aiua-5550	16	60	the	the	DET
aiua-5550	16	61	pua	pua	PROPN
aiua-5550	16	62	increased	increase	VERB
aiua-5550	16	63	from	from	ADP
aiua-5550	16	64	35	35	NUM
aiua-5550	16	65	°	°	NOUN
aiua-5550	16	66	to	to	ADP
aiua-5550	16	67	90	90	NUM
aiua-5550	16	68	°	°	NOUN
aiua-5550	16	69	(	(	PUNCT
aiua-5550	16	70	11	11	NUM
aiua-5550	16	71	)	)	PUNCT
aiua-5550	16	72	.	.	PUNCT
aiua-5550	17	1	patients	patient	NOUN
aiua-5550	17	2	with	with	ADP
aiua-5550	17	3	pua	pua	PROPN
aiua-5550	17	4	≥	≥	NUM
aiua-5550	17	5	35	35	NUM
aiua-5550	17	6	°	°	PROPN
aiua-5550	17	7	had	have	VERB
aiua-5550	17	8	larger	large	ADJ
aiua-5550	17	9	prostate	prostate	NOUN
aiua-5550	17	10	volume	volume	NOUN
aiua-5550	17	11	and	and	CCONJ
aiua-5550	17	12	higher	high	ADJ
aiua-5550	17	13	boo	boo	NOUN
aiua-5550	17	14	index	index	NOUN
aiua-5550	17	15	,	,	PUNCT
aiua-5550	17	16	in	in	ADP
aiua-5550	17	17	comparison	comparison	NOUN
aiua-5550	17	18	with	with	ADP
aiua-5550	17	19	those	those	PRON
aiua-5550	17	20	who	who	PRON
aiua-5550	17	21	had	have	VERB
aiua-5550	17	22	pua	pua	PROPN
aiua-5550	17	23	<	<	X
aiua-5550	17	24	35	35	NUM
aiua-5550	17	25	°	°	NOUN
aiua-5550	17	26	(	(	PUNCT
aiua-5550	17	27	12	12	NUM
aiua-5550	17	28	)	)	PUNCT
aiua-5550	17	29	.	.	PUNCT
aiua-5550	18	1	further	further	ADJ
aiua-5550	18	2	studies	study	NOUN
aiua-5550	18	3	showed	show	VERB
aiua-5550	18	4	that	that	SCONJ
aiua-5550	18	5	the	the	DET
aiua-5550	18	6	pua	pua	PROPN
aiua-5550	18	7	is	be	AUX
aiua-5550	18	8	significantly	significantly	ADV
aiua-5550	18	9	associated	associate	VERB
aiua-5550	18	10	with	with	ADP
aiua-5550	18	11	maximum	maximum	ADJ
aiua-5550	18	12	flow	flow	NOUN
aiua-5550	18	13	rate	rate	NOUN
aiua-5550	18	14	(	(	PUNCT
aiua-5550	18	15	qmax	qmax	PROPN
aiua-5550	18	16	)	)	PUNCT
aiua-5550	18	17	and	and	CCONJ
aiua-5550	18	18	voiding	void	VERB
aiua-5550	18	19	symptom	symptom	NOUN
aiua-5550	18	20	scores	score	NOUN
aiua-5550	18	21	in	in	ADP
aiua-5550	18	22	men	man	NOUN
aiua-5550	18	23	with	with	ADP
aiua-5550	18	24	luts	luts	PROPN
aiua-5550	18	25	(	(	PUNCT
aiua-5550	18	26	13	13	NUM
aiua-5550	18	27	-	-	SYM
aiua-5550	18	28	14	14	NUM
aiua-5550	18	29	)	)	PUNCT
aiua-5550	18	30	.	.	PUNCT
aiua-5550	19	1	in	in	ADP
aiua-5550	19	2	terms	term	NOUN
aiua-5550	19	3	of	of	ADP
aiua-5550	19	4	medical	medical	ADJ
aiua-5550	19	5	therapy	therapy	NOUN
aiua-5550	19	6	for	for	ADP
aiua-5550	19	7	bph	bph	NOUN
aiua-5550	19	8	several	several	ADJ
aiua-5550	19	9	drugs	drug	NOUN
aiua-5550	19	10	are	be	AUX
aiua-5550	19	11	widely	widely	ADV
aiua-5550	19	12	distributed	distribute	VERB
aiua-5550	19	13	in	in	ADP
aiua-5550	19	14	the	the	DET
aiua-5550	19	15	market	market	NOUN
aiua-5550	19	16	and	and	CCONJ
aiua-5550	19	17	selective	selective	ADJ
aiua-5550	19	18	α1	α1	NOUN
aiua-5550	19	19	-	-	PUNCT
aiua-5550	19	20	blocker	blocker	NOUN
aiua-5550	19	21	is	be	AUX
aiua-5550	19	22	the	the	DET
aiua-5550	19	23	recommended	recommend	VERB
aiua-5550	19	24	treatment	treatment	NOUN
aiua-5550	19	25	(	(	PUNCT
aiua-5550	19	26	15	15	NUM
aiua-5550	19	27	)	)	PUNCT
aiua-5550	19	28	.	.	PUNCT
aiua-5550	20	1	tamsulosin	tamsulosin	NOUN
aiua-5550	20	2	hydrochloride	hydrochloride	NOUN
aiua-5550	20	3	is	be	AUX
aiua-5550	20	4	a	a	DET
aiua-5550	20	5	highly	highly	ADV
aiua-5550	20	6	selective	selective	ADJ
aiua-5550	20	7	α1a	α1a	NOUN
aiua-5550	20	8	-	-	NOUN
aiua-5550	20	9	blocker	blocker	NOUN
aiua-5550	20	10	that	that	PRON
aiua-5550	20	11	is	be	AUX
aiua-5550	20	12	currently	currently	ADV
aiua-5550	20	13	used	use	VERB
aiua-5550	20	14	and	and	CCONJ
aiua-5550	20	15	proved	prove	VERB
aiua-5550	20	16	to	to	PART
aiua-5550	20	17	be	be	AUX
aiua-5550	20	18	effective	effective	ADJ
aiua-5550	20	19	and	and	CCONJ
aiua-5550	20	20	safe	safe	ADJ
aiua-5550	20	21	in	in	ADP
aiua-5550	20	22	treatment	treatment	NOUN
aiua-5550	20	23	of	of	ADP
aiua-5550	20	24	symptomatic	symptomatic	ADJ
aiua-5550	20	25	bph	bph	NOUN
aiua-5550	20	26	alone	alone	ADJ
aiua-5550	20	27	or	or	CCONJ
aiua-5550	20	28	in	in	ADP
aiua-5550	20	29	combination	combination	NOUN
aiua-5550	20	30	with	with	ADP
aiua-5550	20	31	other	other	ADJ
aiua-5550	20	32	drugs	drug	NOUN
aiua-5550	20	33	(	(	PUNCT
aiua-5550	20	34	16	16	NUM
aiua-5550	20	35	)	)	PUNCT
aiua-5550	20	36	.	.	PUNCT
aiua-5550	21	1	the	the	DET
aiua-5550	21	2	effect	effect	NOUN
aiua-5550	21	3	of	of	ADP
aiua-5550	21	4	pua	pua	NOUN
aiua-5550	21	5	on	on	ADP
aiua-5550	21	6	the	the	DET
aiua-5550	21	7	treatment	treatment	NOUN
aiua-5550	21	8	outcome	outcome	NOUN
aiua-5550	21	9	of	of	ADP
aiua-5550	21	10	tamsulosin	tamsulosin	NOUN
aiua-5550	21	11	hydrochloride	hydrochloride	NOUN
aiua-5550	21	12	on	on	ADP
aiua-5550	21	13	men	man	NOUN
aiua-5550	21	14	with	with	ADP
aiua-5550	21	15	luts	luts	PROPN
aiua-5550	21	16	was	be	AUX
aiua-5550	21	17	first	first	ADV
aiua-5550	21	18	evaluated	evaluate	VERB
aiua-5550	21	19	and	and	CCONJ
aiua-5550	21	20	pua	pua	PROPN
aiua-5550	21	21	was	be	AUX
aiua-5550	21	22	inversely	inversely	ADV
aiua-5550	21	23	correlated	correlate	VERB
aiua-5550	21	24	with	with	ADP
aiua-5550	21	25	changes	change	NOUN
aiua-5550	21	26	in	in	ADP
aiua-5550	21	27	qmax	qmax	NOUN
aiua-5550	21	28	and	and	CCONJ
aiua-5550	21	29	symptoms	symptom	NOUN
aiua-5550	21	30	score	score	VERB
aiua-5550	21	31	after	after	ADP
aiua-5550	21	32	treatment	treatment	NOUN
aiua-5550	21	33	(	(	PUNCT
aiua-5550	21	34	17	17	NUM
aiua-5550	21	35	)	)	PUNCT
aiua-5550	21	36	.	.	PUNCT
aiua-5550	22	1	the	the	DET
aiua-5550	22	2	aim	aim	NOUN
aiua-5550	22	3	of	of	ADP
aiua-5550	22	4	the	the	DET
aiua-5550	22	5	present	present	ADJ
aiua-5550	22	6	study	study	NOUN
aiua-5550	22	7	is	be	AUX
aiua-5550	22	8	to	to	PART
aiua-5550	22	9	evaluate	evaluate	VERB
aiua-5550	22	10	the	the	DET
aiua-5550	22	11	clinical	clinical	ADJ
aiua-5550	22	12	outcome	outcome	NOUN
aiua-5550	22	13	of	of	ADP
aiua-5550	22	14	medical	medical	ADJ
aiua-5550	22	15	treatment	treatment	NOUN
aiua-5550	22	16	(	(	PUNCT
aiua-5550	22	17	by	by	ADP
aiua-5550	22	18	selective	selective	ADJ
aiua-5550	22	19	α1a	α1a	PROPN
aiua-5550	22	20	-	-	NOUN
aiua-5550	22	21	blocker	blocker	NOUN
aiua-5550	22	22	)	)	PUNCT
aiua-5550	22	23	on	on	ADP
aiua-5550	22	24	male	male	ADJ
aiua-5550	22	25	patients	patient	NOUN
aiua-5550	22	26	presented	present	VERB
aiua-5550	22	27	with	with	ADP
aiua-5550	22	28	luts	luts	PROPN
aiua-5550	22	29	/	/	SYM
aiua-5550	22	30	bph	bph	NOUN
aiua-5550	22	31	and	and	CCONJ
aiua-5550	22	32	its	its	PRON
aiua-5550	22	33	correlation	correlation	NOUN
aiua-5550	22	34	to	to	ADP
aiua-5550	22	35	the	the	DET
aiua-5550	22	36	degree	degree	NOUN
aiua-5550	22	37	of	of	ADP
aiua-5550	22	38	pua	pua	PROPN
aiua-5550	22	39	.	.	PUNCT
aiua-5550	23	1	patients	patient	NOUN
aiua-5550	23	2	and	and	CCONJ
aiua-5550	23	3	methods	method	NOUN
aiua-5550	23	4	this	this	DET
aiua-5550	23	5	prospective	prospective	ADJ
aiua-5550	23	6	comparative	comparative	ADJ
aiua-5550	23	7	study	study	NOUN
aiua-5550	23	8	was	be	AUX
aiua-5550	23	9	conducted	conduct	VERB
aiua-5550	23	10	at	at	ADP
aiua-5550	23	11	our	our	PRON
aiua-5550	23	12	outpatient	outpatient	NOUN
aiua-5550	23	13	clinic	clinic	NOUN
aiua-5550	23	14	of	of	ADP
aiua-5550	23	15	the	the	DET
aiua-5550	23	16	urology	urology	NOUN
aiua-5550	23	17	department	department	NOUN
aiua-5550	23	18	in	in	ADP
aiua-5550	23	19	the	the	DET
aiua-5550	23	20	doi	doi	NOUN
aiua-5550	23	21	:	:	PUNCT
aiua-5550	23	22	10.4081	10.4081	NUM
aiua-5550	23	23	/	/	SYM
aiua-5550	23	24	aiua.2015.3.238	aiua.2015.3.238	NOUN
aiua-5550	23	25	introduction	introduction	NOUN
aiua-5550	23	26	benign	benign	ADJ
aiua-5550	23	27	prostatic	prostatic	ADJ
aiua-5550	23	28	hyperplasia	hyperplasia	NOUN
aiua-5550	23	29	(	(	PUNCT
aiua-5550	23	30	bph	bph	NOUN
aiua-5550	23	31	)	)	PUNCT
aiua-5550	23	32	is	be	AUX
aiua-5550	23	33	one	one	NUM
aiua-5550	23	34	of	of	ADP
aiua-5550	23	35	the	the	DET
aiua-5550	23	36	most	most	ADV
aiua-5550	23	37	common	common	ADJ
aiua-5550	23	38	health	health	NOUN
aiua-5550	23	39	problems	problem	NOUN
aiua-5550	23	40	affecting	affect	VERB
aiua-5550	23	41	the	the	DET
aiua-5550	23	42	aging	age	VERB
aiua-5550	23	43	males	male	NOUN
aiua-5550	23	44	.	.	PUNCT
aiua-5550	24	1	it	it	PRON
aiua-5550	24	2	affects	affect	VERB
aiua-5550	24	3	more	more	ADJ
aiua-5550	24	4	than	than	ADP
aiua-5550	24	5	200	200	NUM
aiua-5550	24	6	million	million	NUM
aiua-5550	24	7	males	male	NOUN
aiua-5550	24	8	globally	globally	ADV
aiua-5550	24	9	(	(	PUNCT
aiua-5550	24	10	1	1	NUM
aiua-5550	24	11	)	)	PUNCT
aiua-5550	24	12	.	.	PUNCT
aiua-5550	25	1	lower	low	ADJ
aiua-5550	25	2	urinary	urinary	ADJ
aiua-5550	25	3	tract	tract	NOUN
aiua-5550	25	4	symptoms	symptom	NOUN
aiua-5550	25	5	(	(	PUNCT
aiua-5550	25	6	luts	luts	PROPN
aiua-5550	25	7	)	)	PUNCT
aiua-5550	25	8	secondary	secondary	ADJ
aiua-5550	25	9	to	to	ADP
aiua-5550	25	10	bph	bph	NOUN
aiua-5550	25	11	(	(	PUNCT
aiua-5550	25	12	luts	luts	PROPN
aiua-5550	25	13	/	/	SYM
aiua-5550	25	14	bph	bph	NOUN
aiua-5550	25	15	)	)	PUNCT
aiua-5550	25	16	are	be	AUX
aiua-5550	25	17	bothersome	bothersome	ADJ
aiua-5550	25	18	symptoms	symptom	NOUN
aiua-5550	25	19	which	which	PRON
aiua-5550	25	20	have	have	VERB
aiua-5550	25	21	a	a	DET
aiua-5550	25	22	negative	negative	ADJ
aiua-5550	25	23	impact	impact	NOUN
aiua-5550	25	24	on	on	ADP
aiua-5550	25	25	men	man	NOUN
aiua-5550	25	26	's	's	PART
aiua-5550	25	27	quality	quality	NOUN
aiua-5550	25	28	of	of	ADP
aiua-5550	25	29	life	life	NOUN
aiua-5550	25	30	(	(	PUNCT
aiua-5550	25	31	qol	qol	NOUN
aiua-5550	25	32	)	)	PUNCT
aiua-5550	25	33	.	.	PUNCT
aiua-5550	26	1	ali	ali	PROPN
aiua-5550	26	2	raheem_stesura	raheem_stesura	PROPN
aiua-5550	26	3	seveso	seveso	VERB
aiua-5550	27	1	30/09/15	30/09/15	PROPN
aiua-5550	27	2	09:38	09:38	NUM
aiua-5550	27	3	pagina	pagina	NOUN
aiua-5550	27	4	238	238	NUM
aiua-5550	27	5	239archivio	239archivio	PROPN
aiua-5550	27	6	italiano	italiano	NOUN
aiua-5550	27	7	di	di	X
aiua-5550	27	8	urologia	urologia	PROPN
aiua-5550	27	9	e	e	PROPN
aiua-5550	27	10	andrologia	andrologia	NOUN
aiua-5550	27	11	2015	2015	NUM
aiua-5550	27	12	;	;	PUNCT
aiua-5550	27	13	87	87	NUM
aiua-5550	27	14	,	,	PUNCT
aiua-5550	27	15	3	3	NUM
aiua-5550	27	16	impact	impact	NOUN
aiua-5550	27	17	of	of	ADP
aiua-5550	27	18	prostatic	prostatic	ADJ
aiua-5550	27	19	-	-	PUNCT
aiua-5550	27	20	urethral	urethral	ADJ
aiua-5550	27	21	angulation	angulation	NOUN
aiua-5550	27	22	on	on	ADP
aiua-5550	27	23	treatment	treatment	NOUN
aiua-5550	27	24	of	of	ADP
aiua-5550	27	25	bph	bph	NOUN
aiua-5550	27	26	period	period	NOUN
aiua-5550	27	27	between	between	ADP
aiua-5550	27	28	october	october	PROPN
aiua-5550	27	29	2012	2012	NUM
aiua-5550	27	30	and	and	CCONJ
aiua-5550	27	31	october	october	PROPN
aiua-5550	27	32	2014	2014	NUM
aiua-5550	27	33	.	.	PUNCT
aiua-5550	28	1	the	the	DET
aiua-5550	28	2	study	study	NOUN
aiua-5550	28	3	was	be	AUX
aiua-5550	28	4	approved	approve	VERB
aiua-5550	28	5	from	from	ADP
aiua-5550	28	6	our	our	PRON
aiua-5550	28	7	ethical	ethical	ADJ
aiua-5550	28	8	committee	committee	NOUN
aiua-5550	28	9	and	and	CCONJ
aiua-5550	28	10	an	an	DET
aiua-5550	28	11	informed	informed	ADJ
aiua-5550	28	12	consent	consent	NOUN
aiua-5550	28	13	was	be	AUX
aiua-5550	28	14	taken	take	VERB
aiua-5550	28	15	from	from	ADP
aiua-5550	28	16	all	all	DET
aiua-5550	28	17	patients	patient	NOUN
aiua-5550	28	18	before	before	ADP
aiua-5550	28	19	the	the	DET
aiua-5550	28	20	start	start	NOUN
aiua-5550	28	21	of	of	ADP
aiua-5550	28	22	the	the	DET
aiua-5550	28	23	study	study	NOUN
aiua-5550	28	24	.	.	PUNCT
aiua-5550	29	1	we	we	PRON
aiua-5550	29	2	included	include	VERB
aiua-5550	29	3	male	male	ADJ
aiua-5550	29	4	patients	patient	NOUN
aiua-5550	29	5	aged	age	VERB
aiua-5550	29	6	≥	≥	NUM
aiua-5550	29	7	40	40	NUM
aiua-5550	29	8	years	year	NOUN
aiua-5550	29	9	and	and	CCONJ
aiua-5550	29	10	<	<	X
aiua-5550	29	11	70	70	NUM
aiua-5550	29	12	years	year	NOUN
aiua-5550	29	13	who	who	PRON
aiua-5550	29	14	presented	present	VERB
aiua-5550	29	15	with	with	ADP
aiua-5550	29	16	luts	luts	PROPN
aiua-5550	29	17	/	/	SYM
aiua-5550	29	18	bph	bph	NOUN
aiua-5550	29	19	for	for	ADP
aiua-5550	29	20	at	at	ADV
aiua-5550	29	21	least	least	ADV
aiua-5550	29	22	6	6	NUM
aiua-5550	29	23	months	month	NOUN
aiua-5550	29	24	and	and	CCONJ
aiua-5550	29	25	who	who	PRON
aiua-5550	29	26	did	do	AUX
aiua-5550	29	27	not	not	PART
aiua-5550	29	28	receive	receive	VERB
aiua-5550	29	29	any	any	DET
aiua-5550	29	30	medical	medical	ADJ
aiua-5550	29	31	treatment	treatment	NOUN
aiua-5550	29	32	for	for	ADP
aiua-5550	29	33	bph	bph	NOUN
aiua-5550	29	34	before	before	ADV
aiua-5550	29	35	.	.	PUNCT
aiua-5550	30	1	we	we	PRON
aiua-5550	30	2	excluded	exclude	VERB
aiua-5550	30	3	patients	patient	NOUN
aiua-5550	30	4	with	with	ADP
aiua-5550	30	5	suspicious	suspicious	ADJ
aiua-5550	30	6	hypersensitivity	hypersensitivity	NOUN
aiua-5550	30	7	to	to	ADP
aiua-5550	30	8	alpha	alpha	NOUN
aiua-5550	30	9	blockers	blocker	NOUN
aiua-5550	30	10	,	,	PUNCT
aiua-5550	30	11	a	a	DET
aiua-5550	30	12	disease	disease	NOUN
aiua-5550	30	13	causing	cause	VERB
aiua-5550	30	14	luts	lut	NOUN
aiua-5550	30	15	such	such	ADJ
aiua-5550	30	16	as	as	ADP
aiua-5550	30	17	(	(	PUNCT
aiua-5550	30	18	urinary	urinary	ADJ
aiua-5550	30	19	calculi	calculi	NOUN
aiua-5550	30	20	,	,	PUNCT
aiua-5550	30	21	urethral	urethral	ADJ
aiua-5550	30	22	stricture	stricture	NOUN
aiua-5550	30	23	,	,	PUNCT
aiua-5550	30	24	urinary	urinary	ADJ
aiua-5550	30	25	tract	tract	NOUN
aiua-5550	30	26	infection	infection	NOUN
aiua-5550	30	27	,	,	PUNCT
aiua-5550	30	28	primary	primary	ADJ
aiua-5550	30	29	renal	renal	ADJ
aiua-5550	30	30	disease	disease	NOUN
aiua-5550	30	31	,	,	PUNCT
aiua-5550	30	32	neurogenic	neurogenic	ADJ
aiua-5550	30	33	bladder	bladder	NOUN
aiua-5550	30	34	,	,	PUNCT
aiua-5550	30	35	prostatitis	prostatitis	NOUN
aiua-5550	30	36	)	)	PUNCT
aiua-5550	30	37	,	,	PUNCT
aiua-5550	30	38	associated	associate	VERB
aiua-5550	30	39	co	co	NOUN
aiua-5550	30	40	-	-	NOUN
aiua-5550	30	41	morbidities	morbidity	NOUN
aiua-5550	30	42	such	such	ADJ
aiua-5550	30	43	as	as	ADP
aiua-5550	30	44	uncontrolled	uncontrolled	ADJ
aiua-5550	30	45	diabetes	diabetes	NOUN
aiua-5550	30	46	mellitus	mellitus	NOUN
aiua-5550	30	47	,	,	PUNCT
aiua-5550	30	48	a	a	DET
aiua-5550	30	49	history	history	NOUN
aiua-5550	30	50	of	of	ADP
aiua-5550	30	51	bladder	bladder	NOUN
aiua-5550	30	52	or	or	CCONJ
aiua-5550	30	53	prostate	prostate	NOUN
aiua-5550	30	54	carcinoma	carcinoma	NOUN
aiua-5550	30	55	,	,	PUNCT
aiua-5550	30	56	previous	previous	ADJ
aiua-5550	30	57	lower	low	ADJ
aiua-5550	30	58	urinary	urinary	ADJ
aiua-5550	30	59	tract	tract	NOUN
aiua-5550	30	60	surgery	surgery	NOUN
aiua-5550	30	61	,	,	PUNCT
aiua-5550	30	62	renal	renal	ADJ
aiua-5550	30	63	impairment	impairment	NOUN
aiua-5550	30	64	,	,	PUNCT
aiua-5550	30	65	serum	serum	NOUN
aiua-5550	30	66	psa	psa	VERB
aiua-5550	30	67	≥	≥	NUM
aiua-5550	30	68	4	4	NUM
aiua-5550	30	69	ng	ng	PROPN
aiua-5550	30	70	/	/	SYM
aiua-5550	30	71	ml	ml	PROPN
aiua-5550	30	72	and	and	CCONJ
aiua-5550	30	73	a	a	DET
aiua-5550	30	74	post	post	ADJ
aiua-5550	30	75	-	-	ADJ
aiua-5550	30	76	void	void	ADJ
aiua-5550	30	77	residual	residual	ADJ
aiua-5550	30	78	(	(	PUNCT
aiua-5550	30	79	pvr	pvr	NOUN
aiua-5550	30	80	)	)	PUNCT
aiua-5550	30	81	urine	urine	NOUN
aiua-5550	30	82	volume	volume	NOUN
aiua-5550	30	83	>	>	X
aiua-5550	30	84	150	150	NUM
aiua-5550	30	85	ml	ml	NOUN
aiua-5550	30	86	.	.	PUNCT
aiua-5550	31	1	all	all	DET
aiua-5550	31	2	patients	patient	NOUN
aiua-5550	31	3	were	be	AUX
aiua-5550	31	4	evaluated	evaluate	VERB
aiua-5550	31	5	through	through	ADP
aiua-5550	31	6	detailed	detailed	ADJ
aiua-5550	31	7	history	history	NOUN
aiua-5550	31	8	,	,	PUNCT
aiua-5550	31	9	full	full	ADJ
aiua-5550	31	10	physical	physical	ADJ
aiua-5550	31	11	examination	examination	NOUN
aiua-5550	31	12	including	include	VERB
aiua-5550	31	13	digital	digital	ADJ
aiua-5550	31	14	rectal	rectal	ADJ
aiua-5550	31	15	examination	examination	NOUN
aiua-5550	31	16	and	and	CCONJ
aiua-5550	31	17	neurological	neurological	ADJ
aiua-5550	31	18	examination	examination	NOUN
aiua-5550	31	19	.	.	PUNCT
aiua-5550	32	1	the	the	DET
aiua-5550	32	2	international	international	ADJ
aiua-5550	32	3	prostate	prostate	NOUN
aiua-5550	32	4	symptom	symptom	NOUN
aiua-5550	32	5	score	score	NOUN
aiua-5550	32	6	and	and	CCONJ
aiua-5550	32	7	quality	quality	NOUN
aiua-5550	32	8	of	of	ADP
aiua-5550	32	9	life	life	NOUN
aiua-5550	32	10	score	score	NOUN
aiua-5550	32	11	(	(	PUNCT
aiua-5550	32	12	ipss	ipss	PROPN
aiua-5550	32	13	/	/	SYM
aiua-5550	32	14	qol	qol	PROPN
aiua-5550	32	15	score	score	NOUN
aiua-5550	32	16	)	)	PUNCT
aiua-5550	32	17	were	be	AUX
aiua-5550	32	18	estimated	estimate	VERB
aiua-5550	32	19	for	for	ADP
aiua-5550	32	20	each	each	DET
aiua-5550	32	21	patient	patient	NOUN
aiua-5550	32	22	and	and	CCONJ
aiua-5550	32	23	ipss	ipss	PROPN
aiua-5550	32	24	score	score	NOUN
aiua-5550	32	25	was	be	AUX
aiua-5550	32	26	subdivided	subdivide	VERB
aiua-5550	32	27	according	accord	VERB
aiua-5550	32	28	to	to	ADP
aiua-5550	32	29	storage	storage	NOUN
aiua-5550	32	30	symptoms	symptom	NOUN
aiua-5550	32	31	subscore	subscore	ADV
aiua-5550	32	32	and	and	CCONJ
aiua-5550	32	33	voiding	void	VERB
aiua-5550	32	34	symptoms	symptom	NOUN
aiua-5550	32	35	subscore	subscore	ADJ
aiua-5550	32	36	.	.	PUNCT
aiua-5550	33	1	laboratory	laboratory	NOUN
aiua-5550	33	2	investigations	investigation	NOUN
aiua-5550	33	3	included	include	VERB
aiua-5550	33	4	urine	urine	NOUN
aiua-5550	33	5	analysis	analysis	NOUN
aiua-5550	33	6	,	,	PUNCT
aiua-5550	33	7	fasting	fast	VERB
aiua-5550	33	8	blood	blood	NOUN
aiua-5550	33	9	glucose	glucose	NOUN
aiua-5550	33	10	level	level	NOUN
aiua-5550	33	11	,	,	PUNCT
aiua-5550	33	12	serum	serum	NOUN
aiua-5550	33	13	creatinine	creatinine	NOUN
aiua-5550	33	14	and	and	CCONJ
aiua-5550	33	15	serum	serum	NOUN
aiua-5550	33	16	prostate	prostate	NOUN
aiua-5550	33	17	-	-	PUNCT
aiua-5550	33	18	specific	specific	ADJ
aiua-5550	33	19	antigen	antigen	NOUN
aiua-5550	33	20	(	(	PUNCT
aiua-5550	33	21	psa	psa	NOUN
aiua-5550	33	22	)	)	PUNCT
aiua-5550	33	23	.	.	PUNCT
aiua-5550	34	1	all	all	DET
aiua-5550	34	2	patients	patient	NOUN
aiua-5550	34	3	underwent	undergo	VERB
aiua-5550	34	4	transrectal	transrectal	ADJ
aiua-5550	34	5	ultrasound	ultrasound	NOUN
aiua-5550	34	6	by	by	ADP
aiua-5550	34	7	the	the	DET
aiua-5550	34	8	same	same	ADJ
aiua-5550	34	9	radiologist	radiologist	NOUN
aiua-5550	34	10	to	to	PART
aiua-5550	34	11	assess	assess	VERB
aiua-5550	34	12	the	the	DET
aiua-5550	34	13	degree	degree	NOUN
aiua-5550	34	14	of	of	ADP
aiua-5550	34	15	pua	pua	NOUN
aiua-5550	34	16	and	and	CCONJ
aiua-5550	34	17	total	total	ADJ
aiua-5550	34	18	prostate	prostate	NOUN
aiua-5550	34	19	volume	volume	NOUN
aiua-5550	34	20	(	(	PUNCT
aiua-5550	34	21	tpv	tpv	PROPN
aiua-5550	34	22	)	)	PUNCT
aiua-5550	34	23	.	.	PUNCT
aiua-5550	35	1	we	we	PRON
aiua-5550	35	2	used	use	VERB
aiua-5550	35	3	gevoluson	gevoluson	PROPN
aiua-5550	35	4	e8	e8	PROPN
aiua-5550	35	5	ultrasound	ultrasound	PROPN
aiua-5550	35	6	machine	machine	NOUN
aiua-5550	35	7	(	(	PUNCT
aiua-5550	35	8	8	8	NUM
aiua-5550	35	9	mhz	mhz	NOUN
aiua-5550	35	10	,	,	PUNCT
aiua-5550	35	11	general	general	ADJ
aiua-5550	35	12	electric	electric	ADJ
aiua-5550	35	13	company	company	NOUN
aiua-5550	35	14	,	,	PUNCT
aiua-5550	35	15	usa	usa	PROPN
aiua-5550	35	16	)	)	PUNCT
aiua-5550	35	17	,	,	PUNCT
aiua-5550	35	18	the	the	DET
aiua-5550	35	19	patient	patient	NOUN
aiua-5550	35	20	was	be	AUX
aiua-5550	35	21	placed	place	VERB
aiua-5550	35	22	in	in	ADP
aiua-5550	35	23	right	right	ADJ
aiua-5550	35	24	sided	sided	ADJ
aiua-5550	35	25	raised	raise	VERB
aiua-5550	35	26	position	position	NOUN
aiua-5550	35	27	and	and	CCONJ
aiua-5550	35	28	anal	anal	ADJ
aiua-5550	35	29	dilatation	dilatation	NOUN
aiua-5550	35	30	was	be	AUX
aiua-5550	35	31	done	do	VERB
aiua-5550	35	32	before	before	ADP
aiua-5550	35	33	insertion	insertion	NOUN
aiua-5550	35	34	of	of	ADP
aiua-5550	35	35	the	the	DET
aiua-5550	35	36	rectal	rectal	ADJ
aiua-5550	35	37	probe	probe	NOUN
aiua-5550	35	38	.	.	PUNCT
aiua-5550	36	1	we	we	PRON
aiua-5550	36	2	acquired	acquire	VERB
aiua-5550	36	3	b	b	NUM
aiua-5550	36	4	-	-	PUNCT
aiua-5550	36	5	mode	mode	NOUN
aiua-5550	36	6	picture	picture	NOUN
aiua-5550	36	7	to	to	PART
aiua-5550	36	8	locate	locate	VERB
aiua-5550	36	9	the	the	DET
aiua-5550	36	10	longitudinal	longitudinal	ADJ
aiua-5550	36	11	section	section	NOUN
aiua-5550	36	12	for	for	ADP
aiua-5550	36	13	the	the	DET
aiua-5550	36	14	prostate	prostate	NOUN
aiua-5550	36	15	and	and	CCONJ
aiua-5550	36	16	choose	choose	VERB
aiua-5550	36	17	the	the	DET
aiua-5550	36	18	generic	generic	ADJ
aiua-5550	36	19	angle	angle	NOUN
aiua-5550	36	20	and	and	CCONJ
aiua-5550	36	21	caliber	caliber	NOUN
aiua-5550	36	22	lists	list	NOUN
aiua-5550	36	23	(	(	PUNCT
aiua-5550	36	24	from	from	ADP
aiua-5550	36	25	the	the	DET
aiua-5550	36	26	keyboard	keyboard	NOUN
aiua-5550	36	27	of	of	ADP
aiua-5550	36	28	the	the	DET
aiua-5550	36	29	apparatus	apparatus	NOUN
aiua-5550	36	30	)	)	PUNCT
aiua-5550	36	31	.	.	PUNCT
aiua-5550	37	1	a	a	DET
aiua-5550	37	2	line	line	NOUN
aiua-5550	37	3	was	be	AUX
aiua-5550	37	4	drawn	draw	VERB
aiua-5550	37	5	passing	pass	VERB
aiua-5550	37	6	longitudinally	longitudinally	ADV
aiua-5550	37	7	through	through	ADP
aiua-5550	37	8	the	the	DET
aiua-5550	37	9	proximal	proximal	ADJ
aiua-5550	37	10	part	part	NOUN
aiua-5550	37	11	of	of	ADP
aiua-5550	37	12	prostatic	prostatic	ADJ
aiua-5550	37	13	urethra	urethra	NOUN
aiua-5550	37	14	and	and	CCONJ
aiua-5550	37	15	another	another	DET
aiua-5550	37	16	line	line	NOUN
aiua-5550	37	17	passing	pass	VERB
aiua-5550	37	18	longitudinally	longitudinally	ADV
aiua-5550	37	19	through	through	ADP
aiua-5550	37	20	the	the	DET
aiua-5550	37	21	distal	distal	ADJ
aiua-5550	37	22	part	part	NOUN
aiua-5550	37	23	of	of	ADP
aiua-5550	37	24	prostatic	prostatic	ADJ
aiua-5550	37	25	urethra	urethra	NOUN
aiua-5550	37	26	.	.	PUNCT
aiua-5550	38	1	the	the	DET
aiua-5550	38	2	angle	angle	NOUN
aiua-5550	38	3	between	between	ADP
aiua-5550	38	4	the	the	DET
aiua-5550	38	5	two	two	NUM
aiua-5550	38	6	lines	line	NOUN
aiua-5550	38	7	represents	represent	VERB
aiua-5550	38	8	the	the	DET
aiua-5550	38	9	pua	pua	PROPN
aiua-5550	38	10	(	(	PUNCT
aiua-5550	38	11	figure	figure	NOUN
aiua-5550	38	12	1	1	NUM
aiua-5550	38	13	)	)	PUNCT
aiua-5550	38	14	.	.	PUNCT
aiua-5550	39	1	the	the	DET
aiua-5550	39	2	tpv	tpv	PROPN
aiua-5550	39	3	was	be	AUX
aiua-5550	39	4	determined	determine	VERB
aiua-5550	39	5	by	by	ADP
aiua-5550	39	6	measuring	measure	VERB
aiua-5550	39	7	the	the	DET
aiua-5550	39	8	length	length	NOUN
aiua-5550	39	9	,	,	PUNCT
aiua-5550	39	10	height	height	NOUN
aiua-5550	39	11	,	,	PUNCT
aiua-5550	39	12	and	and	CCONJ
aiua-5550	39	13	width	width	NOUN
aiua-5550	39	14	of	of	ADP
aiua-5550	39	15	the	the	DET
aiua-5550	39	16	whole	whole	ADJ
aiua-5550	39	17	prostate	prostate	NOUN
aiua-5550	39	18	in	in	ADP
aiua-5550	39	19	both	both	PRON
aiua-5550	39	20	transverse	transverse	NOUN
aiua-5550	39	21	and	and	CCONJ
aiua-5550	39	22	axial	axial	ADJ
aiua-5550	39	23	sections	section	NOUN
aiua-5550	39	24	using	use	VERB
aiua-5550	39	25	the	the	DET
aiua-5550	39	26	formula	formula	NOUN
aiua-5550	39	27	(	(	PUNCT
aiua-5550	39	28	length	length	NOUN
aiua-5550	39	29	×	×	NOUN
aiua-5550	39	30	width	width	NOUN
aiua-5550	39	31	×	×	NOUN
aiua-5550	39	32	height	height	NOUN
aiua-5550	39	33	×	×	NOUN
aiua-5550	39	34	0.52	0.52	NUM
aiua-5550	39	35	)	)	PUNCT
aiua-5550	39	36	.	.	PUNCT
aiua-5550	40	1	uroflowmetry	uroflowmetry	NOUN
aiua-5550	40	2	was	be	AUX
aiua-5550	40	3	performed	perform	VERB
aiua-5550	40	4	for	for	ADP
aiua-5550	40	5	all	all	DET
aiua-5550	40	6	patients	patient	NOUN
aiua-5550	40	7	(	(	PUNCT
aiua-5550	40	8	at	at	ADP
aiua-5550	40	9	least	least	ADJ
aiua-5550	40	10	2	2	NUM
aiua-5550	40	11	voids	void	NOUN
aiua-5550	40	12	with	with	ADP
aiua-5550	40	13	minimum	minimum	NOUN
aiua-5550	40	14	voided	void	VERB
aiua-5550	40	15	volume	volume	NOUN
aiua-5550	40	16	=	=	NOUN
aiua-5550	40	17	150	150	NUM
aiua-5550	40	18	ml	ml	NOUN
aiua-5550	40	19	)	)	PUNCT
aiua-5550	40	20	,	,	PUNCT
aiua-5550	40	21	pvr	pvr	NOUN
aiua-5550	40	22	urine	urine	NOUN
aiua-5550	40	23	was	be	AUX
aiua-5550	40	24	measured	measure	VERB
aiua-5550	40	25	using	use	VERB
aiua-5550	40	26	bladder	bladder	NOUN
aiua-5550	40	27	scan	scan	NOUN
aiua-5550	40	28	after	after	ADP
aiua-5550	40	29	micturition	micturition	NOUN
aiua-5550	40	30	using	use	VERB
aiua-5550	40	31	the	the	DET
aiua-5550	40	32	formula	formula	NOUN
aiua-5550	40	33	(	(	PUNCT
aiua-5550	40	34	length	length	NOUN
aiua-5550	40	35	×	×	NOUN
aiua-5550	40	36	width	width	NOUN
aiua-5550	40	37	×	×	NOUN
aiua-5550	40	38	height	height	NOUN
aiua-5550	40	39	×	×	NOUN
aiua-5550	40	40	0.7	0.7	NUM
aiua-5550	40	41	)	)	PUNCT
aiua-5550	40	42	.	.	PUNCT
aiua-5550	41	1	patients	patient	NOUN
aiua-5550	41	2	were	be	AUX
aiua-5550	41	3	classified	classify	VERB
aiua-5550	41	4	into	into	ADP
aiua-5550	41	5	two	two	NUM
aiua-5550	41	6	groups	group	NOUN
aiua-5550	41	7	as	as	ADP
aiua-5550	41	8	consecutive	consecutive	ADJ
aiua-5550	41	9	cases	case	NOUN
aiua-5550	41	10	according	accord	VERB
aiua-5550	41	11	to	to	ADP
aiua-5550	41	12	the	the	DET
aiua-5550	41	13	pua	pua	NOUN
aiua-5550	41	14	:	:	PUNCT
aiua-5550	41	15	group	group	NOUN
aiua-5550	41	16	a	a	X
aiua-5550	41	17	(	(	PUNCT
aiua-5550	41	18	patients	patient	NOUN
aiua-5550	41	19	with	with	ADP
aiua-5550	41	20	pua	pua	PROPN
aiua-5550	41	21	≤	≤	NOUN
aiua-5550	41	22	35º	35º	NUM
aiua-5550	41	23	)	)	PUNCT
aiua-5550	41	24	and	and	CCONJ
aiua-5550	41	25	group	group	NOUN
aiua-5550	41	26	b	b	PROPN
aiua-5550	41	27	(	(	PUNCT
aiua-5550	41	28	patient	patient	NOUN
aiua-5550	41	29	with	with	ADP
aiua-5550	41	30	pua	pua	PROPN
aiua-5550	41	31	>	>	X
aiua-5550	41	32	35º	35º	NUM
aiua-5550	41	33	)	)	PUNCT
aiua-5550	41	34	.	.	PUNCT
aiua-5550	42	1	the	the	DET
aiua-5550	42	2	pua	pua	PROPN
aiua-5550	42	3	cutoff	cutoff	NOUN
aiua-5550	42	4	value	value	NOUN
aiua-5550	42	5	in	in	ADP
aiua-5550	42	6	previous	previous	ADJ
aiua-5550	42	7	studies	study	NOUN
aiua-5550	42	8	was	be	AUX
aiua-5550	42	9	35˚	35˚	NUM
aiua-5550	42	10	;	;	PUNCT
aiua-5550	42	11	at	at	ADP
aiua-5550	42	12	this	this	DET
aiua-5550	42	13	angle	angle	NOUN
aiua-5550	42	14	a	a	DET
aiua-5550	42	15	significant	significant	ADJ
aiua-5550	42	16	difference	difference	NOUN
aiua-5550	42	17	in	in	ADP
aiua-5550	42	18	clinical	clinical	ADJ
aiua-5550	42	19	symptoms	symptom	NOUN
aiua-5550	42	20	and	and	CCONJ
aiua-5550	42	21	urodynamics	urodynamic	NOUN
aiua-5550	42	22	parameters	parameter	NOUN
aiua-5550	42	23	in	in	ADP
aiua-5550	42	24	patients	patient	NOUN
aiua-5550	42	25	and	and	CCONJ
aiua-5550	42	26	healthy	healthy	ADJ
aiua-5550	42	27	men	man	NOUN
aiua-5550	42	28	were	be	AUX
aiua-5550	42	29	found	find	VERB
aiua-5550	42	30	.	.	PUNCT
aiua-5550	43	1	subsequently	subsequently	ADV
aiua-5550	43	2	,	,	PUNCT
aiua-5550	43	3	we	we	PRON
aiua-5550	43	4	classified	classify	VERB
aiua-5550	43	5	our	our	PRON
aiua-5550	43	6	patients	patient	NOUN
aiua-5550	43	7	into	into	ADP
aiua-5550	43	8	2	2	NUM
aiua-5550	43	9	categories	category	NOUN
aiua-5550	43	10	(	(	PUNCT
aiua-5550	43	11	pua	pua	PROPN
aiua-5550	43	12	≤	≤	NOUN
aiua-5550	43	13	35º	35º	NUM
aiua-5550	43	14	and	and	CCONJ
aiua-5550	43	15	pua	pua	PROPN
aiua-5550	43	16	>	>	X
aiua-5550	43	17	35º	35º	NUM
aiua-5550	43	18	)	)	PUNCT
aiua-5550	43	19	based	base	VERB
aiua-5550	43	20	on	on	ADP
aiua-5550	43	21	these	these	DET
aiua-5550	43	22	studies	study	NOUN
aiua-5550	43	23	(	(	PUNCT
aiua-5550	43	24	11	11	NUM
aiua-5550	43	25	-	-	SYM
aiua-5550	43	26	12	12	NUM
aiua-5550	43	27	)	)	PUNCT
aiua-5550	43	28	.	.	PUNCT
aiua-5550	44	1	all	all	DET
aiua-5550	44	2	patients	patient	NOUN
aiua-5550	44	3	received	receive	VERB
aiua-5550	44	4	medical	medical	ADJ
aiua-5550	44	5	treatment	treatment	NOUN
aiua-5550	44	6	in	in	ADP
aiua-5550	44	7	the	the	DET
aiua-5550	44	8	form	form	NOUN
aiua-5550	44	9	of	of	ADP
aiua-5550	44	10	tamsulosin	tamsulosin	NOUN
aiua-5550	44	11	hydrochloride	hydrochloride	NOUN
aiua-5550	44	12	0.4	0.4	NUM
aiua-5550	44	13	mg	mg	ADP
aiua-5550	44	14	once	once	ADV
aiua-5550	44	15	daily	daily	ADV
aiua-5550	44	16	for	for	ADP
aiua-5550	44	17	8	8	NUM
aiua-5550	44	18	weeks	week	NOUN
aiua-5550	44	19	.	.	PUNCT
aiua-5550	45	1	the	the	DET
aiua-5550	45	2	clinical	clinical	ADJ
aiua-5550	45	3	significance	significance	NOUN
aiua-5550	45	4	of	of	ADP
aiua-5550	45	5	pua	pua	PROPN
aiua-5550	45	6	was	be	AUX
aiua-5550	45	7	evaluated	evaluate	VERB
aiua-5550	45	8	subjectively	subjectively	ADV
aiua-5550	45	9	by	by	ADP
aiua-5550	45	10	measuring	measure	VERB
aiua-5550	45	11	the	the	DET
aiua-5550	45	12	ipss	ipss	PROPN
aiua-5550	45	13	/	/	SYM
aiua-5550	45	14	qol	qol	NOUN
aiua-5550	45	15	score	score	NOUN
aiua-5550	45	16	and	and	CCONJ
aiua-5550	45	17	objectively	objectively	ADV
aiua-5550	45	18	by	by	ADP
aiua-5550	45	19	measuring	measure	VERB
aiua-5550	45	20	uroflowmetry	uroflowmetry	NOUN
aiua-5550	45	21	parameters	parameter	NOUN
aiua-5550	45	22	(	(	PUNCT
aiua-5550	45	23	qmax	qmax	NOUN
aiua-5550	45	24	and	and	CCONJ
aiua-5550	45	25	pvr	pvr	PROPN
aiua-5550	45	26	volume	volume	NOUN
aiua-5550	45	27	)	)	PUNCT
aiua-5550	45	28	.	.	PUNCT
aiua-5550	46	1	statistical	statistical	ADJ
aiua-5550	46	2	analysis	analysis	NOUN
aiua-5550	46	3	was	be	AUX
aiua-5550	46	4	performed	perform	VERB
aiua-5550	46	5	using	use	VERB
aiua-5550	46	6	spss	spss	PROPN
aiua-5550	46	7	®	®	PROPN
aiua-5550	46	8	17	17	NUM
aiua-5550	46	9	.	.	PUNCT
aiua-5550	47	1	data	datum	NOUN
aiua-5550	47	2	are	be	AUX
aiua-5550	47	3	shown	show	VERB
aiua-5550	47	4	as	as	ADP
aiua-5550	47	5	the	the	DET
aiua-5550	47	6	mean	mean	ADJ
aiua-5550	47	7	±	±	NOUN
aiua-5550	47	8	sd	sd	NOUN
aiua-5550	47	9	unless	unless	SCONJ
aiua-5550	47	10	otherwise	otherwise	ADV
aiua-5550	47	11	specified	specify	VERB
aiua-5550	47	12	.	.	PUNCT
aiua-5550	48	1	the	the	DET
aiua-5550	48	2	student	student	NOUN
aiua-5550	48	3	t	t	PROPN
aiua-5550	48	4	and	and	CCONJ
aiua-5550	48	5	paired	pair	VERB
aiua-5550	48	6	sample	sample	NOUN
aiua-5550	48	7	t	t	NOUN
aiua-5550	48	8	tests	test	NOUN
aiua-5550	48	9	were	be	AUX
aiua-5550	48	10	used	use	VERB
aiua-5550	48	11	for	for	ADP
aiua-5550	48	12	comparison	comparison	NOUN
aiua-5550	48	13	between	between	ADP
aiua-5550	48	14	groups	group	NOUN
aiua-5550	48	15	and	and	CCONJ
aiua-5550	48	16	in	in	ADP
aiua-5550	48	17	the	the	DET
aiua-5550	48	18	same	same	ADJ
aiua-5550	48	19	group	group	NOUN
aiua-5550	48	20	,	,	PUNCT
aiua-5550	48	21	respectively	respectively	ADV
aiua-5550	48	22	.	.	PUNCT
aiua-5550	49	1	statistical	statistical	ADJ
aiua-5550	49	2	significance	significance	NOUN
aiua-5550	49	3	was	be	AUX
aiua-5550	49	4	considered	consider	VERB
aiua-5550	49	5	at	at	ADP
aiua-5550	49	6	p	p	NOUN
aiua-5550	49	7	<	<	X
aiua-5550	49	8	0.05	0.05	NUM
aiua-5550	49	9	.	.	PUNCT
aiua-5550	50	1	results	result	NOUN
aiua-5550	50	2	eighty	eighty	NUM
aiua-5550	50	3	patients	patient	NOUN
aiua-5550	50	4	were	be	AUX
aiua-5550	50	5	included	include	VERB
aiua-5550	50	6	in	in	ADP
aiua-5550	50	7	our	our	PRON
aiua-5550	50	8	study	study	NOUN
aiua-5550	50	9	,	,	PUNCT
aiua-5550	50	10	40	40	NUM
aiua-5550	50	11	in	in	ADP
aiua-5550	50	12	each	each	DET
aiua-5550	50	13	group	group	NOUN
aiua-5550	50	14	.	.	PUNCT
aiua-5550	51	1	two	two	NUM
aiua-5550	51	2	patients	patient	NOUN
aiua-5550	51	3	were	be	AUX
aiua-5550	51	4	excluded	exclude	VERB
aiua-5550	51	5	as	as	SCONJ
aiua-5550	51	6	they	they	PRON
aiua-5550	51	7	were	be	AUX
aiua-5550	51	8	lost	lose	VERB
aiua-5550	51	9	during	during	ADP
aiua-5550	51	10	follow	follow	NOUN
aiua-5550	51	11	-	-	PUNCT
aiua-5550	51	12	up	up	NOUN
aiua-5550	51	13	(	(	PUNCT
aiua-5550	51	14	1	1	NUM
aiua-5550	51	15	patient	patient	NOUN
aiua-5550	51	16	in	in	ADP
aiua-5550	51	17	each	each	DET
aiua-5550	51	18	group	group	NOUN
aiua-5550	51	19	)	)	PUNCT
aiua-5550	51	20	.	.	PUNCT
aiua-5550	52	1	patients	patient	NOUN
aiua-5550	52	2	mean	mean	VERB
aiua-5550	52	3	age	age	NOUN
aiua-5550	52	4	was	be	AUX
aiua-5550	52	5	53.3	53.3	NUM
aiua-5550	52	6	±	±	NUM
aiua-5550	52	7	6.3	6.3	NUM
aiua-5550	52	8	(	(	PUNCT
aiua-5550	52	9	range	range	NOUN
aiua-5550	52	10	47	47	NUM
aiua-5550	52	11	-	-	SYM
aiua-5550	52	12	70	70	NUM
aiua-5550	52	13	)	)	PUNCT
aiua-5550	52	14	.	.	PUNCT
aiua-5550	53	1	mean	mean	PROPN
aiua-5550	53	2	ipss	ipss	PROPN
aiua-5550	53	3	score	score	PROPN
aiua-5550	53	4	,	,	PUNCT
aiua-5550	53	5	qol	qol	PROPN
aiua-5550	53	6	score	score	NOUN
aiua-5550	53	7	;	;	PUNCT
aiua-5550	53	8	qmax	qmax	PROPN
aiua-5550	53	9	,	,	PUNCT
aiua-5550	53	10	pvr	pvr	NOUN
aiua-5550	53	11	and	and	CCONJ
aiua-5550	53	12	tpv	tpv	PROPN
aiua-5550	53	13	for	for	ADP
aiua-5550	53	14	all	all	DET
aiua-5550	53	15	patients	patient	NOUN
aiua-5550	53	16	were	be	AUX
aiua-5550	53	17	16.8	16.8	NUM
aiua-5550	53	18	±	±	NUM
aiua-5550	53	19	2.5	2.5	NUM
aiua-5550	53	20	,	,	PUNCT
aiua-5550	53	21	3.43	3.43	NUM
aiua-5550	53	22	±	±	NUM
aiua-5550	53	23	0.9	0.9	NUM
aiua-5550	53	24	,	,	PUNCT
aiua-5550	53	25	9.9	9.9	NUM
aiua-5550	53	26	±	±	NUM
aiua-5550	53	27	1.5	1.5	NUM
aiua-5550	53	28	,	,	PUNCT
aiua-5550	53	29	62.4	62.4	NUM
aiua-5550	53	30	±	±	NUM
aiua-5550	53	31	12.2	12.2	NUM
aiua-5550	53	32	and	and	CCONJ
aiua-5550	53	33	57.3	57.3	NUM
aiua-5550	53	34	±	±	NUM
aiua-5550	53	35	11.9	11.9	NUM
aiua-5550	53	36	respectively	respectively	ADV
aiua-5550	53	37	.	.	PUNCT
aiua-5550	54	1	baseline	baseline	PROPN
aiua-5550	54	2	evaluation	evaluation	NOUN
aiua-5550	54	3	data	datum	NOUN
aiua-5550	54	4	(	(	PUNCT
aiua-5550	54	5	pre	pre	ADJ
aiua-5550	54	6	-	-	NOUN
aiua-5550	54	7	treatment	treatment	NOUN
aiua-5550	54	8	)	)	PUNCT
aiua-5550	54	9	for	for	ADP
aiua-5550	54	10	both	both	DET
aiua-5550	54	11	groups	group	NOUN
aiua-5550	54	12	were	be	AUX
aiua-5550	54	13	comparable	comparable	ADJ
aiua-5550	54	14	to	to	ADP
aiua-5550	54	15	each	each	DET
aiua-5550	54	16	other	other	ADJ
aiua-5550	54	17	with	with	ADP
aiua-5550	54	18	no	no	DET
aiua-5550	54	19	clinically	clinically	ADV
aiua-5550	54	20	significant	significant	ADJ
aiua-5550	54	21	difference	difference	NOUN
aiua-5550	54	22	regarding	regard	VERB
aiua-5550	54	23	age	age	NOUN
aiua-5550	54	24	,	,	PUNCT
aiua-5550	54	25	psa	psa	NOUN
aiua-5550	54	26	,	,	PUNCT
aiua-5550	54	27	ipss	ipss	PROPN
aiua-5550	54	28	/	/	SYM
aiua-5550	54	29	qol	qol	PROPN
aiua-5550	54	30	score	score	NOUN
aiua-5550	54	31	,	,	PUNCT
aiua-5550	54	32	uroflometry	uroflometry	NOUN
aiua-5550	54	33	and	and	CCONJ
aiua-5550	54	34	ipp	ipp	PROPN
aiua-5550	54	35	(	(	PUNCT
aiua-5550	54	36	p	p	NOUN
aiua-5550	54	37	-	-	PUNCT
aiua-5550	54	38	value	value	NOUN
aiua-5550	54	39	>	>	NOUN
aiua-5550	54	40	0.05	0.05	NUM
aiua-5550	54	41	)	)	PUNCT
aiua-5550	54	42	.	.	PUNCT
aiua-5550	55	1	on	on	ADP
aiua-5550	55	2	the	the	DET
aiua-5550	55	3	contrary	contrary	NOUN
aiua-5550	55	4	,	,	PUNCT
aiua-5550	55	5	patients	patient	NOUN
aiua-5550	55	6	in	in	ADP
aiua-5550	55	7	group	group	PROPN
aiua-5550	55	8	a	a	PRON
aiua-5550	55	9	had	have	VERB
aiua-5550	55	10	a	a	DET
aiua-5550	55	11	smaller	small	ADJ
aiua-5550	55	12	prostate	prostate	NOUN
aiua-5550	55	13	than	than	ADP
aiua-5550	55	14	those	those	PRON
aiua-5550	55	15	in	in	ADP
aiua-5550	55	16	group	group	PROPN
aiua-5550	55	17	b	b	PROPN
aiua-5550	55	18	with	with	ADP
aiua-5550	55	19	mean	mean	PROPN
aiua-5550	55	20	tpv	tpv	PROPN
aiua-5550	55	21	49.54	49.54	NUM
aiua-5550	55	22	±	±	NUM
aiua-5550	55	23	9.03	9.03	NUM
aiua-5550	55	24	and	and	CCONJ
aiua-5550	55	25	tzv	tzv	VERB
aiua-5550	55	26	11.6	11.6	NUM
aiua-5550	55	27	±	±	NUM
aiua-5550	55	28	1.4	1.4	NUM
aiua-5550	55	29	(	(	PUNCT
aiua-5550	55	30	p	p	NOUN
aiua-5550	55	31	-	-	PUNCT
aiua-5550	55	32	value	value	NOUN
aiua-5550	55	33	=	=	NOUN
aiua-5550	55	34	0.001	0.001	NUM
aiua-5550	55	35	and	and	CCONJ
aiua-5550	55	36	0.001	0.001	NUM
aiua-5550	55	37	,	,	PUNCT
aiua-5550	55	38	respectively	respectively	ADV
aiua-5550	55	39	)	)	PUNCT
aiua-5550	55	40	(	(	PUNCT
aiua-5550	55	41	table	table	NOUN
aiua-5550	55	42	1	1	NUM
aiua-5550	55	43	)	)	PUNCT
aiua-5550	55	44	.	.	PUNCT
aiua-5550	56	1	figure	figure	NOUN
aiua-5550	56	2	1	1	NUM
aiua-5550	56	3	.	.	PUNCT
aiua-5550	56	4	ultrasound	ultrasound	NOUN
aiua-5550	56	5	image	image	NOUN
aiua-5550	56	6	used	use	VERB
aiua-5550	56	7	in	in	ADP
aiua-5550	56	8	measurement	measurement	NOUN
aiua-5550	56	9	for	for	ADP
aiua-5550	56	10	pua	pua	NOUN
aiua-5550	56	11	in	in	ADP
aiua-5550	56	12	two	two	NUM
aiua-5550	56	13	patients	patient	NOUN
aiua-5550	56	14	of	of	ADP
aiua-5550	56	15	both	both	DET
aiua-5550	56	16	groups	group	NOUN
aiua-5550	56	17	(	(	PUNCT
aiua-5550	56	18	lt	lt	PROPN
aiua-5550	56	19	.	.	PROPN
aiua-5550	56	20	photo	photo	NOUN
aiua-5550	56	21	:	:	PUNCT
aiua-5550	56	22	pua	pua	PROPN
aiua-5550	56	23	=	=	SYM
aiua-5550	56	24	32.3º	32.3º	PROPN
aiua-5550	56	25	,	,	PUNCT
aiua-5550	57	1	rt	rt	PROPN
aiua-5550	57	2	.	.	PUNCT
aiua-5550	57	3	photo	photo	PROPN
aiua-5550	57	4	:	:	PUNCT
aiua-5550	57	5	pua	pua	PROPN
aiua-5550	57	6	=	=	SYM
aiua-5550	57	7	44.4º	44.4º	NUM
aiua-5550	57	8	)	)	PUNCT
aiua-5550	57	9	.	.	PUNCT
aiua-5550	58	1	ali	ali	PROPN
aiua-5550	58	2	raheem_stesura	raheem_stesura	PROPN
aiua-5550	58	3	seveso	seveso	VERB
aiua-5550	59	1	30/09/15	30/09/15	PROPN
aiua-5550	59	2	09:38	09:38	NUM
aiua-5550	59	3	pagina	pagina	NOUN
aiua-5550	59	4	239	239	NUM
aiua-5550	59	5	archivio	archivio	NOUN
aiua-5550	59	6	italiano	italiano	NOUN
aiua-5550	59	7	di	di	X
aiua-5550	59	8	urologia	urologia	PROPN
aiua-5550	59	9	e	e	PROPN
aiua-5550	59	10	andrologia	andrologia	NOUN
aiua-5550	59	11	2015	2015	NUM
aiua-5550	59	12	;	;	PUNCT
aiua-5550	59	13	87	87	NUM
aiua-5550	59	14	,	,	PUNCT
aiua-5550	59	15	3	3	NUM
aiua-5550	59	16	hassan	hassan	PROPN
aiua-5550	59	17	el	el	PROPN
aiua-5550	59	18	-	-	PUNCT
aiua-5550	59	19	tatawy	tatawy	PROPN
aiua-5550	59	20	,	,	PUNCT
aiua-5550	59	21	tarek	tarek	PROPN
aiua-5550	59	22	gameel	gameel	PROPN
aiua-5550	59	23	,	,	PUNCT
aiua-5550	59	24	mohammed	mohammed	PROPN
aiua-5550	59	25	abo	abo	PROPN
aiua-5550	59	26	el	el	PROPN
aiua-5550	59	27	-	-	PUNCT
aiua-5550	59	28	enen	enen	PROPN
aiua-5550	59	29	,	,	PUNCT
aiua-5550	59	30	ayman	ayman	PROPN
aiua-5550	59	31	hagras	hagras	PROPN
aiua-5550	59	32	,	,	PUNCT
aiua-5550	59	33	ayman	ayman	PROPN
aiua-5550	59	34	mousa	mousa	PROPN
aiua-5550	59	35	,	,	PUNCT
aiua-5550	59	36	abdel	abdel	PROPN
aiua-5550	59	37	hamid	hamid	PROPN
aiua-5550	59	38	el	el	PROPN
aiua-5550	59	39	-	-	PROPN
aiua-5550	59	40	bahnasy	bahnasy	PROPN
aiua-5550	59	41	,	,	PUNCT
aiua-5550	59	42	ali	ali	PROPN
aiua-5550	59	43	abdel	abdel	PROPN
aiua-5550	59	44	raheem	raheem	PROPN
aiua-5550	59	45	,	,	PUNCT
aiua-5550	59	46	khaled	khaled	PROPN
aiua-5550	59	47	abu	abu	PROPN
aiua-5550	59	48	-	-	PUNCT
aiua-5550	59	49	dewan	dewan	PROPN
aiua-5550	59	50	240	240	NUM
aiua-5550	59	51	after	after	ADP
aiua-5550	59	52	8	8	NUM
aiua-5550	59	53	weeks	week	NOUN
aiua-5550	59	54	of	of	ADP
aiua-5550	59	55	follow	follow	NOUN
aiua-5550	59	56	-	-	PUNCT
aiua-5550	59	57	up	up	NOUN
aiua-5550	59	58	of	of	ADP
aiua-5550	59	59	medication	medication	NOUN
aiua-5550	59	60	with	with	ADP
aiua-5550	59	61	tamsulosin	tamsulosin	NOUN
aiua-5550	59	62	hydrochloride	hydrochloride	NOUN
aiua-5550	59	63	there	there	PRON
aiua-5550	59	64	was	be	VERB
aiua-5550	59	65	a	a	DET
aiua-5550	59	66	significant	significant	ADJ
aiua-5550	59	67	improvement	improvement	NOUN
aiua-5550	59	68	in	in	ADP
aiua-5550	59	69	ipss	ipss	PROPN
aiua-5550	59	70	/	/	SYM
aiua-5550	59	71	qol	qol	PROPN
aiua-5550	59	72	score	score	NOUN
aiua-5550	59	73	,	,	PUNCT
aiua-5550	59	74	qmax	qmax	PROPN
aiua-5550	59	75	and	and	CCONJ
aiua-5550	59	76	pvr	pvr	NOUN
aiua-5550	59	77	urine	urine	NOUN
aiua-5550	59	78	in	in	ADP
aiua-5550	59	79	group	group	PROPN
aiua-5550	59	80	a	a	DET
aiua-5550	59	81	(	(	PUNCT
aiua-5550	59	82	pvalue	pvalue	NOUN
aiua-5550	59	83	=	=	SYM
aiua-5550	59	84	0.001	0.001	NUM
aiua-5550	59	85	,	,	PUNCT
aiua-5550	59	86	0.001	0.001	NUM
aiua-5550	59	87	,	,	PUNCT
aiua-5550	59	88	0.002	0.002	NUM
aiua-5550	59	89	and	and	CCONJ
aiua-5550	59	90	0.04	0.04	NUM
aiua-5550	59	91	respectively	respectively	ADV
aiua-5550	59	92	)	)	PUNCT
aiua-5550	59	93	.	.	PUNCT
aiua-5550	60	1	on	on	ADP
aiua-5550	60	2	the	the	DET
aiua-5550	60	3	other	other	ADJ
aiua-5550	60	4	hand	hand	NOUN
aiua-5550	60	5	,	,	PUNCT
aiua-5550	60	6	there	there	PRON
aiua-5550	60	7	was	be	VERB
aiua-5550	60	8	no	no	DET
aiua-5550	60	9	significant	significant	ADJ
aiua-5550	60	10	improvement	improvement	NOUN
aiua-5550	60	11	in	in	ADP
aiua-5550	60	12	the	the	DET
aiua-5550	60	13	above	above	ADJ
aiua-5550	60	14	mentioned	mention	VERB
aiua-5550	60	15	parameters	parameter	NOUN
aiua-5550	60	16	in	in	ADP
aiua-5550	60	17	group	group	PROPN
aiua-5550	60	18	b	b	PROPN
aiua-5550	60	19	(	(	PUNCT
aiua-5550	60	20	table	table	NOUN
aiua-5550	60	21	2	2	NUM
aiua-5550	60	22	)	)	PUNCT
aiua-5550	60	23	.	.	PUNCT
aiua-5550	61	1	on	on	ADP
aiua-5550	61	2	comparison	comparison	NOUN
aiua-5550	61	3	between	between	ADP
aiua-5550	61	4	both	both	DET
aiua-5550	61	5	groups	group	NOUN
aiua-5550	61	6	there	there	PRON
aiua-5550	61	7	was	be	VERB
aiua-5550	61	8	a	a	DET
aiua-5550	61	9	statistically	statistically	ADV
aiua-5550	61	10	significant	significant	ADJ
aiua-5550	61	11	improvement	improvement	NOUN
aiua-5550	61	12	in	in	ADP
aiua-5550	61	13	group	group	NOUN
aiua-5550	61	14	a	a	PROPN
aiua-5550	61	15	in	in	ADP
aiua-5550	61	16	ipss	ipss	PROPN
aiua-5550	61	17	/	/	SYM
aiua-5550	61	18	qol	qol	PROPN
aiua-5550	61	19	score	score	NOUN
aiua-5550	61	20	,	,	PUNCT
aiua-5550	61	21	qmax	qmax	PROPN
aiua-5550	61	22	and	and	CCONJ
aiua-5550	61	23	pvr	pvr	NOUN
aiua-5550	61	24	volume	volume	NOUN
aiua-5550	61	25	compared	compare	VERB
aiua-5550	61	26	to	to	ADP
aiua-5550	61	27	group	group	PROPN
aiua-5550	61	28	b	b	PROPN
aiua-5550	61	29	(	(	PUNCT
aiua-5550	61	30	pvalue	pvalue	NOUN
aiua-5550	61	31	=	=	NOUN
aiua-5550	61	32	0.001	0.001	NUM
aiua-5550	61	33	,	,	PUNCT
aiua-5550	61	34	0.03	0.03	NUM
aiua-5550	61	35	,	,	PUNCT
aiua-5550	61	36	0.01	0.01	NUM
aiua-5550	61	37	,	,	PUNCT
aiua-5550	61	38	0.05	0.05	NUM
aiua-5550	61	39	and	and	CCONJ
aiua-5550	61	40	0.002	0.002	NUM
aiua-5550	61	41	,	,	PUNCT
aiua-5550	61	42	respectively	respectively	ADV
aiua-5550	61	43	)	)	PUNCT
aiua-5550	61	44	(	(	PUNCT
aiua-5550	61	45	table	table	NOUN
aiua-5550	61	46	2	2	NUM
aiua-5550	61	47	)	)	PUNCT
aiua-5550	61	48	.	.	PUNCT
aiua-5550	62	1	there	there	PRON
aiua-5550	62	2	were	be	VERB
aiua-5550	62	3	no	no	DET
aiua-5550	62	4	moderate	moderate	ADJ
aiua-5550	62	5	or	or	CCONJ
aiua-5550	62	6	severe	severe	ADJ
aiua-5550	62	7	side	side	NOUN
aiua-5550	62	8	effects	effect	NOUN
aiua-5550	62	9	in	in	ADP
aiua-5550	62	10	either	either	CCONJ
aiua-5550	62	11	group	group	NOUN
aiua-5550	62	12	lead	lead	NOUN
aiua-5550	62	13	to	to	ADP
aiua-5550	62	14	discontinuation	discontinuation	NOUN
aiua-5550	62	15	of	of	ADP
aiua-5550	62	16	medical	medical	ADJ
aiua-5550	62	17	treatment	treatment	NOUN
aiua-5550	62	18	.	.	PUNCT
aiua-5550	63	1	in	in	ADP
aiua-5550	63	2	our	our	PRON
aiua-5550	63	3	study	study	NOUN
aiua-5550	63	4	,	,	PUNCT
aiua-5550	63	5	the	the	DET
aiua-5550	63	6	most	most	ADV
aiua-5550	63	7	common	common	ADJ
aiua-5550	63	8	adverse	adverse	ADJ
aiua-5550	63	9	event	event	NOUN
aiua-5550	63	10	was	be	AUX
aiua-5550	63	11	dizziness	dizziness	ADJ
aiua-5550	63	12	in	in	ADP
aiua-5550	63	13	7.6	7.6	NUM
aiua-5550	63	14	%	%	NOUN
aiua-5550	63	15	of	of	ADP
aiua-5550	63	16	patients	patient	NOUN
aiua-5550	63	17	(	(	PUNCT
aiua-5550	63	18	3	3	NUM
aiua-5550	63	19	in	in	ADP
aiua-5550	63	20	each	each	DET
aiua-5550	63	21	group	group	NOUN
aiua-5550	63	22	)	)	PUNCT
aiua-5550	63	23	,	,	PUNCT
aiua-5550	63	24	while	while	SCONJ
aiua-5550	63	25	the	the	DET
aiua-5550	63	26	abnormal	abnormal	ADJ
aiua-5550	63	27	ejaculation	ejaculation	NOUN
aiua-5550	63	28	rates	rate	NOUN
aiua-5550	63	29	were	be	AUX
aiua-5550	63	30	5.1	5.1	NUM
aiua-5550	63	31	%	%	NOUN
aiua-5550	63	32	in	in	ADP
aiua-5550	63	33	group	group	NOUN
aiua-5550	63	34	a	a	PROPN
aiua-5550	63	35	and	and	CCONJ
aiua-5550	63	36	7.7	7.7	NUM
aiua-5550	63	37	%	%	NOUN
aiua-5550	63	38	in	in	ADP
aiua-5550	63	39	group	group	PROPN
aiua-5550	63	40	b.	b.	PROPN
aiua-5550	63	41	discussion	discussion	PROPN
aiua-5550	63	42	several	several	ADJ
aiua-5550	63	43	anatomical	anatomical	ADJ
aiua-5550	63	44	factors	factor	NOUN
aiua-5550	63	45	of	of	ADP
aiua-5550	63	46	the	the	DET
aiua-5550	63	47	prostate	prostate	NOUN
aiua-5550	63	48	other	other	ADJ
aiua-5550	63	49	that	that	SCONJ
aiua-5550	63	50	its	its	PRON
aiua-5550	63	51	volume	volume	NOUN
aiua-5550	63	52	were	be	AUX
aiua-5550	63	53	studied	study	VERB
aiua-5550	63	54	in	in	ADP
aiua-5550	63	55	the	the	DET
aiua-5550	63	56	past	past	ADJ
aiua-5550	63	57	years	year	NOUN
aiua-5550	63	58	to	to	PART
aiua-5550	63	59	assess	assess	VERB
aiua-5550	63	60	its	its	PRON
aiua-5550	63	61	impact	impact	NOUN
aiua-5550	63	62	on	on	ADP
aiua-5550	63	63	the	the	DET
aiua-5550	63	64	clinical	clinical	ADJ
aiua-5550	63	65	symptoms	symptom	NOUN
aiua-5550	63	66	progression	progression	NOUN
aiua-5550	63	67	such	such	ADJ
aiua-5550	63	68	as	as	ADP
aiua-5550	63	69	ipp	ipp	PROPN
aiua-5550	63	70	,	,	PUNCT
aiua-5550	63	71	tzi	tzi	PROPN
aiua-5550	63	72	,	,	PUNCT
aiua-5550	63	73	tzv	tzv	NOUN
aiua-5550	63	74	and	and	CCONJ
aiua-5550	63	75	presumed	presume	VERB
aiua-5550	63	76	circle	circle	NOUN
aiua-5550	63	77	area	area	NOUN
aiua-5550	63	78	ratio	ratio	NOUN
aiua-5550	63	79	(	(	PUNCT
aiua-5550	63	80	2	2	NUM
aiua-5550	63	81	-	-	SYM
aiua-5550	63	82	9	9	NUM
aiua-5550	63	83	)	)	PUNCT
aiua-5550	63	84	.	.	PUNCT
aiua-5550	63	85	)	)	PUNCT
aiua-5550	64	1	another	another	DET
aiua-5550	64	2	recent	recent	ADJ
aiua-5550	64	3	anatomical	anatomical	ADJ
aiua-5550	64	4	factor	factor	NOUN
aiua-5550	64	5	was	be	AUX
aiua-5550	64	6	introduced	introduce	VERB
aiua-5550	64	7	by	by	ADP
aiua-5550	64	8	cho	cho	PROPN
aiua-5550	64	9	et	et	PROPN
aiua-5550	64	10	al	al	PROPN
aiua-5550	64	11	.	.	PROPN
aiua-5550	65	1	and	and	CCONJ
aiua-5550	65	2	it	it	PRON
aiua-5550	65	3	might	might	AUX
aiua-5550	65	4	play	play	VERB
aiua-5550	65	5	a	a	DET
aiua-5550	65	6	role	role	NOUN
aiua-5550	65	7	in	in	ADP
aiua-5550	65	8	the	the	DET
aiua-5550	65	9	pathogenesis	pathogenesis	NOUN
aiua-5550	65	10	of	of	ADP
aiua-5550	65	11	pbh	pbh	PROPN
aiua-5550	65	12	is	be	AUX
aiua-5550	65	13	the	the	DET
aiua-5550	65	14	pua	pua	PROPN
aiua-5550	65	15	.	.	PUNCT
aiua-5550	66	1	the	the	DET
aiua-5550	66	2	prostatic	prostatic	ADJ
aiua-5550	66	3	urethra	urethra	NOUN
aiua-5550	66	4	is	be	AUX
aiua-5550	66	5	a	a	DET
aiua-5550	66	6	bent	bent	ADJ
aiua-5550	66	7	tube	tube	NOUN
aiua-5550	66	8	and	and	CCONJ
aiua-5550	66	9	by	by	ADP
aiua-5550	66	10	applying	apply	VERB
aiua-5550	66	11	the	the	DET
aiua-5550	66	12	concept	concept	NOUN
aiua-5550	66	13	of	of	ADP
aiua-5550	66	14	fluid	fluid	ADJ
aiua-5550	66	15	dynamics	dynamic	NOUN
aiua-5550	66	16	to	to	ADP
aiua-5550	66	17	the	the	DET
aiua-5550	66	18	micturition	micturition	NOUN
aiua-5550	66	19	process	process	NOUN
aiua-5550	66	20	in	in	ADP
aiua-5550	66	21	the	the	DET
aiua-5550	66	22	prostatic	prostatic	ADJ
aiua-5550	66	23	urethra	urethra	NOUN
aiua-5550	66	24	,	,	PUNCT
aiua-5550	66	25	they	they	PRON
aiua-5550	66	26	hypothesized	hypothesize	VERB
aiua-5550	66	27	that	that	SCONJ
aiua-5550	66	28	some	some	DET
aiua-5550	66	29	energy	energy	NOUN
aiua-5550	66	30	loss	loss	NOUN
aiua-5550	66	31	could	could	AUX
aiua-5550	66	32	occur	occur	VERB
aiua-5550	66	33	during	during	ADP
aiua-5550	66	34	this	this	DET
aiua-5550	66	35	process	process	NOUN
aiua-5550	66	36	and	and	CCONJ
aiua-5550	66	37	hence	hence	ADV
aiua-5550	66	38	decreasing	decrease	VERB
aiua-5550	66	39	the	the	DET
aiua-5550	66	40	velocity	velocity	NOUN
aiua-5550	66	41	of	of	ADP
aiua-5550	66	42	urine	urine	NOUN
aiua-5550	66	43	.	.	PUNCT
aiua-5550	67	1	in	in	ADP
aiua-5550	67	2	addition	addition	NOUN
aiua-5550	67	3	,	,	PUNCT
aiua-5550	67	4	they	they	PRON
aiua-5550	67	5	suggested	suggest	VERB
aiua-5550	67	6	that	that	SCONJ
aiua-5550	67	7	this	this	DET
aiua-5550	67	8	energy	energy	NOUN
aiua-5550	67	9	loss	loss	NOUN
aiua-5550	67	10	increased	increase	VERB
aiua-5550	67	11	proportionally	proportionally	ADV
aiua-5550	67	12	as	as	SCONJ
aiua-5550	67	13	the	the	DET
aiua-5550	67	14	pua	pua	PROPN
aiua-5550	67	15	increased	increase	VERB
aiua-5550	67	16	and	and	CCONJ
aiua-5550	67	17	qmax	qmax	PROPN
aiua-5550	67	18	decreased	decrease	VERB
aiua-5550	67	19	by	by	ADP
aiua-5550	67	20	more	more	ADJ
aiua-5550	67	21	than	than	ADP
aiua-5550	67	22	27	27	NUM
aiua-5550	67	23	%	%	NOUN
aiua-5550	67	24	as	as	SCONJ
aiua-5550	67	25	the	the	DET
aiua-5550	67	26	pua	pua	PROPN
aiua-5550	67	27	increased	increase	VERB
aiua-5550	67	28	from	from	ADP
aiua-5550	67	29	35	35	NUM
aiua-5550	67	30	°	°	NOUN
aiua-5550	67	31	to	to	ADP
aiua-5550	67	32	90	90	NUM
aiua-5550	67	33	°	°	NOUN
aiua-5550	67	34	(	(	PUNCT
aiua-5550	67	35	10	10	NUM
aiua-5550	67	36	-	-	SYM
aiua-5550	67	37	11	11	NUM
aiua-5550	67	38	)	)	PUNCT
aiua-5550	67	39	.	.	PUNCT
aiua-5550	68	1	the	the	DET
aiua-5550	68	2	present	present	ADJ
aiua-5550	68	3	study	study	NOUN
aiua-5550	68	4	is	be	AUX
aiua-5550	68	5	the	the	DET
aiua-5550	68	6	first	first	ADJ
aiua-5550	68	7	prospective	prospective	ADJ
aiua-5550	68	8	comparative	comparative	ADJ
aiua-5550	68	9	study	study	NOUN
aiua-5550	68	10	that	that	PRON
aiua-5550	68	11	addresses	address	VERB
aiua-5550	68	12	the	the	DET
aiua-5550	68	13	importance	importance	NOUN
aiua-5550	68	14	of	of	ADP
aiua-5550	68	15	the	the	DET
aiua-5550	68	16	pua	pua	PROPN
aiua-5550	68	17	as	as	ADP
aiua-5550	68	18	a	a	DET
aiua-5550	68	19	predictor	predictor	NOUN
aiua-5550	68	20	of	of	ADP
aiua-5550	68	21	the	the	DET
aiua-5550	68	22	clinical	clinical	ADJ
aiua-5550	68	23	status	status	NOUN
aiua-5550	68	24	and	and	CCONJ
aiua-5550	68	25	treatment	treatment	NOUN
aiua-5550	68	26	outcome	outcome	NOUN
aiua-5550	68	27	in	in	ADP
aiua-5550	68	28	patients	patient	NOUN
aiua-5550	68	29	with	with	ADP
aiua-5550	68	30	luts	luts	PROPN
aiua-5550	68	31	/	/	SYM
aiua-5550	68	32	bph	bph	NOUN
aiua-5550	68	33	who	who	PRON
aiua-5550	68	34	received	receive	VERB
aiua-5550	68	35	selective	selective	ADJ
aiua-5550	68	36	α1ablockers	α1ablocker	NOUN
aiua-5550	68	37	.	.	PUNCT
aiua-5550	69	1	as	as	SCONJ
aiua-5550	69	2	we	we	PRON
aiua-5550	69	3	know	know	VERB
aiua-5550	69	4	α	α	NUM
aiua-5550	69	5	-	-	PUNCT
aiua-5550	69	6	blockers	blocker	NOUN
aiua-5550	69	7	help	help	VERB
aiua-5550	69	8	to	to	PART
aiua-5550	69	9	treat	treat	VERB
aiua-5550	69	10	bph	bph	NOUN
aiua-5550	69	11	by	by	ADP
aiua-5550	69	12	relaxation	relaxation	NOUN
aiua-5550	69	13	of	of	ADP
aiua-5550	69	14	the	the	DET
aiua-5550	69	15	smooth	smooth	ADJ
aiua-5550	69	16	-	-	PUNCT
aiua-5550	69	17	muscle	muscle	NOUN
aiua-5550	69	18	tissue	tissue	NOUN
aiua-5550	69	19	in	in	ADP
aiua-5550	69	20	the	the	DET
aiua-5550	69	21	bladder	bladder	NOUN
aiua-5550	69	22	neck	neck	NOUN
aiua-5550	69	23	and	and	CCONJ
aiua-5550	69	24	the	the	DET
aiua-5550	69	25	prostate	prostate	NOUN
aiua-5550	69	26	,	,	PUNCT
aiua-5550	69	27	which	which	PRON
aiua-5550	69	28	facilitate	facilitate	VERB
aiua-5550	69	29	urinary	urinary	ADJ
aiua-5550	69	30	outflow	outflow	NOUN
aiua-5550	69	31	from	from	ADP
aiua-5550	69	32	the	the	DET
aiua-5550	69	33	bladder	bladder	NOUN
aiua-5550	69	34	more	more	ADV
aiua-5550	69	35	easily	easily	ADV
aiua-5550	69	36	.	.	PUNCT
aiua-5550	70	1	we	we	PRON
aiua-5550	70	2	chose	choose	VERB
aiua-5550	70	3	tamsulosin	tamsulosin	NOUN
aiua-5550	70	4	hydrochloride	hydrochloride	NOUN
aiua-5550	70	5	in	in	ADP
aiua-5550	70	6	our	our	PRON
aiua-5550	70	7	study	study	NOUN
aiua-5550	70	8	because	because	SCONJ
aiua-5550	70	9	it	it	PRON
aiua-5550	70	10	is	be	AUX
aiua-5550	70	11	a	a	DET
aiua-5550	70	12	highly	highly	ADV
aiua-5550	70	13	selective	selective	ADJ
aiua-5550	70	14	α1a	α1a	NOUN
aiua-5550	70	15	-	-	NOUN
aiua-5550	70	16	blocker	blocker	NOUN
aiua-5550	70	17	,	,	PUNCT
aiua-5550	70	18	safe	safe	ADJ
aiua-5550	70	19	and	and	CCONJ
aiua-5550	70	20	has	have	VERB
aiua-5550	70	21	long	long	ADJ
aiua-5550	70	22	-	-	PUNCT
aiua-5550	70	23	term	term	NOUN
aiua-5550	70	24	treatment	treatment	NOUN
aiua-5550	70	25	efficacy	efficacy	NOUN
aiua-5550	70	26	(	(	PUNCT
aiua-5550	70	27	15	15	NUM
aiua-5550	70	28	,	,	PUNCT
aiua-5550	70	29	16	16	NUM
aiua-5550	70	30	,	,	PUNCT
aiua-5550	70	31	18	18	NUM
aiua-5550	70	32	)	)	PUNCT
aiua-5550	70	33	.	.	PUNCT
aiua-5550	71	1	in	in	ADP
aiua-5550	71	2	the	the	DET
aiua-5550	71	3	present	present	ADJ
aiua-5550	71	4	study	study	NOUN
aiua-5550	71	5	,	,	PUNCT
aiua-5550	71	6	baseline	baseline	NOUN
aiua-5550	71	7	age	age	NOUN
aiua-5550	71	8	,	,	PUNCT
aiua-5550	71	9	psa	psa	NOUN
aiua-5550	71	10	,	,	PUNCT
aiua-5550	71	11	ipp	ipp	PROPN
aiua-5550	71	12	,	,	PUNCT
aiua-5550	71	13	uroflowmetry	uroflowmetry	NOUN
aiua-5550	71	14	,	,	PUNCT
aiua-5550	71	15	ipss	ipss	PROPN
aiua-5550	71	16	/	/	SYM
aiua-5550	71	17	qol	qol	PROPN
aiua-5550	71	18	score	score	NOUN
aiua-5550	71	19	did	do	AUX
aiua-5550	71	20	not	not	PART
aiua-5550	71	21	differ	differ	VERB
aiua-5550	71	22	significantly	significantly	ADV
aiua-5550	71	23	between	between	ADP
aiua-5550	71	24	the	the	DET
aiua-5550	71	25	two	two	NUM
aiua-5550	71	26	groups	group	NOUN
aiua-5550	71	27	.	.	PUNCT
aiua-5550	72	1	however	however	ADV
aiua-5550	72	2	,	,	PUNCT
aiua-5550	72	3	tpv	tpv	PROPN
aiua-5550	72	4	and	and	CCONJ
aiua-5550	72	5	tzv	tzv	NOUN
aiua-5550	72	6	did	do	AUX
aiua-5550	72	7	differ	differ	VERB
aiua-5550	72	8	significantly	significantly	ADV
aiua-5550	72	9	between	between	ADP
aiua-5550	72	10	the	the	DET
aiua-5550	72	11	groups	group	NOUN
aiua-5550	72	12	at	at	ADP
aiua-5550	72	13	baseline	baseline	NOUN
aiua-5550	72	14	(	(	PUNCT
aiua-5550	72	15	p	p	X
aiua-5550	72	16	<	<	X
aiua-5550	72	17	0.05	0.05	NUM
aiua-5550	72	18	)	)	PUNCT
aiua-5550	72	19	.	.	PUNCT
aiua-5550	73	1	tpv	tpv	PROPN
aiua-5550	73	2	and	and	CCONJ
aiua-5550	73	3	tzv	tzv	NOUN
aiua-5550	73	4	were	be	AUX
aiua-5550	73	5	higher	high	ADJ
aiua-5550	73	6	in	in	ADP
aiua-5550	73	7	patients	patient	NOUN
aiua-5550	73	8	with	with	ADP
aiua-5550	73	9	pua	pua	PROPN
aiua-5550	73	10	>	>	X
aiua-5550	73	11	35º	35º	NUM
aiua-5550	73	12	compared	compare	VERB
aiua-5550	73	13	to	to	ADP
aiua-5550	73	14	those	those	PRON
aiua-5550	73	15	with	with	ADP
aiua-5550	73	16	lower	low	ADJ
aiua-5550	73	17	pua	pua	NOUN
aiua-5550	73	18	and	and	CCONJ
aiua-5550	73	19	these	these	DET
aiua-5550	73	20	findings	finding	NOUN
aiua-5550	73	21	were	be	AUX
aiua-5550	73	22	in	in	ADP
aiua-5550	73	23	accordance	accordance	NOUN
aiua-5550	73	24	to	to	ADP
aiua-5550	73	25	ku	ku	PROPN
aiua-5550	73	26	et	et	PROPN
aiua-5550	73	27	al	al	PROPN
aiua-5550	73	28	.	.	PROPN
aiua-5550	73	29	who	who	PRON
aiua-5550	73	30	showed	show	VERB
aiua-5550	73	31	that	that	SCONJ
aiua-5550	73	32	patients	patient	NOUN
aiua-5550	73	33	with	with	ADP
aiua-5550	73	34	pua	pua	PROPN
aiua-5550	73	35	>	>	X
aiua-5550	73	36	35	35	NUM
aiua-5550	73	37	have	have	VERB
aiua-5550	73	38	higher	high	ADJ
aiua-5550	73	39	prostate	prostate	NOUN
aiua-5550	73	40	volume	volume	NOUN
aiua-5550	73	41	than	than	ADP
aiua-5550	73	42	those	those	PRON
aiua-5550	73	43	with	with	ADP
aiua-5550	73	44	pua	pua	PROPN
aiua-5550	73	45	≤	≤	PROPN
aiua-5550	73	46	35	35	NUM
aiua-5550	73	47	(	(	PUNCT
aiua-5550	73	48	12	12	NUM
aiua-5550	73	49	)	)	PUNCT
aiua-5550	73	50	.	.	PUNCT
aiua-5550	74	1	our	our	PRON
aiua-5550	74	2	study	study	NOUN
aiua-5550	74	3	showed	show	VERB
aiua-5550	74	4	no	no	DET
aiua-5550	74	5	significant	significant	ADJ
aiua-5550	74	6	difference	difference	NOUN
aiua-5550	74	7	in	in	ADP
aiua-5550	74	8	qmax	qmax	NOUN
aiua-5550	74	9	values	value	NOUN
aiua-5550	74	10	in	in	ADP
aiua-5550	74	11	the	the	DET
aiua-5550	74	12	two	two	NUM
aiua-5550	74	13	groups	group	NOUN
aiua-5550	74	14	of	of	ADP
aiua-5550	74	15	patients	patient	NOUN
aiua-5550	74	16	(	(	PUNCT
aiua-5550	74	17	p	p	NOUN
aiua-5550	74	18	-	-	PUNCT
aiua-5550	74	19	value	value	NOUN
aiua-5550	74	20	=	=	NOUN
aiua-5550	74	21	0.45	0.45	NUM
aiua-5550	74	22	)	)	PUNCT
aiua-5550	74	23	(	(	PUNCT
aiua-5550	74	24	table	table	NOUN
aiua-5550	74	25	1	1	NUM
aiua-5550	74	26	)	)	PUNCT
aiua-5550	74	27	.	.	PUNCT
aiua-5550	75	1	in	in	ADP
aiua-5550	75	2	contrast	contrast	NOUN
aiua-5550	75	3	to	to	ADP
aiua-5550	75	4	our	our	PRON
aiua-5550	75	5	findings	finding	NOUN
aiua-5550	75	6	,	,	PUNCT
aiua-5550	75	7	the	the	DET
aiua-5550	75	8	urinary	urinary	ADJ
aiua-5550	75	9	flow	flow	NOUN
aiua-5550	75	10	rate	rate	NOUN
aiua-5550	75	11	was	be	AUX
aiua-5550	75	12	found	find	VERB
aiua-5550	75	13	inversely	inversely	ADV
aiua-5550	75	14	associated	associate	VERB
aiua-5550	75	15	with	with	ADP
aiua-5550	75	16	the	the	DET
aiua-5550	75	17	pua	pua	PROPN
aiua-5550	75	18	(	(	PUNCT
aiua-5550	75	19	11	11	NUM
aiua-5550	75	20	)	)	PUNCT
aiua-5550	75	21	,	,	PUNCT
aiua-5550	75	22	and	and	CCONJ
aiua-5550	75	23	a	a	DET
aiua-5550	75	24	larger	large	ADJ
aiua-5550	75	25	pua	pua	NOUN
aiua-5550	75	26	was	be	AUX
aiua-5550	75	27	associated	associate	VERB
aiua-5550	75	28	with	with	ADP
aiua-5550	75	29	a	a	DET
aiua-5550	75	30	lower	low	ADJ
aiua-5550	75	31	urinary	urinary	ADJ
aiua-5550	75	32	flow	flow	NOUN
aiua-5550	75	33	rate	rate	NOUN
aiua-5550	75	34	(	(	PUNCT
aiua-5550	75	35	14	14	NUM
aiua-5550	75	36	)	)	PUNCT
aiua-5550	75	37	.	.	PUNCT
aiua-5550	76	1	on	on	ADP
aiua-5550	76	2	the	the	DET
aiua-5550	76	3	other	other	ADJ
aiua-5550	76	4	hand	hand	NOUN
aiua-5550	76	5	,	,	PUNCT
aiua-5550	76	6	no	no	DET
aiua-5550	76	7	significant	significant	ADJ
aiua-5550	76	8	difference	difference	NOUN
aiua-5550	76	9	in	in	ADP
aiua-5550	76	10	qmax	qmax	NOUN
aiua-5550	76	11	values	value	NOUN
aiua-5550	76	12	between	between	ADP
aiua-5550	76	13	patients	patient	NOUN
aiua-5550	76	14	with	with	ADP
aiua-5550	76	15	pua	pua	PROPN
aiua-5550	76	16	more	more	ADV
aiua-5550	76	17	or	or	CCONJ
aiua-5550	76	18	less	less	ADJ
aiua-5550	76	19	35˚	35˚	NUM
aiua-5550	76	20	was	be	AUX
aiua-5550	76	21	reported	report	VERB
aiua-5550	76	22	(	(	PUNCT
aiua-5550	76	23	12	12	NUM
aiua-5550	76	24	)	)	PUNCT
aiua-5550	76	25	.	.	PUNCT
aiua-5550	77	1	the	the	DET
aiua-5550	77	2	reason	reason	NOUN
aiua-5550	77	3	for	for	ADP
aiua-5550	77	4	this	this	DET
aiua-5550	77	5	difference	difference	NOUN
aiua-5550	77	6	between	between	ADP
aiua-5550	77	7	our	our	PRON
aiua-5550	77	8	study	study	NOUN
aiua-5550	77	9	and	and	CCONJ
aiua-5550	77	10	others	other	NOUN
aiua-5550	77	11	may	may	AUX
aiua-5550	77	12	be	be	AUX
aiua-5550	77	13	the	the	DET
aiua-5550	77	14	selection	selection	NOUN
aiua-5550	77	15	of	of	ADP
aiua-5550	77	16	our	our	PRON
aiua-5550	77	17	patients	patient	NOUN
aiua-5550	77	18	.	.	PUNCT
aiua-5550	78	1	in	in	ADP
aiua-5550	78	2	fact	fact	NOUN
aiua-5550	78	3	we	we	PRON
aiua-5550	78	4	excluded	exclude	VERB
aiua-5550	78	5	all	all	DET
aiua-5550	78	6	patients	patient	NOUN
aiua-5550	78	7	with	with	ADP
aiua-5550	78	8	insignificant	insignificant	ADJ
aiua-5550	78	9	symptoms	symptom	NOUN
aiua-5550	78	10	related	relate	VERB
aiua-5550	78	11	to	to	ADP
aiua-5550	78	12	their	their	PRON
aiua-5550	78	13	enlarged	enlarge	VERB
aiua-5550	78	14	prostate	prostate	NOUN
aiua-5550	78	15	.	.	PUNCT
aiua-5550	79	1	consequently	consequently	ADV
aiua-5550	79	2	,	,	PUNCT
aiua-5550	79	3	the	the	DET
aiua-5550	79	4	pre	pre	ADJ
aiua-5550	79	5	-	-	ADJ
aiua-5550	79	6	treatment	treatment	ADJ
aiua-5550	79	7	symptoms	symptom	NOUN
aiua-5550	79	8	and	and	CCONJ
aiua-5550	79	9	related	relate	VERB
aiua-5550	79	10	objective	objective	ADJ
aiua-5550	79	11	signs	sign	NOUN
aiua-5550	79	12	are	be	AUX
aiua-5550	79	13	expected	expect	VERB
aiua-5550	79	14	to	to	PART
aiua-5550	79	15	be	be	AUX
aiua-5550	79	16	matching	match	VERB
aiua-5550	79	17	.	.	PUNCT
aiua-5550	80	1	in	in	ADP
aiua-5550	80	2	contrary	contrary	PROPN
aiua-5550	80	3	,	,	PUNCT
aiua-5550	80	4	cho	cho	PROPN
aiua-5550	80	5	et	et	PROPN
aiua-5550	80	6	al	al	PROPN
aiua-5550	80	7	.	.	PROPN
aiua-5550	81	1	(	(	PUNCT
aiua-5550	81	2	11	11	NUM
aiua-5550	81	3	)	)	PUNCT
aiua-5550	81	4	did	do	AUX
aiua-5550	81	5	not	not	PART
aiua-5550	81	6	choose	choose	VERB
aiua-5550	81	7	their	their	PRON
aiua-5550	81	8	patients	patient	NOUN
aiua-5550	81	9	on	on	ADP
aiua-5550	81	10	such	such	ADJ
aiua-5550	81	11	group	group	NOUN
aiua-5550	81	12	a	a	DET
aiua-5550	81	13	group	group	NOUN
aiua-5550	81	14	b	b	PROPN
aiua-5550	81	15	p	p	ADJ
aiua-5550	81	16	-	-	PUNCT
aiua-5550	81	17	value	value	NOUN
aiua-5550	81	18	mean	mean	NOUN
aiua-5550	81	19	±	±	NUM
aiua-5550	81	20	sd	sd	ADP
aiua-5550	81	21	mean	mean	VERB
aiua-5550	81	22	±	±	PROPN
aiua-5550	81	23	sd	sd	ADP
aiua-5550	81	24	pua˚	pua˚	PROPN
aiua-5550	81	25	≤	≤	NOUN
aiua-5550	81	26	35º	35º	NUM
aiua-5550	81	27	>	>	X
aiua-5550	81	28	35º	35º	NUM
aiua-5550	81	29	--patients	--patients	PUNCT
aiua-5550	81	30	number	number	NOUN
aiua-5550	81	31	40	40	NUM
aiua-5550	81	32	40	40	NUM
aiua-5550	81	33	--age	--age	NOUN
aiua-5550	81	34	(	(	PUNCT
aiua-5550	81	35	yr	yr	NOUN
aiua-5550	81	36	)	)	PUNCT
aiua-5550	81	37	55.41	55.41	NUM
aiua-5550	81	38	±	±	NUM
aiua-5550	81	39	9.03	9.03	NUM
aiua-5550	81	40	58.23	58.23	NUM
aiua-5550	81	41	±	±	NUM
aiua-5550	81	42	6.37	6.37	NUM
aiua-5550	81	43	0.78	0.78	NUM
aiua-5550	81	44	psa	psa	NOUN
aiua-5550	81	45	(	(	PUNCT
aiua-5550	81	46	ng	ng	PROPN
aiua-5550	81	47	/	/	SYM
aiua-5550	81	48	ml	ml	NOUN
aiua-5550	81	49	)	)	PUNCT
aiua-5550	81	50	2.4	2.4	NUM
aiua-5550	81	51	±	±	NUM
aiua-5550	81	52	1.13	1.13	NUM
aiua-5550	81	53	2.4	2.4	NUM
aiua-5550	81	54	±	±	NUM
aiua-5550	81	55	1.39	1.39	NUM
aiua-5550	81	56	0.83	0.83	NUM
aiua-5550	81	57	prostatic	prostatic	ADJ
aiua-5550	81	58	measurements	measurement	NOUN
aiua-5550	81	59	:	:	PUNCT
aiua-5550	81	60	tpv	tpv	PROPN
aiua-5550	81	61	(	(	PUNCT
aiua-5550	81	62	cm3	cm3	PROPN
aiua-5550	81	63	)	)	PUNCT
aiua-5550	81	64	49.54	49.54	NUM
aiua-5550	81	65	±	±	NUM
aiua-5550	81	66	9.03	9.03	NUM
aiua-5550	81	67	62.32	62.32	NUM
aiua-5550	81	68	±	±	NUM
aiua-5550	81	69	11.99	11.99	NUM
aiua-5550	81	70	0.001	0.001	NUM
aiua-5550	81	71	ipp	ipp	NOUN
aiua-5550	81	72	(	(	PUNCT
aiua-5550	81	73	mm	mm	NOUN
aiua-5550	81	74	)	)	PUNCT
aiua-5550	81	75	3.5	3.5	NUM
aiua-5550	81	76	±	±	NUM
aiua-5550	81	77	1.1	1.1	NUM
aiua-5550	81	78	3.7	3.7	NUM
aiua-5550	81	79	±	±	NUM
aiua-5550	81	80	0.8	0.8	NUM
aiua-5550	81	81	0.19	0.19	NUM
aiua-5550	81	82	tzv	tzv	NOUN
aiua-5550	81	83	(	(	PUNCT
aiua-5550	81	84	cm3	cm3	NOUN
aiua-5550	81	85	)	)	PUNCT
aiua-5550	81	86	11.6	11.6	NUM
aiua-5550	81	87	±	±	NUM
aiua-5550	81	88	1.4	1.4	NUM
aiua-5550	81	89	19.5	19.5	NUM
aiua-5550	81	90	±	±	NUM
aiua-5550	81	91	1.3	1.3	NUM
aiua-5550	81	92	0.001	0.001	NUM
aiua-5550	81	93	uroflometry	uroflometry	NOUN
aiua-5550	81	94	data	datum	NOUN
aiua-5550	81	95	:	:	PUNCT
aiua-5550	81	96	qmax	qmax	PROPN
aiua-5550	81	97	(	(	PUNCT
aiua-5550	81	98	ml	ml	PROPN
aiua-5550	81	99	/	/	SYM
aiua-5550	81	100	s	s	NOUN
aiua-5550	81	101	)	)	PUNCT
aiua-5550	81	102	9.75	9.75	NUM
aiua-5550	81	103	±	±	NUM
aiua-5550	81	104	1.34	1.34	NUM
aiua-5550	81	105	10.37	10.37	NUM
aiua-5550	81	106	±	±	NUM
aiua-5550	81	107	1.43	1.43	NUM
aiua-5550	81	108	0.45	0.45	NUM
aiua-5550	81	109	pvr	pvr	NOUN
aiua-5550	81	110	(	(	PUNCT
aiua-5550	81	111	ml	ml	NOUN
aiua-5550	81	112	)	)	PUNCT
aiua-5550	81	113	69.66	69.66	NUM
aiua-5550	81	114	±	±	NUM
aiua-5550	81	115	10.49	10.49	NUM
aiua-5550	81	116	66.12±11.76	66.12±11.76	PROPN
aiua-5550	81	117	0.09	0.09	NUM
aiua-5550	81	118	voided	void	VERB
aiua-5550	81	119	volume	volume	NOUN
aiua-5550	81	120	(	(	PUNCT
aiua-5550	81	121	ml	ml	NOUN
aiua-5550	81	122	)	)	PUNCT
aiua-5550	81	123	185.9	185.9	NUM
aiua-5550	81	124	±	±	NUM
aiua-5550	81	125	11.5	11.5	NUM
aiua-5550	81	126	198.72±17.51	198.72±17.51	NUM
aiua-5550	81	127	0.43	0.43	NUM
aiua-5550	81	128	overall	overall	ADJ
aiua-5550	81	129	ipss	ipss	PROPN
aiua-5550	81	130	score	score	NOUN
aiua-5550	81	131	:	:	PUNCT
aiua-5550	81	132	17.95	17.95	NUM
aiua-5550	81	133	±	±	NUM
aiua-5550	81	134	3.61	3.61	NUM
aiua-5550	81	135	15.54	15.54	NUM
aiua-5550	81	136	±	±	NUM
aiua-5550	81	137	3.53	3.53	NUM
aiua-5550	81	138	0.68	0.68	NUM
aiua-5550	81	139	voiding	void	VERB
aiua-5550	81	140	symptoms	symptom	NOUN
aiua-5550	81	141	7.84	7.84	NUM
aiua-5550	81	142	±	±	NUM
aiua-5550	81	143	2.2	2.2	NUM
aiua-5550	81	144	6.88	6.88	NUM
aiua-5550	81	145	±	±	NUM
aiua-5550	81	146	1.72	1.72	NUM
aiua-5550	81	147	0.06	0.06	NUM
aiua-5550	81	148	storage	storage	NOUN
aiua-5550	81	149	symptoms	symptom	NOUN
aiua-5550	81	150	8.48	8.48	NUM
aiua-5550	81	151	±	±	NUM
aiua-5550	81	152	2.33	2.33	NUM
aiua-5550	81	153	7.35	7.35	NUM
aiua-5550	81	154	±	±	NUM
aiua-5550	81	155	1.64	1.64	NUM
aiua-5550	81	156	0.13	0.13	NUM
aiua-5550	81	157	bother	bother	VERB
aiua-5550	81	158	score	score	NOUN
aiua-5550	81	159	(	(	PUNCT
aiua-5550	81	160	qol	qol	NOUN
aiua-5550	81	161	)	)	PUNCT
aiua-5550	81	162	3.1	3.1	NUM
aiua-5550	81	163	±	±	NUM
aiua-5550	81	164	1.79	1.79	NUM
aiua-5550	81	165	3.37	3.37	NUM
aiua-5550	81	166	±	±	NUM
aiua-5550	81	167	0.96	0.96	NUM
aiua-5550	81	168	0.09	0.09	NUM
aiua-5550	81	169	group	group	NOUN
aiua-5550	81	170	a	a	DET
aiua-5550	81	171	group	group	NOUN
aiua-5550	81	172	b	b	NOUN
aiua-5550	81	173	mean	mean	NOUN
aiua-5550	81	174	±	±	NUM
aiua-5550	81	175	sd	sd	ADP
aiua-5550	81	176	mean	mean	VERB
aiua-5550	81	177	±	±	NOUN
aiua-5550	81	178	sd	sd	ADP
aiua-5550	81	179	subjective	subjective	ADJ
aiua-5550	81	180	/	/	SYM
aiua-5550	81	181	objective	objective	ADJ
aiua-5550	81	182	baseline	baseline	NOUN
aiua-5550	81	183	after	after	ADP
aiua-5550	81	184	treatment	treatment	NOUN
aiua-5550	81	185	p	p	NOUN
aiua-5550	81	186	-	-	PUNCT
aiua-5550	81	187	value	value	NOUN
aiua-5550	81	188	baseline	baseline	NOUN
aiua-5550	81	189	after	after	ADP
aiua-5550	81	190	treatment	treatment	NOUN
aiua-5550	81	191	p	p	NOUN
aiua-5550	81	192	-	-	PUNCT
aiua-5550	81	193	value	value	NOUN
aiua-5550	81	194	post	post	ADJ
aiua-5550	81	195	-	-	ADJ
aiua-5550	81	196	treatment	treatment	ADJ
aiua-5550	81	197	parameters	parameter	NOUN
aiua-5550	81	198	p	p	NOUN
aiua-5550	81	199	-	-	PUNCT
aiua-5550	81	200	value	value	NOUN
aiua-5550	81	201	total	total	NOUN
aiua-5550	81	202	ipss	ipss	PROPN
aiua-5550	81	203	score	score	NOUN
aiua-5550	81	204	:	:	PUNCT
aiua-5550	81	205	17.95	17.95	NUM
aiua-5550	81	206	±	±	NUM
aiua-5550	81	207	3.61	3.61	NUM
aiua-5550	81	208	11.85	11.85	NUM
aiua-5550	81	209	±	±	NUM
aiua-5550	81	210	2.43	2.43	NUM
aiua-5550	81	211	0.000	0.000	NUM
aiua-5550	81	212	15.54	15.54	NUM
aiua-5550	81	213	±	±	NUM
aiua-5550	81	214	3.53	3.53	NUM
aiua-5550	81	215	14.34	14.34	NUM
aiua-5550	81	216	±	±	NUM
aiua-5550	81	217	3.71	3.71	NUM
aiua-5550	81	218	0.9	0.9	NUM
aiua-5550	81	219	0.001	0.001	NUM
aiua-5550	81	220	voiding	void	VERB
aiua-5550	81	221	symptoms	symptom	NOUN
aiua-5550	81	222	7.84	7.84	NUM
aiua-5550	81	223	±	±	NUM
aiua-5550	81	224	2.2	2.2	NUM
aiua-5550	81	225	5.93	5.93	NUM
aiua-5550	81	226	±	±	NUM
aiua-5550	81	227	2.12	2.12	NUM
aiua-5550	81	228	0.001	0.001	NUM
aiua-5550	81	229	6.88	6.88	NUM
aiua-5550	81	230	±	±	NUM
aiua-5550	81	231	1.72	1.72	NUM
aiua-5550	81	232	6.10	6.10	NUM
aiua-5550	81	233	±	±	NUM
aiua-5550	81	234	1.43	1.43	NUM
aiua-5550	81	235	0.27	0.27	NUM
aiua-5550	81	236	0.03	0.03	NUM
aiua-5550	81	237	storage	storage	NOUN
aiua-5550	81	238	symptoms	symptom	NOUN
aiua-5550	81	239	8.48	8.48	NUM
aiua-5550	81	240	±	±	NUM
aiua-5550	81	241	2.33	2.33	NUM
aiua-5550	81	242	5.95	5.95	NUM
aiua-5550	81	243	±	±	NUM
aiua-5550	81	244	1.89	1.89	NUM
aiua-5550	81	245	0.001	0.001	NUM
aiua-5550	81	246	7.35	7.35	NUM
aiua-5550	81	247	±	±	NUM
aiua-5550	81	248	1.64	1.64	NUM
aiua-5550	81	249	5.53	5.53	NUM
aiua-5550	81	250	±	±	NUM
aiua-5550	81	251	1.79	1.79	NUM
aiua-5550	81	252	0.03	0.03	NUM
aiua-5550	81	253	0.01	0.01	NUM
aiua-5550	81	254	qol	qol	NOUN
aiua-5550	81	255	score	score	NOUN
aiua-5550	81	256	3.17	3.17	NUM
aiua-5550	81	257	±	±	NUM
aiua-5550	81	258	1.79	1.79	NUM
aiua-5550	81	259	1.97	1.97	NUM
aiua-5550	81	260	±	±	NUM
aiua-5550	81	261	1.82	1.82	NUM
aiua-5550	81	262	0.0011	0.0011	NUM
aiua-5550	81	263	3.37	3.37	NUM
aiua-5550	81	264	±	±	NUM
aiua-5550	81	265	0.96	0.96	NUM
aiua-5550	81	266	3.12	3.12	NUM
aiua-5550	81	267	±	±	NUM
aiua-5550	81	268	1.20	1.20	NUM
aiua-5550	81	269	0.42	0.42	NUM
aiua-5550	81	270	0.006	0.006	NUM
aiua-5550	81	271	uroflometry	uroflometry	NOUN
aiua-5550	81	272	:	:	PUNCT
aiua-5550	81	273	qmax	qmax	PROPN
aiua-5550	81	274	(	(	PUNCT
aiua-5550	81	275	ml	ml	PROPN
aiua-5550	81	276	/	/	SYM
aiua-5550	81	277	s	s	NOUN
aiua-5550	81	278	)	)	PUNCT
aiua-5550	81	279	9.75	9.75	NUM
aiua-5550	81	280	±	±	NUM
aiua-5550	81	281	1.34	1.34	NUM
aiua-5550	81	282	12.95	12.95	NUM
aiua-5550	81	283	±	±	NUM
aiua-5550	81	284	1.72	1.72	NUM
aiua-5550	81	285	0.002	0.002	NUM
aiua-5550	81	286	10.37	10.37	NUM
aiua-5550	81	287	±	±	NUM
aiua-5550	81	288	1.43	1.43	NUM
aiua-5550	81	289	11.10	11.10	NUM
aiua-5550	81	290	±	±	NUM
aiua-5550	81	291	1.56	1.56	NUM
aiua-5550	81	292	0.06	0.06	NUM
aiua-5550	81	293	0.05	0.05	NUM
aiua-5550	81	294	pvr	pvr	NOUN
aiua-5550	81	295	(	(	PUNCT
aiua-5550	81	296	ml	ml	NOUN
aiua-5550	81	297	)	)	PUNCT
aiua-5550	81	298	69.66	69.66	NUM
aiua-5550	81	299	±	±	NUM
aiua-5550	81	300	10.49	10.49	NUM
aiua-5550	81	301	58.98	58.98	NUM
aiua-5550	81	302	±	±	NUM
aiua-5550	81	303	12.64	12.64	NUM
aiua-5550	81	304	0.04	0.04	NUM
aiua-5550	81	305	66.12	66.12	NUM
aiua-5550	81	306	±	±	NUM
aiua-5550	81	307	11.76	11.76	NUM
aiua-5550	81	308	61.12	61.12	NUM
aiua-5550	81	309	±	±	NUM
aiua-5550	81	310	12.63	12.63	NUM
aiua-5550	81	311	0.32	0.32	NUM
aiua-5550	81	312	0.002	0.002	NUM
aiua-5550	81	313	table	table	NOUN
aiua-5550	81	314	1	1	NUM
aiua-5550	81	315	.	.	PUNCT
aiua-5550	82	1	patients	patient	NOUN
aiua-5550	82	2	characteristics	characteristic	NOUN
aiua-5550	82	3	(	(	PUNCT
aiua-5550	82	4	pretreatment	pretreatment	NOUN
aiua-5550	82	5	data	datum	NOUN
aiua-5550	82	6	)	)	PUNCT
aiua-5550	82	7	in	in	ADP
aiua-5550	82	8	both	both	DET
aiua-5550	82	9	groups	group	NOUN
aiua-5550	82	10	.	.	PUNCT
aiua-5550	83	1	table	table	NOUN
aiua-5550	83	2	2	2	NUM
aiua-5550	83	3	.	.	X
aiua-5550	83	4	intragroup	intragroup	ADV
aiua-5550	83	5	and	and	CCONJ
aiua-5550	83	6	intergroup	intergroup	ADJ
aiua-5550	83	7	comparisons	comparison	NOUN
aiua-5550	83	8	of	of	ADP
aiua-5550	83	9	subjective	subjective	ADJ
aiua-5550	83	10	(	(	PUNCT
aiua-5550	83	11	ipss	ipss	PROPN
aiua-5550	83	12	score	score	PROPN
aiua-5550	83	13	)	)	PUNCT
aiua-5550	83	14	and	and	CCONJ
aiua-5550	83	15	objective	objective	ADJ
aiua-5550	83	16	(	(	PUNCT
aiua-5550	83	17	uroflometry	uroflometry	NOUN
aiua-5550	83	18	)	)	PUNCT
aiua-5550	83	19	parameters	parameter	NOUN
aiua-5550	83	20	after	after	ADP
aiua-5550	83	21	2	2	NUM
aiua-5550	83	22	months	month	NOUN
aiua-5550	83	23	of	of	ADP
aiua-5550	83	24	treatment	treatment	NOUN
aiua-5550	83	25	with	with	ADP
aiua-5550	83	26	tamsulosin	tamsulosin	NOUN
aiua-5550	83	27	hydrochloride	hydrochloride	NOUN
aiua-5550	83	28	.	.	PUNCT
aiua-5550	84	1	ali	ali	PROPN
aiua-5550	84	2	raheem_stesura	raheem_stesura	PROPN
aiua-5550	84	3	seveso	seveso	VERB
aiua-5550	85	1	30/09/15	30/09/15	PROPN
aiua-5550	85	2	09:39	09:39	NUM
aiua-5550	85	3	pagina	pagina	NOUN
aiua-5550	85	4	240	240	NUM
aiua-5550	85	5	241archivio	241archivio	PROPN
aiua-5550	85	6	italiano	italiano	NOUN
aiua-5550	85	7	di	di	X
aiua-5550	85	8	urologia	urologia	PROPN
aiua-5550	85	9	e	e	PROPN
aiua-5550	85	10	andrologia	andrologia	NOUN
aiua-5550	85	11	2015	2015	NUM
aiua-5550	85	12	;	;	PUNCT
aiua-5550	85	13	87	87	NUM
aiua-5550	85	14	,	,	PUNCT
aiua-5550	85	15	3	3	NUM
aiua-5550	85	16	impact	impact	NOUN
aiua-5550	85	17	of	of	ADP
aiua-5550	85	18	prostatic	prostatic	ADJ
aiua-5550	85	19	-	-	PUNCT
aiua-5550	85	20	urethral	urethral	ADJ
aiua-5550	85	21	angulation	angulation	NOUN
aiua-5550	85	22	on	on	ADP
aiua-5550	85	23	treatment	treatment	NOUN
aiua-5550	85	24	of	of	ADP
aiua-5550	85	25	bph	bph	NOUN
aiua-5550	85	26	basis	basis	NOUN
aiua-5550	85	27	,	,	PUNCT
aiua-5550	85	28	that	that	PRON
aiua-5550	85	29	is	be	AUX
aiua-5550	85	30	symptomatic	symptomatic	ADJ
aiua-5550	85	31	patients	patient	NOUN
aiua-5550	85	32	who	who	PRON
aiua-5550	85	33	require	require	VERB
aiua-5550	85	34	treatment	treatment	NOUN
aiua-5550	85	35	.	.	PUNCT
aiua-5550	86	1	in	in	ADP
aiua-5550	86	2	their	their	PRON
aiua-5550	86	3	study	study	NOUN
aiua-5550	86	4	the	the	DET
aiua-5550	86	5	patients	patient	NOUN
aiua-5550	86	6	were	be	AUX
aiua-5550	86	7	healthy	healthy	ADJ
aiua-5550	86	8	men	man	NOUN
aiua-5550	86	9	with	with	ADP
aiua-5550	86	10	no	no	DET
aiua-5550	86	11	evidence	evidence	NOUN
aiua-5550	86	12	of	of	ADP
aiua-5550	86	13	boo	boo	NOUN
aiua-5550	86	14	(	(	PUNCT
aiua-5550	86	15	patients	patient	NOUN
aiua-5550	86	16	age	age	VERB
aiua-5550	86	17	50	50	NUM
aiua-5550	86	18	to	to	PART
aiua-5550	86	19	59	59	NUM
aiua-5550	86	20	years	year	NOUN
aiua-5550	86	21	with	with	ADP
aiua-5550	86	22	prostate	prostate	NOUN
aiua-5550	86	23	volume	volume	NOUN
aiua-5550	86	24	30	30	NUM
aiua-5550	86	25	ml	ml	NOUN
aiua-5550	86	26	and	and	CCONJ
aiua-5550	86	27	qmax	qmax	PROPN
aiua-5550	86	28	15	15	NUM
aiua-5550	86	29	ml	ml	NOUN
aiua-5550	86	30	/	/	SYM
aiua-5550	86	31	s	s	NOUN
aiua-5550	86	32	)	)	PUNCT
aiua-5550	86	33	.	.	PUNCT
aiua-5550	87	1	moreover	moreover	ADV
aiua-5550	87	2	,	,	PUNCT
aiua-5550	87	3	the	the	DET
aiua-5550	87	4	large	large	ADJ
aiua-5550	87	5	number	number	NOUN
aiua-5550	87	6	of	of	ADP
aiua-5550	87	7	patients	patient	NOUN
aiua-5550	87	8	in	in	ADP
aiua-5550	87	9	these	these	DET
aiua-5550	87	10	studies	study	NOUN
aiua-5550	87	11	may	may	AUX
aiua-5550	87	12	help	help	VERB
aiua-5550	87	13	to	to	PART
aiua-5550	87	14	make	make	VERB
aiua-5550	87	15	clear	clear	ADJ
aiua-5550	87	16	explanations	explanation	NOUN
aiua-5550	87	17	.	.	PUNCT
aiua-5550	88	1	after	after	ADP
aiua-5550	88	2	2	2	NUM
aiua-5550	88	3	months	month	NOUN
aiua-5550	88	4	of	of	ADP
aiua-5550	88	5	medical	medical	ADJ
aiua-5550	88	6	treatment	treatment	NOUN
aiua-5550	88	7	,	,	PUNCT
aiua-5550	88	8	a	a	DET
aiua-5550	88	9	significant	significant	ADJ
aiua-5550	88	10	improvement	improvement	NOUN
aiua-5550	88	11	in	in	ADP
aiua-5550	88	12	qmax	qmax	PROPN
aiua-5550	88	13	and	and	CCONJ
aiua-5550	88	14	pvr	pvr	NOUN
aiua-5550	88	15	urine	urine	NOUN
aiua-5550	88	16	was	be	AUX
aiua-5550	88	17	found	find	VERB
aiua-5550	88	18	in	in	ADP
aiua-5550	88	19	group	group	PROPN
aiua-5550	88	20	a	a	DET
aiua-5550	88	21	(	(	PUNCT
aiua-5550	88	22	p	p	NOUN
aiua-5550	88	23	-	-	PUNCT
aiua-5550	88	24	value	value	NOUN
aiua-5550	88	25	=	=	NOUN
aiua-5550	88	26	0.000	0.000	NUM
aiua-5550	88	27	and	and	CCONJ
aiua-5550	88	28	0.04	0.04	NUM
aiua-5550	88	29	)	)	PUNCT
aiua-5550	88	30	,	,	PUNCT
aiua-5550	88	31	while	while	SCONJ
aiua-5550	88	32	no	no	DET
aiua-5550	88	33	improvement	improvement	NOUN
aiua-5550	88	34	was	be	AUX
aiua-5550	88	35	present	present	ADJ
aiua-5550	88	36	in	in	ADP
aiua-5550	88	37	group	group	PROPN
aiua-5550	88	38	b	b	PROPN
aiua-5550	88	39	(	(	PUNCT
aiua-5550	88	40	p	p	NOUN
aiua-5550	88	41	-	-	PUNCT
aiua-5550	88	42	value	value	NOUN
aiua-5550	88	43	=	=	NOUN
aiua-5550	88	44	0.9	0.9	NUM
aiua-5550	88	45	and	and	CCONJ
aiua-5550	88	46	0.32	0.32	NUM
aiua-5550	88	47	)	)	PUNCT
aiua-5550	88	48	(	(	PUNCT
aiua-5550	88	49	table	table	NOUN
aiua-5550	88	50	2	2	NUM
aiua-5550	88	51	)	)	PUNCT
aiua-5550	88	52	.	.	PUNCT
aiua-5550	89	1	more	more	ADV
aiua-5550	89	2	recently	recently	ADV
aiua-5550	89	3	,	,	PUNCT
aiua-5550	89	4	it	it	PRON
aiua-5550	89	5	was	be	AUX
aiua-5550	89	6	found	find	VERB
aiua-5550	89	7	that	that	SCONJ
aiua-5550	89	8	the	the	DET
aiua-5550	89	9	improvement	improvement	NOUN
aiua-5550	89	10	in	in	ADP
aiua-5550	89	11	qmax	qmax	PROPN
aiua-5550	89	12	values	value	NOUN
aiua-5550	89	13	from	from	ADP
aiua-5550	89	14	baseline	baseline	NOUN
aiua-5550	89	15	after	after	ADP
aiua-5550	89	16	3	3	NUM
aiua-5550	89	17	months	month	NOUN
aiua-5550	89	18	of	of	ADP
aiua-5550	89	19	tamsulosin	tamsulosin	NOUN
aiua-5550	89	20	therapy	therapy	NOUN
aiua-5550	89	21	was	be	AUX
aiua-5550	89	22	poor	poor	ADJ
aiua-5550	89	23	in	in	ADP
aiua-5550	89	24	patients	patient	NOUN
aiua-5550	89	25	with	with	ADP
aiua-5550	89	26	higher	high	ADJ
aiua-5550	89	27	pua	pua	NOUN
aiua-5550	89	28	,	,	PUNCT
aiua-5550	89	29	and	and	CCONJ
aiua-5550	89	30	this	this	PRON
aiua-5550	89	31	is	be	AUX
aiua-5550	89	32	evident	evident	ADJ
aiua-5550	89	33	in	in	ADP
aiua-5550	89	34	our	our	PRON
aiua-5550	89	35	study	study	NOUN
aiua-5550	89	36	(	(	PUNCT
aiua-5550	89	37	17	17	NUM
aiua-5550	89	38	)	)	PUNCT
aiua-5550	89	39	.	.	PUNCT
aiua-5550	90	1	it	it	PRON
aiua-5550	90	2	is	be	AUX
aiua-5550	90	3	well	well	ADV
aiua-5550	90	4	known	known	ADJ
aiua-5550	90	5	to	to	ADP
aiua-5550	90	6	us	we	PRON
aiua-5550	90	7	that	that	SCONJ
aiua-5550	90	8	the	the	DET
aiua-5550	90	9	ipss	ipss	PROPN
aiua-5550	90	10	/	/	SYM
aiua-5550	90	11	qol	qol	PROPN
aiua-5550	90	12	score	score	NOUN
aiua-5550	90	13	is	be	AUX
aiua-5550	90	14	an	an	DET
aiua-5550	90	15	essential	essential	ADJ
aiua-5550	90	16	subjective	subjective	ADJ
aiua-5550	90	17	tool	tool	NOUN
aiua-5550	90	18	for	for	ADP
aiua-5550	90	19	assessing	assess	VERB
aiua-5550	90	20	symptoms	symptom	NOUN
aiua-5550	90	21	severity	severity	NOUN
aiua-5550	90	22	and	and	CCONJ
aiua-5550	90	23	disease	disease	NOUN
aiua-5550	90	24	-	-	PUNCT
aiua-5550	90	25	specific	specific	ADJ
aiua-5550	90	26	qol	qol	NOUN
aiua-5550	90	27	when	when	SCONJ
aiua-5550	90	28	determining	determine	VERB
aiua-5550	90	29	treatment	treatment	NOUN
aiua-5550	90	30	strategies	strategy	NOUN
aiua-5550	90	31	and	and	CCONJ
aiua-5550	90	32	evaluating	evaluate	VERB
aiua-5550	90	33	treatment	treatment	NOUN
aiua-5550	90	34	outcome	outcome	NOUN
aiua-5550	90	35	in	in	ADP
aiua-5550	90	36	men	man	NOUN
aiua-5550	90	37	with	with	ADP
aiua-5550	90	38	luts	luts	PROPN
aiua-5550	90	39	/	/	SYM
aiua-5550	90	40	bph	bph	PROPN
aiua-5550	90	41	(	(	PUNCT
aiua-5550	90	42	19	19	NUM
aiua-5550	90	43	)	)	PUNCT
aiua-5550	90	44	.	.	PUNCT
aiua-5550	91	1	we	we	PRON
aiua-5550	91	2	utilized	utilize	VERB
aiua-5550	91	3	the	the	DET
aiua-5550	91	4	ipss	ipss	PROPN
aiua-5550	91	5	/	/	SYM
aiua-5550	91	6	qol	qol	PROPN
aiua-5550	91	7	score	score	NOUN
aiua-5550	91	8	in	in	ADP
aiua-5550	91	9	the	the	DET
aiua-5550	91	10	subjective	subjective	ADJ
aiua-5550	91	11	evaluation	evaluation	NOUN
aiua-5550	91	12	of	of	ADP
aiua-5550	91	13	medical	medical	ADJ
aiua-5550	91	14	treatment	treatment	NOUN
aiua-5550	91	15	outcome	outcome	NOUN
aiua-5550	91	16	in	in	ADP
aiua-5550	91	17	our	our	PRON
aiua-5550	91	18	patients	patient	NOUN
aiua-5550	91	19	.	.	PUNCT
aiua-5550	92	1	at	at	ADP
aiua-5550	92	2	baseline	baseline	ADJ
aiua-5550	92	3	evaluation	evaluation	NOUN
aiua-5550	92	4	(	(	PUNCT
aiua-5550	92	5	pre	pre	NOUN
aiua-5550	92	6	-	-	NOUN
aiua-5550	92	7	treatment	treatment	NOUN
aiua-5550	92	8	)	)	PUNCT
aiua-5550	92	9	,	,	PUNCT
aiua-5550	92	10	no	no	DET
aiua-5550	92	11	difference	difference	NOUN
aiua-5550	92	12	in	in	ADP
aiua-5550	92	13	the	the	DET
aiua-5550	92	14	ipss	ipss	PROPN
aiua-5550	92	15	/	/	SYM
aiua-5550	92	16	qol	qol	PROPN
aiua-5550	92	17	score	score	NOUN
aiua-5550	92	18	was	be	AUX
aiua-5550	92	19	found	find	VERB
aiua-5550	92	20	between	between	ADP
aiua-5550	92	21	both	both	DET
aiua-5550	92	22	groups	group	NOUN
aiua-5550	92	23	(	(	PUNCT
aiua-5550	92	24	p	p	NOUN
aiua-5550	92	25	-	-	PUNCT
aiua-5550	92	26	value	value	NOUN
aiua-5550	92	27	=	=	NOUN
aiua-5550	92	28	0.68	0.68	NUM
aiua-5550	92	29	and	and	CCONJ
aiua-5550	92	30	0.09	0.09	NUM
aiua-5550	92	31	respectively	respectively	ADV
aiua-5550	92	32	)	)	PUNCT
aiua-5550	92	33	(	(	PUNCT
aiua-5550	92	34	table	table	NOUN
aiua-5550	92	35	1	1	NUM
aiua-5550	92	36	)	)	PUNCT
aiua-5550	92	37	.	.	PUNCT
aiua-5550	93	1	these	these	DET
aiua-5550	93	2	findings	finding	NOUN
aiua-5550	93	3	are	be	AUX
aiua-5550	93	4	similar	similar	ADJ
aiua-5550	93	5	and	and	CCONJ
aiua-5550	93	6	agree	agree	VERB
aiua-5550	93	7	with	with	ADP
aiua-5550	93	8	previous	previous	ADJ
aiua-5550	93	9	reports	report	NOUN
aiua-5550	93	10	(	(	PUNCT
aiua-5550	93	11	12	12	NUM
aiua-5550	93	12	-	-	SYM
aiua-5550	93	13	13	13	NUM
aiua-5550	93	14	)	)	PUNCT
aiua-5550	93	15	.	.	PUNCT
aiua-5550	94	1	at	at	ADP
aiua-5550	94	2	2	2	NUM
aiua-5550	94	3	months	month	NOUN
aiua-5550	94	4	of	of	ADP
aiua-5550	94	5	follow	follow	NOUN
aiua-5550	94	6	-	-	PUNCT
aiua-5550	94	7	up	up	NOUN
aiua-5550	94	8	our	our	PRON
aiua-5550	94	9	study	study	NOUN
aiua-5550	94	10	showed	show	VERB
aiua-5550	94	11	a	a	DET
aiua-5550	94	12	statistically	statistically	ADV
aiua-5550	94	13	significant	significant	ADJ
aiua-5550	94	14	improvement	improvement	NOUN
aiua-5550	94	15	in	in	ADP
aiua-5550	94	16	the	the	DET
aiua-5550	94	17	ipss	ipss	PROPN
aiua-5550	94	18	/	/	SYM
aiua-5550	94	19	qol	qol	PROPN
aiua-5550	94	20	scores	score	NOUN
aiua-5550	94	21	in	in	ADP
aiua-5550	94	22	group	group	PROPN
aiua-5550	94	23	a	a	PRON
aiua-5550	94	24	compared	compare	VERB
aiua-5550	94	25	to	to	ADP
aiua-5550	94	26	group	group	PROPN
aiua-5550	94	27	b	b	PROPN
aiua-5550	94	28	(	(	PUNCT
aiua-5550	94	29	p	p	NOUN
aiua-5550	94	30	-	-	PUNCT
aiua-5550	94	31	value	value	NOUN
aiua-5550	94	32	=	=	NOUN
aiua-5550	94	33	0.0005	0.0005	NUM
aiua-5550	94	34	and	and	CCONJ
aiua-5550	94	35	<	<	X
aiua-5550	94	36	0.000	0.000	NUM
aiua-5550	94	37	respectively	respectively	ADV
aiua-5550	94	38	)	)	PUNCT
aiua-5550	94	39	(	(	PUNCT
aiua-5550	94	40	table	table	NOUN
aiua-5550	94	41	2	2	NUM
aiua-5550	94	42	)	)	PUNCT
aiua-5550	94	43	.	.	PUNCT
aiua-5550	95	1	this	this	PRON
aiua-5550	95	2	can	can	AUX
aiua-5550	95	3	be	be	AUX
aiua-5550	95	4	explained	explain	VERB
aiua-5550	95	5	by	by	ADP
aiua-5550	95	6	the	the	DET
aiua-5550	95	7	presence	presence	NOUN
aiua-5550	95	8	of	of	ADP
aiua-5550	95	9	significant	significant	ADJ
aiua-5550	95	10	mechanical	mechanical	ADJ
aiua-5550	95	11	factors	factor	NOUN
aiua-5550	95	12	for	for	ADP
aiua-5550	95	13	obstruction	obstruction	NOUN
aiua-5550	95	14	among	among	ADP
aiua-5550	95	15	patients	patient	NOUN
aiua-5550	95	16	in	in	ADP
aiua-5550	95	17	group	group	PROPN
aiua-5550	95	18	b	b	PROPN
aiua-5550	95	19	(	(	PUNCT
aiua-5550	95	20	pua	pua	PROPN
aiua-5550	95	21	>	>	X
aiua-5550	95	22	35	35	NUM
aiua-5550	95	23	)	)	PUNCT
aiua-5550	95	24	.	.	PUNCT
aiua-5550	96	1	in	in	ADP
aiua-5550	96	2	presence	presence	NOUN
aiua-5550	96	3	of	of	ADP
aiua-5550	96	4	this	this	DET
aiua-5550	96	5	factor	factor	NOUN
aiua-5550	96	6	it	it	PRON
aiua-5550	96	7	would	would	AUX
aiua-5550	96	8	be	be	AUX
aiua-5550	96	9	expected	expect	VERB
aiua-5550	96	10	no	no	DET
aiua-5550	96	11	response	response	NOUN
aiua-5550	96	12	to	to	ADP
aiua-5550	96	13	alpha	alpha	NOUN
aiua-5550	96	14	blocker	blocker	NOUN
aiua-5550	96	15	drugs	drug	NOUN
aiua-5550	96	16	that	that	PRON
aiua-5550	96	17	usually	usually	ADV
aiua-5550	96	18	affect	affect	VERB
aiua-5550	96	19	the	the	DET
aiua-5550	96	20	dynamic	dynamic	ADJ
aiua-5550	96	21	part	part	NOUN
aiua-5550	96	22	of	of	ADP
aiua-5550	96	23	the	the	DET
aiua-5550	96	24	obstruction	obstruction	NOUN
aiua-5550	96	25	.	.	PUNCT
aiua-5550	97	1	our	our	PRON
aiua-5550	97	2	findings	finding	NOUN
aiua-5550	97	3	were	be	AUX
aiua-5550	97	4	similar	similar	ADJ
aiua-5550	97	5	to	to	ADP
aiua-5550	97	6	those	those	PRON
aiua-5550	97	7	of	of	ADP
aiua-5550	97	8	hou	hou	PROPN
aiua-5550	97	9	et	et	PROPN
aiua-5550	97	10	al	al	PROPN
aiua-5550	97	11	.	.	PROPN
aiua-5550	97	12	who	who	PRON
aiua-5550	97	13	investigated	investigate	VERB
aiua-5550	97	14	the	the	DET
aiua-5550	97	15	association	association	NOUN
aiua-5550	97	16	of	of	ADP
aiua-5550	97	17	the	the	DET
aiua-5550	97	18	pua	pua	PROPN
aiua-5550	97	19	and	and	CCONJ
aiua-5550	97	20	the	the	DET
aiua-5550	97	21	severity	severity	NOUN
aiua-5550	97	22	of	of	ADP
aiua-5550	97	23	luts	luts	PROPN
aiua-5550	97	24	on	on	ADP
aiua-5550	97	25	the	the	DET
aiua-5550	97	26	aging	age	VERB
aiua-5550	97	27	male	male	NOUN
aiua-5550	97	28	.	.	PUNCT
aiua-5550	98	1	they	they	PRON
aiua-5550	98	2	also	also	ADV
aiua-5550	98	3	evaluated	evaluate	VERB
aiua-5550	98	4	the	the	DET
aiua-5550	98	5	pua	pua	PROPN
aiua-5550	98	6	effect	effect	NOUN
aiua-5550	98	7	on	on	ADP
aiua-5550	98	8	tamsulosin	tamsulosin	NOUN
aiua-5550	98	9	hydrochloride	hydrochloride	NOUN
aiua-5550	98	10	therapy	therapy	NOUN
aiua-5550	98	11	:	:	PUNCT
aiua-5550	98	12	after	after	ADP
aiua-5550	98	13	3	3	NUM
aiua-5550	98	14	months	month	NOUN
aiua-5550	98	15	of	of	ADP
aiua-5550	98	16	medical	medical	ADJ
aiua-5550	98	17	treatment	treatment	NOUN
aiua-5550	98	18	they	they	PRON
aiua-5550	98	19	found	find	VERB
aiua-5550	98	20	that	that	SCONJ
aiua-5550	98	21	the	the	DET
aiua-5550	98	22	pua	pua	PROPN
aiua-5550	98	23	had	have	VERB
aiua-5550	98	24	an	an	DET
aiua-5550	98	25	extremely	extremely	ADV
aiua-5550	98	26	strong	strong	ADJ
aiua-5550	98	27	correlation	correlation	NOUN
aiua-5550	98	28	with	with	ADP
aiua-5550	98	29	ipss	ipss	PROPN
aiua-5550	98	30	score	score	NOUN
aiua-5550	98	31	and	and	CCONJ
aiua-5550	98	32	was	be	AUX
aiua-5550	98	33	inversely	inversely	ADV
aiua-5550	98	34	correlated	correlate	VERB
aiua-5550	98	35	with	with	ADP
aiua-5550	98	36	changes	change	NOUN
aiua-5550	98	37	in	in	ADP
aiua-5550	98	38	the	the	DET
aiua-5550	98	39	ipss	ipss	PROPN
aiua-5550	98	40	score	score	NOUN
aiua-5550	98	41	after	after	ADP
aiua-5550	98	42	tamsulosin	tamsulosin	NOUN
aiua-5550	98	43	treatment	treatment	NOUN
aiua-5550	98	44	(	(	PUNCT
aiua-5550	98	45	17	17	NUM
aiua-5550	98	46	)	)	PUNCT
aiua-5550	98	47	.	.	PUNCT
aiua-5550	99	1	to	to	ADP
aiua-5550	99	2	our	our	PRON
aiua-5550	99	3	knowledge	knowledge	NOUN
aiua-5550	99	4	,	,	PUNCT
aiua-5550	99	5	the	the	DET
aiua-5550	99	6	prostatic	prostatic	ADJ
aiua-5550	99	7	urethra	urethra	NOUN
aiua-5550	99	8	passes	pass	VERB
aiua-5550	99	9	through	through	ADP
aiua-5550	99	10	the	the	DET
aiua-5550	99	11	prostate	prostate	NOUN
aiua-5550	99	12	from	from	ADP
aiua-5550	99	13	its	its	PRON
aiua-5550	99	14	base	base	NOUN
aiua-5550	99	15	to	to	ADP
aiua-5550	99	16	its	its	PRON
aiua-5550	99	17	apex	apex	NOUN
aiua-5550	99	18	and	and	CCONJ
aiua-5550	99	19	this	this	DET
aiua-5550	99	20	lead	lead	NOUN
aiua-5550	99	21	to	to	ADP
aiua-5550	99	22	formation	formation	NOUN
aiua-5550	99	23	of	of	ADP
aiua-5550	99	24	an	an	DET
aiua-5550	99	25	anterior	anterior	ADJ
aiua-5550	99	26	angle	angle	NOUN
aiua-5550	99	27	of	of	ADP
aiua-5550	99	28	35	35	NUM
aiua-5550	99	29	°	°	NOUN
aiua-5550	99	30	proximal	proximal	ADJ
aiua-5550	99	31	to	to	ADP
aiua-5550	99	32	the	the	DET
aiua-5550	99	33	veru	veru	PROPN
aiua-5550	99	34	montanum	montanum	PROPN
aiua-5550	99	35	,	,	PUNCT
aiua-5550	99	36	this	this	DET
aiua-5550	99	37	angle	angle	NOUN
aiua-5550	99	38	divides	divide	VERB
aiua-5550	99	39	the	the	DET
aiua-5550	99	40	urethra	urethra	NOUN
aiua-5550	99	41	into	into	ADP
aiua-5550	99	42	proximal	proximal	ADJ
aiua-5550	99	43	and	and	CCONJ
aiua-5550	99	44	distal	distal	ADJ
aiua-5550	99	45	regions	region	NOUN
aiua-5550	99	46	(	(	PUNCT
aiua-5550	99	47	20	20	NUM
aiua-5550	99	48	)	)	PUNCT
aiua-5550	99	49	.	.	PUNCT
aiua-5550	100	1	in	in	ADP
aiua-5550	100	2	men	man	NOUN
aiua-5550	100	3	with	with	ADP
aiua-5550	100	4	nodular	nodular	ADJ
aiua-5550	100	5	hyperplasia	hyperplasia	NOUN
aiua-5550	100	6	the	the	DET
aiua-5550	100	7	angle	angle	NOUN
aiua-5550	100	8	tends	tend	VERB
aiua-5550	100	9	to	to	PART
aiua-5550	100	10	be	be	AUX
aiua-5550	100	11	>	>	X
aiua-5550	100	12	35	35	NUM
aiua-5550	100	13	°	°	NOUN
aiua-5550	100	14	,	,	PUNCT
aiua-5550	100	15	however	however	ADV
aiua-5550	100	16	,	,	PUNCT
aiua-5550	100	17	it	it	PRON
aiua-5550	100	18	could	could	AUX
aiua-5550	100	19	be	be	AUX
aiua-5550	100	20	also	also	ADV
aiua-5550	100	21	increased	increase	VERB
aiua-5550	100	22	in	in	ADP
aiua-5550	100	23	men	man	NOUN
aiua-5550	100	24	without	without	ADP
aiua-5550	100	25	nodular	nodular	ADJ
aiua-5550	100	26	hyperplasia	hyperplasia	NOUN
aiua-5550	100	27	,	,	PUNCT
aiua-5550	100	28	as	as	SCONJ
aiua-5550	100	29	found	find	VERB
aiua-5550	100	30	during	during	ADP
aiua-5550	100	31	cystoscopic	cystoscopic	ADJ
aiua-5550	100	32	examination	examination	NOUN
aiua-5550	100	33	;	;	PUNCT
aiua-5550	100	34	an	an	DET
aiua-5550	100	35	increased	increase	VERB
aiua-5550	100	36	pua	pua	NOUN
aiua-5550	100	37	,	,	PUNCT
aiua-5550	100	38	results	result	VERB
aiua-5550	100	39	in	in	ADP
aiua-5550	100	40	a	a	DET
aiua-5550	100	41	higher	high	ADJ
aiua-5550	100	42	bladder	bladder	NOUN
aiua-5550	100	43	neck	neck	NOUN
aiua-5550	100	44	without	without	ADP
aiua-5550	100	45	lateral	lateral	ADJ
aiua-5550	100	46	or	or	CCONJ
aiua-5550	100	47	median	median	ADJ
aiua-5550	100	48	lobe	lobe	NOUN
aiua-5550	100	49	enlargement	enlargement	NOUN
aiua-5550	100	50	which	which	PRON
aiua-5550	100	51	is	be	AUX
aiua-5550	100	52	suggested	suggest	VERB
aiua-5550	100	53	as	as	ADP
aiua-5550	100	54	a	a	DET
aiua-5550	100	55	clinically	clinically	ADV
aiua-5550	100	56	significant	significant	ADJ
aiua-5550	100	57	causal	causal	ADJ
aiua-5550	100	58	factor	factor	NOUN
aiua-5550	100	59	of	of	ADP
aiua-5550	100	60	male	male	ADJ
aiua-5550	100	61	luts	luts	PROPN
aiua-5550	100	62	(	(	PUNCT
aiua-5550	100	63	10	10	NUM
aiua-5550	100	64	-	-	SYM
aiua-5550	100	65	11	11	NUM
aiua-5550	100	66	)	)	PUNCT
aiua-5550	100	67	.	.	PUNCT
aiua-5550	101	1	looking	look	VERB
aiua-5550	101	2	at	at	ADP
aiua-5550	101	3	measurement	measurement	NOUN
aiua-5550	101	4	of	of	ADP
aiua-5550	101	5	the	the	DET
aiua-5550	101	6	prostatic	prostatic	ADJ
aiua-5550	101	7	parameters	parameter	NOUN
aiua-5550	101	8	in	in	ADP
aiua-5550	101	9	our	our	PRON
aiua-5550	101	10	patients	patient	NOUN
aiua-5550	101	11	,	,	PUNCT
aiua-5550	101	12	the	the	DET
aiua-5550	101	13	tpv	tpv	PROPN
aiua-5550	101	14	and	and	CCONJ
aiua-5550	101	15	tzv	tzv	NOUN
aiua-5550	101	16	were	be	AUX
aiua-5550	101	17	higher	high	ADJ
aiua-5550	101	18	in	in	ADP
aiua-5550	101	19	patients	patient	NOUN
aiua-5550	101	20	with	with	ADP
aiua-5550	101	21	pua	pua	PROPN
aiua-5550	101	22	>	>	X
aiua-5550	101	23	35˚	35˚	NUM
aiua-5550	101	24	and	and	CCONJ
aiua-5550	101	25	the	the	DET
aiua-5550	101	26	ipp	ipp	NOUN
aiua-5550	101	27	was	be	AUX
aiua-5550	101	28	similar	similar	ADJ
aiua-5550	101	29	with	with	ADP
aiua-5550	101	30	no	no	DET
aiua-5550	101	31	significant	significant	ADJ
aiua-5550	101	32	difference	difference	NOUN
aiua-5550	101	33	between	between	ADP
aiua-5550	101	34	both	both	DET
aiua-5550	101	35	groups	group	NOUN
aiua-5550	101	36	.	.	PUNCT
aiua-5550	102	1	in	in	ADP
aiua-5550	102	2	fact	fact	NOUN
aiua-5550	102	3	several	several	ADJ
aiua-5550	102	4	studies	study	NOUN
aiua-5550	102	5	reported	report	VERB
aiua-5550	102	6	that	that	SCONJ
aiua-5550	102	7	the	the	DET
aiua-5550	102	8	prostate	prostate	NOUN
aiua-5550	102	9	volume	volume	NOUN
aiua-5550	102	10	does	do	AUX
aiua-5550	102	11	not	not	PART
aiua-5550	102	12	correlate	correlate	VERB
aiua-5550	102	13	with	with	ADP
aiua-5550	102	14	the	the	DET
aiua-5550	102	15	clinical	clinical	ADJ
aiua-5550	102	16	luts	lut	NOUN
aiua-5550	102	17	and/or	and/or	CCONJ
aiua-5550	102	18	the	the	DET
aiua-5550	102	19	degree	degree	NOUN
aiua-5550	102	20	of	of	ADP
aiua-5550	102	21	boo	boo	NOUN
aiua-5550	102	22	(	(	PUNCT
aiua-5550	102	23	2	2	NUM
aiua-5550	102	24	,	,	PUNCT
aiua-5550	102	25	3	3	NUM
aiua-5550	102	26	)	)	PUNCT
aiua-5550	102	27	;	;	PUNCT
aiua-5550	102	28	in	in	ADP
aiua-5550	102	29	addition	addition	NOUN
aiua-5550	102	30	the	the	DET
aiua-5550	102	31	mean	mean	ADJ
aiua-5550	102	32	ipp	ipp	NOUN
aiua-5550	102	33	of	of	ADP
aiua-5550	102	34	our	our	PRON
aiua-5550	102	35	patients	patient	NOUN
aiua-5550	102	36	was	be	AUX
aiua-5550	102	37	small	small	ADJ
aiua-5550	102	38	3.6	3.6	NUM
aiua-5550	102	39	±	±	NUM
aiua-5550	102	40	1.1	1.1	NUM
aiua-5550	102	41	mm	mm	NOUN
aiua-5550	102	42	,	,	PUNCT
aiua-5550	102	43	while	while	SCONJ
aiua-5550	102	44	keqin	keqin	PROPN
aiua-5550	102	45	et	et	PROPN
aiua-5550	102	46	al	al	PROPN
aiua-5550	102	47	.	.	PROPN
aiua-5550	102	48	used	use	VERB
aiua-5550	102	49	an	an	DET
aiua-5550	102	50	ipp	ipp	NOUN
aiua-5550	102	51	cutoff	cutoff	NOUN
aiua-5550	102	52	value	value	NOUN
aiua-5550	102	53	of	of	ADP
aiua-5550	102	54	10	10	NUM
aiua-5550	102	55	mm	mm	NOUN
aiua-5550	102	56	for	for	ADP
aiua-5550	102	57	better	well	ADJ
aiua-5550	102	58	classification	classification	NOUN
aiua-5550	102	59	of	of	ADP
aiua-5550	102	60	boo	boo	NOUN
aiua-5550	102	61	in	in	ADP
aiua-5550	102	62	patients	patient	NOUN
aiua-5550	102	63	and	and	CCONJ
aiua-5550	102	64	correlation	correlation	NOUN
aiua-5550	102	65	with	with	ADP
aiua-5550	102	66	clinical	clinical	ADJ
aiua-5550	102	67	symptoms	symptom	NOUN
aiua-5550	102	68	(	(	PUNCT
aiua-5550	102	69	21	21	NUM
aiua-5550	102	70	)	)	PUNCT
aiua-5550	102	71	.	.	PUNCT
aiua-5550	103	1	therefore	therefore	ADV
aiua-5550	103	2	,	,	PUNCT
aiua-5550	103	3	it	it	PRON
aiua-5550	103	4	is	be	AUX
aiua-5550	103	5	clearly	clearly	ADV
aiua-5550	103	6	evident	evident	ADJ
aiua-5550	103	7	that	that	SCONJ
aiua-5550	103	8	the	the	DET
aiua-5550	103	9	pua	pua	PROPN
aiua-5550	103	10	is	be	AUX
aiua-5550	103	11	an	an	DET
aiua-5550	103	12	important	important	ADJ
aiua-5550	103	13	prostatic	prostatic	ADJ
aiua-5550	103	14	measurement	measurement	NOUN
aiua-5550	103	15	and	and	CCONJ
aiua-5550	103	16	it	it	PRON
aiua-5550	103	17	might	might	AUX
aiua-5550	103	18	be	be	AUX
aiua-5550	103	19	a	a	DET
aiua-5550	103	20	predictor	predictor	NOUN
aiua-5550	103	21	of	of	ADP
aiua-5550	103	22	treatment	treatment	NOUN
aiua-5550	103	23	efficacy	efficacy	NOUN
aiua-5550	103	24	of	of	ADP
aiua-5550	103	25	α	α	NOUN
aiua-5550	103	26	-	-	PUNCT
aiua-5550	103	27	blockers	blocker	NOUN
aiua-5550	103	28	in	in	ADP
aiua-5550	103	29	men	man	NOUN
aiua-5550	103	30	with	with	ADP
aiua-5550	103	31	luts	luts	PROPN
aiua-5550	103	32	/	/	SYM
aiua-5550	103	33	bph	bph	NOUN
aiua-5550	103	34	.	.	PUNCT
aiua-5550	104	1	medical	medical	ADJ
aiua-5550	104	2	treatment	treatment	NOUN
aiua-5550	104	3	use	use	NOUN
aiua-5550	104	4	for	for	ADP
aiua-5550	104	5	treating	treat	VERB
aiua-5550	104	6	symptomatic	symptomatic	ADJ
aiua-5550	104	7	bph	bph	NOUN
aiua-5550	104	8	patients	patient	NOUN
aiua-5550	104	9	may	may	AUX
aiua-5550	104	10	result	result	VERB
aiua-5550	104	11	in	in	ADP
aiua-5550	104	12	a	a	DET
aiua-5550	104	13	delay	delay	NOUN
aiua-5550	104	14	in	in	ADP
aiua-5550	104	15	the	the	DET
aiua-5550	104	16	surgical	surgical	ADJ
aiua-5550	104	17	intervention	intervention	NOUN
aiua-5550	104	18	decision	decision	NOUN
aiua-5550	104	19	.	.	PUNCT
aiua-5550	105	1	consequently	consequently	ADV
aiua-5550	105	2	,	,	PUNCT
aiua-5550	105	3	patients	patient	NOUN
aiua-5550	105	4	usually	usually	ADV
aiua-5550	105	5	become	become	VERB
aiua-5550	105	6	older	old	ADJ
aiua-5550	105	7	,	,	PUNCT
aiua-5550	105	8	may	may	AUX
aiua-5550	105	9	become	become	VERB
aiua-5550	105	10	unfit	unfit	ADJ
aiua-5550	105	11	for	for	ADP
aiua-5550	105	12	surgery	surgery	NOUN
aiua-5550	105	13	,	,	PUNCT
aiua-5550	105	14	and	and	CCONJ
aiua-5550	105	15	may	may	AUX
aiua-5550	105	16	have	have	VERB
aiua-5550	105	17	advanced	advanced	ADJ
aiua-5550	105	18	disease	disease	NOUN
aiua-5550	105	19	;	;	PUNCT
aiua-5550	105	20	this	this	PRON
aiua-5550	105	21	may	may	AUX
aiua-5550	105	22	result	result	VERB
aiua-5550	105	23	in	in	ADP
aiua-5550	105	24	unfavorable	unfavorable	ADJ
aiua-5550	105	25	outcomes	outcome	NOUN
aiua-5550	105	26	and	and	CCONJ
aiua-5550	105	27	more	more	ADV
aiua-5550	105	28	postoperative	postoperative	ADJ
aiua-5550	105	29	morbidities	morbidity	NOUN
aiua-5550	105	30	and	and	CCONJ
aiua-5550	105	31	complications	complication	NOUN
aiua-5550	105	32	.	.	PUNCT
aiua-5550	106	1	also	also	ADV
aiua-5550	106	2	,	,	PUNCT
aiua-5550	106	3	delay	delay	VERB
aiua-5550	106	4	in	in	ADP
aiua-5550	106	5	surgical	surgical	ADJ
aiua-5550	106	6	treatment	treatment	NOUN
aiua-5550	106	7	results	result	NOUN
aiua-5550	106	8	in	in	ADP
aiua-5550	106	9	more	more	ADV
aiua-5550	106	10	serious	serious	ADJ
aiua-5550	106	11	and	and	CCONJ
aiua-5550	106	12	complicated	complicated	ADJ
aiua-5550	106	13	resection	resection	NOUN
aiua-5550	106	14	(	(	PUNCT
aiua-5550	106	15	22	22	NUM
aiua-5550	106	16	-	-	SYM
aiua-5550	106	17	23	23	NUM
aiua-5550	106	18	)	)	PUNCT
aiua-5550	106	19	.	.	PUNCT
aiua-5550	107	1	for	for	ADP
aiua-5550	107	2	this	this	DET
aiua-5550	107	3	reasons	reason	NOUN
aiua-5550	107	4	,	,	PUNCT
aiua-5550	107	5	a	a	DET
aiua-5550	107	6	predictive	predictive	ADJ
aiua-5550	107	7	factor	factor	NOUN
aiua-5550	107	8	to	to	ADP
aiua-5550	107	9	those	those	DET
aiua-5550	107	10	patients	patient	NOUN
aiua-5550	107	11	who	who	PRON
aiua-5550	107	12	will	will	AUX
aiua-5550	107	13	fail	fail	VERB
aiua-5550	107	14	medical	medical	ADJ
aiua-5550	107	15	treatment	treatment	NOUN
aiua-5550	107	16	in	in	ADP
aiua-5550	107	17	the	the	DET
aiua-5550	107	18	future	future	NOUN
aiua-5550	107	19	can	can	AUX
aiua-5550	107	20	guide	guide	VERB
aiua-5550	107	21	us	we	PRON
aiua-5550	107	22	to	to	PART
aiua-5550	107	23	spend	spend	VERB
aiua-5550	107	24	less	less	ADJ
aiua-5550	107	25	money	money	NOUN
aiua-5550	107	26	as	as	ADV
aiua-5550	107	27	well	well	ADV
aiua-5550	107	28	as	as	ADP
aiua-5550	107	29	to	to	PART
aiua-5550	107	30	avoid	avoid	VERB
aiua-5550	107	31	possible	possible	ADJ
aiua-5550	107	32	complications	complication	NOUN
aiua-5550	107	33	for	for	ADP
aiua-5550	107	34	such	such	ADJ
aiua-5550	107	35	patients	patient	NOUN
aiua-5550	107	36	that	that	PRON
aiua-5550	107	37	can	can	AUX
aiua-5550	107	38	treated	treat	VERB
aiua-5550	107	39	earlier	early	ADV
aiua-5550	107	40	by	by	ADP
aiua-5550	107	41	definitive	definitive	ADJ
aiua-5550	107	42	surgery	surgery	NOUN
aiua-5550	107	43	rather	rather	ADV
aiua-5550	107	44	than	than	ADP
aiua-5550	107	45	remaim	remaim	VERB
aiua-5550	107	46	on	on	ADP
aiua-5550	107	47	medications	medication	NOUN
aiua-5550	107	48	for	for	ADP
aiua-5550	107	49	some	some	DET
aiua-5550	107	50	time	time	NOUN
aiua-5550	107	51	before	before	ADP
aiua-5550	107	52	going	go	VERB
aiua-5550	107	53	to	to	ADP
aiua-5550	107	54	surgery	surgery	NOUN
aiua-5550	107	55	.	.	PUNCT
aiua-5550	108	1	the	the	DET
aiua-5550	108	2	result	result	NOUN
aiua-5550	108	3	of	of	ADP
aiua-5550	108	4	our	our	PRON
aiua-5550	108	5	study	study	NOUN
aiua-5550	108	6	revealed	reveal	VERB
aiua-5550	108	7	that	that	SCONJ
aiua-5550	108	8	patients	patient	NOUN
aiua-5550	108	9	with	with	ADP
aiua-5550	108	10	higher	high	ADJ
aiua-5550	108	11	pua	pua	PROPN
aiua-5550	108	12	>	>	X
aiua-5550	108	13	35˚	35˚	NUM
aiua-5550	108	14	showed	show	VERB
aiua-5550	108	15	a	a	DET
aiua-5550	108	16	poor	poor	ADJ
aiua-5550	108	17	response	response	NOUN
aiua-5550	108	18	to	to	ADP
aiua-5550	108	19	0.4	0.4	NUM
aiua-5550	108	20	mg	mg	PROPN
aiua-5550	108	21	tamsulosin	tamsulosin	NOUN
aiua-5550	108	22	hydrochloride	hydrochloride	NOUN
aiua-5550	108	23	in	in	ADP
aiua-5550	108	24	both	both	CCONJ
aiua-5550	108	25	subjective	subjective	ADJ
aiua-5550	108	26	and	and	CCONJ
aiua-5550	108	27	objective	objective	ADJ
aiua-5550	108	28	parameters	parameter	NOUN
aiua-5550	108	29	than	than	ADP
aiua-5550	108	30	those	those	PRON
aiua-5550	108	31	with	with	ADP
aiua-5550	108	32	pua	pua	NOUN
aiua-5550	108	33	≤	≤	ADJ
aiua-5550	108	34	35˚.	35˚.	NUM
aiua-5550	108	35	in	in	ADP
aiua-5550	108	36	another	another	DET
aiua-5550	108	37	recent	recent	ADJ
aiua-5550	108	38	study	study	NOUN
aiua-5550	108	39	,	,	PUNCT
aiua-5550	108	40	authors	author	NOUN
aiua-5550	108	41	reported	report	VERB
aiua-5550	108	42	that	that	SCONJ
aiua-5550	108	43	patients	patient	NOUN
aiua-5550	108	44	with	with	ADP
aiua-5550	108	45	pua	pua	PROPN
aiua-5550	108	46	<	<	X
aiua-5550	108	47	48.3	48.3	NUM
aiua-5550	108	48	°	°	NOUN
aiua-5550	108	49	,	,	PUNCT
aiua-5550	108	50	did	do	AUX
aiua-5550	108	51	not	not	PART
aiua-5550	108	52	require	require	VERB
aiua-5550	108	53	transurethral	transurethral	ADJ
aiua-5550	108	54	resection	resection	NOUN
aiua-5550	108	55	of	of	ADP
aiua-5550	108	56	the	the	DET
aiua-5550	108	57	prostate	prostate	NOUN
aiua-5550	108	58	(	(	PUNCT
aiua-5550	108	59	turp	turp	NOUN
aiua-5550	108	60	)	)	PUNCT
aiua-5550	108	61	within	within	ADP
aiua-5550	108	62	1	1	NUM
aiua-5550	108	63	year	year	NOUN
aiua-5550	108	64	of	of	ADP
aiua-5550	108	65	medical	medical	ADJ
aiua-5550	108	66	treatment	treatment	NOUN
aiua-5550	108	67	.	.	PUNCT
aiua-5550	109	1	while	while	SCONJ
aiua-5550	109	2	,	,	PUNCT
aiua-5550	109	3	19	19	NUM
aiua-5550	109	4	patients	patient	NOUN
aiua-5550	109	5	of	of	ADP
aiua-5550	109	6	those	those	PRON
aiua-5550	109	7	with	with	ADP
aiua-5550	109	8	pua	pua	PROPN
aiua-5550	109	9	>	>	X
aiua-5550	109	10	48.3	48.3	NUM
aiua-5550	109	11	°	°	PROPN
aiua-5550	109	12	finally	finally	ADV
aiua-5550	109	13	received	receive	VERB
aiua-5550	109	14	turp	turp	NOUN
aiua-5550	109	15	within	within	ADP
aiua-5550	109	16	1	1	NUM
aiua-5550	109	17	year	year	NOUN
aiua-5550	109	18	due	due	ADP
aiua-5550	109	19	to	to	ADP
aiua-5550	109	20	lower	low	ADJ
aiua-5550	109	21	tamsulosin	tamsulosin	NOUN
aiua-5550	109	22	hydrochloride	hydrochloride	NOUN
aiua-5550	109	23	efficacy	efficacy	NOUN
aiua-5550	109	24	(	(	PUNCT
aiua-5550	109	25	17	17	NUM
aiua-5550	109	26	)	)	PUNCT
aiua-5550	109	27	.	.	PUNCT
aiua-5550	110	1	there	there	PRON
aiua-5550	110	2	are	be	VERB
aiua-5550	110	3	some	some	DET
aiua-5550	110	4	limitations	limitation	NOUN
aiua-5550	110	5	in	in	ADP
aiua-5550	110	6	our	our	PRON
aiua-5550	110	7	study	study	NOUN
aiua-5550	110	8	as	as	ADP
aiua-5550	110	9	the	the	DET
aiua-5550	110	10	small	small	ADJ
aiua-5550	110	11	number	number	NOUN
aiua-5550	110	12	of	of	ADP
aiua-5550	110	13	patients	patient	NOUN
aiua-5550	110	14	each	each	DET
aiua-5550	110	15	group	group	NOUN
aiua-5550	110	16	,	,	PUNCT
aiua-5550	110	17	the	the	DET
aiua-5550	110	18	short	short	ADJ
aiua-5550	110	19	term	term	NOUN
aiua-5550	110	20	follow	follow	NOUN
aiua-5550	110	21	-	-	PUNCT
aiua-5550	110	22	up	up	NOUN
aiua-5550	110	23	and	and	CCONJ
aiua-5550	110	24	the	the	DET
aiua-5550	110	25	selection	selection	NOUN
aiua-5550	110	26	bias	bias	NOUN
aiua-5550	110	27	for	for	ADP
aiua-5550	110	28	patients	patient	NOUN
aiua-5550	110	29	during	during	ADP
aiua-5550	110	30	classification	classification	NOUN
aiua-5550	110	31	in	in	ADP
aiua-5550	110	32	groups	group	NOUN
aiua-5550	110	33	based	base	VERB
aiua-5550	110	34	on	on	ADP
aiua-5550	110	35	previous	previous	ADJ
aiua-5550	110	36	cutoff	cutoff	NOUN
aiua-5550	110	37	values	value	NOUN
aiua-5550	110	38	of	of	ADP
aiua-5550	110	39	pua	pua	PROPN
aiua-5550	110	40	in	in	ADP
aiua-5550	110	41	other	other	ADJ
aiua-5550	110	42	studies	study	NOUN
aiua-5550	110	43	.	.	PUNCT
aiua-5550	111	1	looking	look	VERB
aiua-5550	111	2	at	at	ADP
aiua-5550	111	3	the	the	DET
aiua-5550	111	4	objective	objective	NOUN
aiua-5550	111	5	as	as	ADV
aiua-5550	111	6	well	well	ADV
aiua-5550	111	7	as	as	ADP
aiua-5550	111	8	the	the	DET
aiua-5550	111	9	subjective	subjective	ADJ
aiua-5550	111	10	data	datum	NOUN
aiua-5550	111	11	at	at	ADP
aiua-5550	111	12	the	the	DET
aiua-5550	111	13	present	present	ADJ
aiua-5550	111	14	study	study	NOUN
aiua-5550	111	15	,	,	PUNCT
aiua-5550	111	16	we	we	PRON
aiua-5550	111	17	are	be	AUX
aiua-5550	111	18	suggesting	suggest	VERB
aiua-5550	111	19	that	that	SCONJ
aiua-5550	111	20	the	the	DET
aiua-5550	111	21	pua	pua	PROPN
aiua-5550	111	22	may	may	AUX
aiua-5550	111	23	have	have	VERB
aiua-5550	111	24	an	an	DET
aiua-5550	111	25	important	important	ADJ
aiua-5550	111	26	role	role	NOUN
aiua-5550	111	27	in	in	ADP
aiua-5550	111	28	the	the	DET
aiua-5550	111	29	symptomatology	symptomatology	NOUN
aiua-5550	111	30	of	of	ADP
aiua-5550	111	31	the	the	DET
aiua-5550	111	32	patients	patient	NOUN
aiua-5550	111	33	with	with	ADP
aiua-5550	111	34	luts	luts	PROPN
aiua-5550	111	35	/	/	SYM
aiua-5550	111	36	bph	bph	NOUN
aiua-5550	111	37	.	.	PUNCT
aiua-5550	112	1	also	also	ADV
aiua-5550	112	2	,	,	PUNCT
aiua-5550	112	3	based	base	VERB
aiua-5550	112	4	on	on	ADP
aiua-5550	112	5	the	the	DET
aiua-5550	112	6	present	present	ADJ
aiua-5550	112	7	data	datum	NOUN
aiua-5550	112	8	of	of	ADP
aiua-5550	112	9	little	little	ADJ
aiua-5550	112	10	response	response	NOUN
aiua-5550	112	11	to	to	ADP
aiua-5550	112	12	medical	medical	ADJ
aiua-5550	112	13	treatment	treatment	NOUN
aiua-5550	112	14	among	among	ADP
aiua-5550	112	15	those	those	DET
aiua-5550	112	16	patients	patient	NOUN
aiua-5550	112	17	with	with	ADP
aiua-5550	112	18	higher	high	ADJ
aiua-5550	112	19	pua	pua	PROPN
aiua-5550	112	20	>	>	X
aiua-5550	112	21	35	35	NUM
aiua-5550	112	22	,	,	PUNCT
aiua-5550	112	23	we	we	PRON
aiua-5550	112	24	suggest	suggest	VERB
aiua-5550	112	25	that	that	SCONJ
aiua-5550	112	26	patients	patient	NOUN
aiua-5550	112	27	with	with	ADP
aiua-5550	112	28	higher	high	ADJ
aiua-5550	112	29	pua	pua	PROPN
aiua-5550	112	30	should	should	AUX
aiua-5550	112	31	be	be	AUX
aiua-5550	112	32	offered	offer	VERB
aiua-5550	112	33	another	another	DET
aiua-5550	112	34	line	line	NOUN
aiua-5550	112	35	of	of	ADP
aiua-5550	112	36	treatment	treatment	NOUN
aiua-5550	112	37	and	and	CCONJ
aiua-5550	112	38	)	)	PUNCT
aiua-5550	112	39	informed	inform	VERB
aiua-5550	112	40	explaining	explain	VERB
aiua-5550	112	41	the	the	DET
aiua-5550	112	42	expected	expect	VERB
aiua-5550	112	43	results	result	NOUN
aiua-5550	112	44	.	.	PUNCT
aiua-5550	113	1	conclusions	conclusion	NOUN
aiua-5550	113	2	in	in	ADP
aiua-5550	113	3	conclusion	conclusion	NOUN
aiua-5550	113	4	,	,	PUNCT
aiua-5550	113	5	this	this	DET
aiua-5550	113	6	preliminary	preliminary	ADJ
aiua-5550	113	7	study	study	NOUN
aiua-5550	113	8	suggests	suggest	VERB
aiua-5550	113	9	that	that	SCONJ
aiua-5550	113	10	the	the	DET
aiua-5550	113	11	pua	pua	PROPN
aiua-5550	113	12	appears	appear	VERB
aiua-5550	113	13	to	to	PART
aiua-5550	113	14	be	be	AUX
aiua-5550	113	15	one	one	NUM
aiua-5550	113	16	of	of	ADP
aiua-5550	113	17	the	the	DET
aiua-5550	113	18	anatomical	anatomical	ADJ
aiua-5550	113	19	factors	factor	NOUN
aiua-5550	113	20	which	which	PRON
aiua-5550	113	21	has	have	VERB
aiua-5550	113	22	an	an	DET
aiua-5550	113	23	impact	impact	NOUN
aiua-5550	113	24	on	on	ADP
aiua-5550	113	25	medical	medical	ADJ
aiua-5550	113	26	treatment	treatment	NOUN
aiua-5550	113	27	of	of	ADP
aiua-5550	113	28	male	male	ADJ
aiua-5550	113	29	patients	patient	NOUN
aiua-5550	113	30	with	with	ADP
aiua-5550	113	31	luts	luts	PROPN
aiua-5550	113	32	/	/	SYM
aiua-5550	113	33	bph	bph	NOUN
aiua-5550	113	34	and	and	CCONJ
aiua-5550	113	35	it	it	PRON
aiua-5550	113	36	might	might	AUX
aiua-5550	113	37	be	be	AUX
aiua-5550	113	38	a	a	DET
aiua-5550	113	39	predictor	predictor	NOUN
aiua-5550	113	40	for	for	ADP
aiua-5550	113	41	the	the	DET
aiua-5550	113	42	treatment	treatment	NOUN
aiua-5550	113	43	efficacy	efficacy	NOUN
aiua-5550	113	44	of	of	ADP
aiua-5550	113	45	α	α	NOUN
aiua-5550	113	46	-	-	PUNCT
aiua-5550	113	47	blockers	blocker	NOUN
aiua-5550	113	48	.	.	PUNCT
aiua-5550	114	1	more	more	ADJ
aiua-5550	114	2	studies	study	NOUN
aiua-5550	114	3	are	be	AUX
aiua-5550	114	4	warranted	warrant	VERB
aiua-5550	114	5	in	in	ADP
aiua-5550	114	6	the	the	DET
aiua-5550	114	7	future	future	NOUN
aiua-5550	114	8	before	before	ADP
aiua-5550	114	9	drawing	draw	VERB
aiua-5550	114	10	the	the	DET
aiua-5550	114	11	final	final	ADJ
aiua-5550	114	12	conclusion	conclusion	NOUN
aiua-5550	114	13	.	.	PUNCT
aiua-5550	115	1	these	these	DET
aiua-5550	115	2	studies	study	NOUN
aiua-5550	115	3	should	should	AUX
aiua-5550	115	4	include	include	VERB
aiua-5550	115	5	larger	large	ADJ
aiua-5550	115	6	numbers	number	NOUN
aiua-5550	115	7	of	of	ADP
aiua-5550	115	8	patients	patient	NOUN
aiua-5550	115	9	with	with	ADP
aiua-5550	115	10	longer	long	ADJ
aiua-5550	115	11	follow	follow	VERB
aiua-5550	115	12	-	-	PUNCT
aiua-5550	115	13	up	up	ADP
aiua-5550	115	14	periods	period	NOUN
aiua-5550	115	15	and	and	CCONJ
aiua-5550	115	16	should	should	AUX
aiua-5550	115	17	be	be	AUX
aiua-5550	115	18	focused	focus	VERB
aiua-5550	115	19	on	on	ADP
aiua-5550	115	20	the	the	DET
aiua-5550	115	21	pua	pua	NOUN
aiua-5550	115	22	and	and	CCONJ
aiua-5550	115	23	especially	especially	ADV
aiua-5550	115	24	on	on	ADP
aiua-5550	115	25	the	the	DET
aiua-5550	115	26	method	method	NOUN
aiua-5550	115	27	of	of	ADP
aiua-5550	115	28	its	its	PRON
aiua-5550	115	29	measurement	measurement	NOUN
aiua-5550	115	30	and	and	CCONJ
aiua-5550	115	31	the	the	DET
aiua-5550	115	32	relationship	relationship	NOUN
aiua-5550	115	33	to	to	ADP
aiua-5550	115	34	the	the	DET
aiua-5550	115	35	symptoms	symptom	NOUN
aiua-5550	115	36	as	as	ADV
aiua-5550	115	37	well	well	ADV
aiua-5550	115	38	as	as	ADP
aiua-5550	115	39	its	its	PRON
aiua-5550	115	40	effect	effect	NOUN
aiua-5550	115	41	on	on	ADP
aiua-5550	115	42	every	every	DET
aiua-5550	115	43	available	available	ADJ
aiua-5550	115	44	methods	method	NOUN
aiua-5550	115	45	of	of	ADP
aiua-5550	115	46	treatment	treatment	NOUN
aiua-5550	115	47	(	(	PUNCT
aiua-5550	115	48	medical	medical	ADJ
aiua-5550	115	49	,	,	PUNCT
aiua-5550	115	50	minimally	minimally	ADV
aiua-5550	115	51	invasive	invasive	ADJ
aiua-5550	115	52	,	,	PUNCT
aiua-5550	115	53	or	or	CCONJ
aiua-5550	115	54	invasive	invasive	ADJ
aiua-5550	115	55	)	)	PUNCT
aiua-5550	115	56	.	.	PUNCT
aiua-5550	116	1	references	reference	NOUN
aiua-5550	116	2	1	1	NUM
aiua-5550	116	3	.	.	PUNCT
aiua-5550	116	4	verhamme	verhamme	PROPN
aiua-5550	116	5	km	km	PROPN
aiua-5550	116	6	,	,	PUNCT
aiua-5550	116	7	dieleman	dieleman	PROPN
aiua-5550	116	8	jp	jp	NOUN
aiua-5550	116	9	,	,	PUNCT
aiua-5550	116	10	bleumink	bleumink	X
aiua-5550	116	11	gs	gs	PROPN
aiua-5550	116	12	,	,	PUNCT
aiua-5550	116	13	et	et	PROPN
aiua-5550	116	14	al	al	PROPN
aiua-5550	116	15	.	.	PROPN
aiua-5550	116	16	incidence	incidence	NOUN
aiua-5550	116	17	and	and	CCONJ
aiua-5550	116	18	prevalence	prevalence	NOUN
aiua-5550	116	19	of	of	ADP
aiua-5550	116	20	lower	low	ADJ
aiua-5550	116	21	urinary	urinary	ADJ
aiua-5550	116	22	tract	tract	NOUN
aiua-5550	116	23	symptoms	symptom	NOUN
aiua-5550	116	24	suggestive	suggestive	ADJ
aiua-5550	116	25	of	of	ADP
aiua-5550	116	26	benign	benign	ADJ
aiua-5550	116	27	prostatic	prostatic	ADJ
aiua-5550	116	28	hyperplasia	hyperplasia	NOUN
aiua-5550	116	29	in	in	ADP
aiua-5550	116	30	primary	primary	ADJ
aiua-5550	116	31	care	care	NOUN
aiua-5550	116	32	–	–	PUNCT
aiua-5550	116	33	the	the	DET
aiua-5550	116	34	triumph	triumph	NOUN
aiua-5550	116	35	project	project	NOUN
aiua-5550	116	36	.	.	PUNCT
aiua-5550	117	1	eur	eur	PROPN
aiua-5550	117	2	urol	urol	PROPN
aiua-5550	117	3	.	.	PUNCT
aiua-5550	118	1	2002	2002	NUM
aiua-5550	118	2	;	;	PUNCT
aiua-5550	118	3	42:323	42:323	NUM
aiua-5550	118	4	-	-	SYM
aiua-5550	118	5	328	328	NUM
aiua-5550	118	6	.	.	PUNCT
aiua-5550	119	1	2	2	NUM
aiua-5550	119	2	.	.	PUNCT
aiua-5550	119	3	bushman	bushman	PROPN
aiua-5550	119	4	w.	w.	PROPN
aiua-5550	119	5	etiology	etiology	PROPN
aiua-5550	119	6	,	,	PUNCT
aiua-5550	119	7	epidemiology	epidemiology	NOUN
aiua-5550	119	8	,	,	PUNCT
aiua-5550	119	9	and	and	CCONJ
aiua-5550	119	10	natural	natural	ADJ
aiua-5550	119	11	history	history	NOUN
aiua-5550	119	12	.	.	PUNCT
aiua-5550	120	1	urol	urol	PROPN
aiua-5550	120	2	clin	clin	PROPN
aiua-5550	120	3	north	north	PROPN
aiua-5550	120	4	am	am	PROPN
aiua-5550	120	5	.	.	PUNCT
aiua-5550	121	1	2009	2009	NUM
aiua-5550	121	2	;	;	PUNCT
aiua-5550	121	3	36:403	36:403	NUM
aiua-5550	121	4	-	-	SYM
aiua-5550	121	5	415	415	NUM
aiua-5550	121	6	.	.	PUNCT
aiua-5550	122	1	ali	ali	PROPN
aiua-5550	122	2	raheem_stesura	raheem_stesura	PROPN
aiua-5550	122	3	seveso	seveso	VERB
aiua-5550	123	1	30/09/15	30/09/15	PROPN
aiua-5550	123	2	09:39	09:39	NUM
aiua-5550	123	3	pagina	pagina	NOUN
aiua-5550	123	4	241	241	NUM
aiua-5550	123	5	archivio	archivio	PROPN
aiua-5550	123	6	italiano	italiano	X
aiua-5550	123	7	di	di	X
aiua-5550	123	8	urologia	urologia	PROPN
aiua-5550	123	9	e	e	PROPN
aiua-5550	123	10	andrologia	andrologia	NOUN
aiua-5550	123	11	2015	2015	NUM
aiua-5550	123	12	;	;	PUNCT
aiua-5550	123	13	87	87	NUM
aiua-5550	123	14	,	,	PUNCT
aiua-5550	123	15	3	3	NUM
aiua-5550	123	16	hassan	hassan	PROPN
aiua-5550	123	17	el	el	PROPN
aiua-5550	123	18	-	-	PUNCT
aiua-5550	123	19	tatawy	tatawy	PROPN
aiua-5550	123	20	,	,	PUNCT
aiua-5550	123	21	tarek	tarek	PROPN
aiua-5550	123	22	gameel	gameel	PROPN
aiua-5550	123	23	,	,	PUNCT
aiua-5550	123	24	mohammed	mohammed	PROPN
aiua-5550	123	25	abo	abo	PROPN
aiua-5550	123	26	el	el	PROPN
aiua-5550	123	27	-	-	PUNCT
aiua-5550	123	28	enen	enen	PROPN
aiua-5550	123	29	,	,	PUNCT
aiua-5550	123	30	ayman	ayman	PROPN
aiua-5550	123	31	hagras	hagras	PROPN
aiua-5550	123	32	,	,	PUNCT
aiua-5550	123	33	ayman	ayman	PROPN
aiua-5550	123	34	mousa	mousa	PROPN
aiua-5550	123	35	,	,	PUNCT
aiua-5550	123	36	abdel	abdel	PROPN
aiua-5550	123	37	hamid	hamid	PROPN
aiua-5550	123	38	el	el	PROPN
aiua-5550	123	39	-	-	PROPN
aiua-5550	123	40	bahnasy	bahnasy	PROPN
aiua-5550	123	41	,	,	PUNCT
aiua-5550	123	42	ali	ali	PROPN
aiua-5550	123	43	abdel	abdel	PROPN
aiua-5550	123	44	raheem	raheem	PROPN
aiua-5550	123	45	,	,	PUNCT
aiua-5550	123	46	khaled	khaled	PROPN
aiua-5550	123	47	abu	abu	PROPN
aiua-5550	123	48	-	-	PUNCT
aiua-5550	123	49	dewan	dewan	PROPN
aiua-5550	123	50	242	242	NUM
aiua-5550	123	51	3	3	NUM
aiua-5550	123	52	.	.	PUNCT
aiua-5550	123	53	sciarra	sciarra	PROPN
aiua-5550	123	54	a	a	PRON
aiua-5550	123	55	,	,	PUNCT
aiua-5550	123	56	d'eramo	d'eramo	PROPN
aiua-5550	123	57	g	g	NOUN
aiua-5550	123	58	,	,	PUNCT
aiua-5550	123	59	casale	casale	NOUN
aiua-5550	123	60	p	p	NOUN
aiua-5550	123	61	,	,	PUNCT
aiua-5550	123	62	et	et	PROPN
aiua-5550	123	63	al.relationship	al.relationship	NOUN
aiua-5550	123	64	among	among	ADP
aiua-5550	123	65	symptom	symptom	NOUN
aiua-5550	123	66	score	score	NOUN
aiua-5550	123	67	,	,	PUNCT
aiua-5550	123	68	prostate	prostate	NOUN
aiua-5550	123	69	volume	volume	NOUN
aiua-5550	123	70	,	,	PUNCT
aiua-5550	123	71	and	and	CCONJ
aiua-5550	123	72	urinary	urinary	ADJ
aiua-5550	123	73	flow	flow	NOUN
aiua-5550	123	74	rates	rate	NOUN
aiua-5550	123	75	in	in	ADP
aiua-5550	123	76	543	543	NUM
aiua-5550	123	77	patients	patient	NOUN
aiua-5550	123	78	with	with	ADP
aiua-5550	123	79	and	and	CCONJ
aiua-5550	123	80	without	without	ADP
aiua-5550	123	81	benign	benign	ADJ
aiua-5550	123	82	prostatic	prostatic	ADJ
aiua-5550	123	83	hyperplasia	hyperplasia	NOUN
aiua-5550	123	84	.	.	PUNCT
aiua-5550	124	1	prostate	prostate	NOUN
aiua-5550	124	2	1998	1998	NUM
aiua-5550	124	3	;	;	PUNCT
aiua-5550	124	4	34:121	34:121	NUM
aiua-5550	124	5	-	-	SYM
aiua-5550	124	6	128	128	NUM
aiua-5550	124	7	.	.	NOUN
aiua-5550	124	8	4	4	NUM
aiua-5550	124	9	.	.	X
aiua-5550	124	10	kaplan	kaplan	PROPN
aiua-5550	124	11	sa	sa	PROPN
aiua-5550	124	12	,	,	PUNCT
aiua-5550	124	13	te	te	PROPN
aiua-5550	124	14	ae	ae	PROPN
aiua-5550	124	15	,	,	PUNCT
aiua-5550	124	16	pressler	pressler	NOUN
aiua-5550	124	17	lb	lb	PROPN
aiua-5550	124	18	,	,	PUNCT
aiua-5550	124	19	et	et	PROPN
aiua-5550	124	20	al	al	PROPN
aiua-5550	124	21	.	.	PUNCT
aiua-5550	124	22	transition	transition	NOUN
aiua-5550	124	23	zone	zone	NOUN
aiua-5550	124	24	index	index	NOUN
aiua-5550	124	25	as	as	ADP
aiua-5550	124	26	a	a	DET
aiua-5550	124	27	method	method	NOUN
aiua-5550	124	28	of	of	ADP
aiua-5550	124	29	assessing	assess	VERB
aiua-5550	124	30	benign	benign	ADJ
aiua-5550	124	31	prostatic	prostatic	ADJ
aiua-5550	124	32	hyperplasia	hyperplasia	NOUN
aiua-5550	124	33	:	:	PUNCT
aiua-5550	124	34	correlation	correlation	NOUN
aiua-5550	124	35	with	with	ADP
aiua-5550	124	36	symptoms	symptom	NOUN
aiua-5550	124	37	,	,	PUNCT
aiua-5550	124	38	urine	urine	NOUN
aiua-5550	124	39	flow	flow	NOUN
aiua-5550	124	40	and	and	CCONJ
aiua-5550	124	41	detrusor	detrusor	NOUN
aiua-5550	124	42	pressure	pressure	NOUN
aiua-5550	124	43	.	.	PUNCT
aiua-5550	125	1	j	j	PROPN
aiua-5550	125	2	urol	urol	PROPN
aiua-5550	125	3	.	.	PUNCT
aiua-5550	125	4	1995	1995	NUM
aiua-5550	125	5	;	;	PUNCT
aiua-5550	125	6	154:1764	154:1764	NUM
aiua-5550	125	7	-	-	SYM
aiua-5550	125	8	9	9	NUM
aiua-5550	125	9	.	.	NOUN
aiua-5550	125	10	5	5	NUM
aiua-5550	125	11	.	.	X
aiua-5550	125	12	lepor	lepor	PROPN
aiua-5550	125	13	h	h	PROPN
aiua-5550	125	14	,	,	PUNCT
aiua-5550	125	15	nieder	nieder	NOUN
aiua-5550	125	16	a	a	NOUN
aiua-5550	125	17	,	,	PUNCT
aiua-5550	125	18	feser	feser	PROPN
aiua-5550	125	19	j	j	PROPN
aiua-5550	125	20	,	,	PUNCT
aiua-5550	125	21	et	et	PROPN
aiua-5550	125	22	al	al	PROPN
aiua-5550	125	23	.	.	PROPN
aiua-5550	125	24	total	total	ADJ
aiua-5550	125	25	prostate	prostate	NOUN
aiua-5550	125	26	and	and	CCONJ
aiua-5550	125	27	transition	transition	NOUN
aiua-5550	125	28	zone	zone	NOUN
aiua-5550	125	29	volumes	volume	NOUN
aiua-5550	125	30	,	,	PUNCT
aiua-5550	125	31	and	and	CCONJ
aiua-5550	125	32	transition	transition	NOUN
aiua-5550	125	33	zone	zone	NOUN
aiua-5550	125	34	index	index	NOUN
aiua-5550	125	35	are	be	AUX
aiua-5550	125	36	poorly	poorly	ADV
aiua-5550	125	37	correlated	correlate	VERB
aiua-5550	125	38	with	with	ADP
aiua-5550	125	39	objective	objective	ADJ
aiua-5550	125	40	measures	measure	NOUN
aiua-5550	125	41	of	of	ADP
aiua-5550	125	42	clinical	clinical	ADJ
aiua-5550	125	43	benign	benign	ADJ
aiua-5550	125	44	prostatic	prostatic	ADJ
aiua-5550	125	45	hyperplasia	hyperplasia	NOUN
aiua-5550	125	46	.	.	PUNCT
aiua-5550	126	1	j	j	PROPN
aiua-5550	126	2	urol	urol	PROPN
aiua-5550	126	3	.	.	PUNCT
aiua-5550	127	1	1997	1997	NUM
aiua-5550	127	2	;	;	PUNCT
aiua-5550	127	3	158:85	158:85	NUM
aiua-5550	127	4	-	-	SYM
aiua-5550	127	5	8	8	NUM
aiua-5550	127	6	.	.	NOUN
aiua-5550	128	1	6	6	NUM
aiua-5550	128	2	.	.	PUNCT
aiua-5550	128	3	chia	chia	PROPN
aiua-5550	128	4	sj	sj	PROPN
aiua-5550	128	5	,	,	PUNCT
aiua-5550	128	6	heng	heng	PROPN
aiua-5550	128	7	ct	ct	PROPN
aiua-5550	128	8	,	,	PUNCT
aiua-5550	128	9	chan	chan	PROPN
aiua-5550	128	10	sp	sp	PROPN
aiua-5550	128	11	,	,	PUNCT
aiua-5550	128	12	et	et	PROPN
aiua-5550	128	13	al	al	PROPN
aiua-5550	128	14	.	.	PUNCT
aiua-5550	128	15	correlation	correlation	NOUN
aiua-5550	128	16	of	of	ADP
aiua-5550	128	17	intravesical	intravesical	ADJ
aiua-5550	128	18	prostatic	prostatic	ADJ
aiua-5550	128	19	protrusion	protrusion	NOUN
aiua-5550	128	20	with	with	ADP
aiua-5550	128	21	bladder	bladder	NOUN
aiua-5550	128	22	outlet	outlet	NOUN
aiua-5550	128	23	obstruction	obstruction	NOUN
aiua-5550	128	24	.	.	PUNCT
aiua-5550	129	1	bju	bju	NOUN
aiua-5550	129	2	int	int	PROPN
aiua-5550	129	3	.	.	PUNCT
aiua-5550	130	1	2003	2003	NUM
aiua-5550	130	2	;	;	PUNCT
aiua-5550	130	3	91:371	91:371	NUM
aiua-5550	130	4	-	-	SYM
aiua-5550	130	5	4	4	NUM
aiua-5550	130	6	.	.	NOUN
aiua-5550	130	7	7	7	NUM
aiua-5550	130	8	.	.	X
aiua-5550	131	1	keqin	keqin	PROPN
aiua-5550	131	2	z	z	PROPN
aiua-5550	131	3	,	,	PUNCT
aiua-5550	131	4	zhishun	zhishun	PROPN
aiua-5550	131	5	x	x	PRON
aiua-5550	131	6	,	,	PUNCT
aiua-5550	131	7	jing	je	VERB
aiua-5550	132	1	z	z	X
aiua-5550	132	2	,	,	PUNCT
aiua-5550	132	3	et	et	PROPN
aiua-5550	132	4	al	al	PROPN
aiua-5550	132	5	.	.	PROPN
aiua-5550	133	1	clinical	clinical	ADJ
aiua-5550	133	2	significance	significance	NOUN
aiua-5550	133	3	of	of	ADP
aiua-5550	133	4	intravesical	intravesical	ADJ
aiua-5550	133	5	prostatic	prostatic	ADJ
aiua-5550	133	6	protrusion	protrusion	NOUN
aiua-5550	133	7	in	in	ADP
aiua-5550	133	8	patients	patient	NOUN
aiua-5550	133	9	with	with	ADP
aiua-5550	133	10	benign	benign	ADJ
aiua-5550	133	11	prostatic	prostatic	ADJ
aiua-5550	133	12	enlargement	enlargement	NOUN
aiua-5550	133	13	.	.	PUNCT
aiua-5550	134	1	urology	urology	NOUN
aiua-5550	134	2	2007	2007	NUM
aiua-5550	134	3	;	;	PUNCT
aiua-5550	134	4	70:1096	70:1096	X
aiua-5550	134	5	-	-	NOUN
aiua-5550	134	6	1099	1099	NUM
aiua-5550	134	7	.	.	PUNCT
aiua-5550	135	1	8	8	X
aiua-5550	135	2	.	.	PUNCT
aiua-5550	136	1	kojima	kojima	PROPN
aiua-5550	136	2	m	m	PROPN
aiua-5550	136	3	,	,	PUNCT
aiua-5550	136	4	ochiai	ochiai	PROPN
aiua-5550	136	5	a	a	X
aiua-5550	136	6	,	,	PUNCT
aiua-5550	136	7	naya	naya	PROPN
aiua-5550	136	8	y	y	PROPN
aiua-5550	136	9	,	,	PUNCT
aiua-5550	136	10	et	et	PROPN
aiua-5550	136	11	al	al	PROPN
aiua-5550	136	12	.	.	PUNCT
aiua-5550	136	13	correlation	correlation	NOUN
aiua-5550	136	14	of	of	ADP
aiua-5550	136	15	presumed	presume	VERB
aiua-5550	136	16	circle	circle	NOUN
aiua-5550	136	17	area	area	NOUN
aiua-5550	136	18	ratio	ratio	NOUN
aiua-5550	136	19	with	with	ADP
aiua-5550	136	20	infravesical	infravesical	ADJ
aiua-5550	136	21	obstruction	obstruction	NOUN
aiua-5550	136	22	in	in	ADP
aiua-5550	136	23	men	man	NOUN
aiua-5550	136	24	with	with	ADP
aiua-5550	136	25	lower	low	ADJ
aiua-5550	136	26	urinary	urinary	ADJ
aiua-5550	136	27	tract	tract	NOUN
aiua-5550	136	28	symptoms	symptom	NOUN
aiua-5550	136	29	.	.	PUNCT
aiua-5550	137	1	urology	urology	NOUN
aiua-5550	137	2	1997	1997	NUM
aiua-5550	137	3	;	;	PUNCT
aiua-5550	137	4	50:548	50:548	NUM
aiua-5550	137	5	-	-	SYM
aiua-5550	137	6	555	555	NUM
aiua-5550	137	7	.	.	NOUN
aiua-5550	137	8	9	9	NUM
aiua-5550	137	9	.	.	X
aiua-5550	138	1	doo	doo	INTJ
aiua-5550	138	2	ck	ck	INTJ
aiua-5550	139	1	and	and	CCONJ
aiua-5550	139	2	uh	uh	INTJ
aiua-5550	139	3	.	.	PUNCT
aiua-5550	140	1	hs	hs	PROPN
aiua-5550	140	2	.	.	PROPN
aiua-5550	140	3	anatomic	anatomic	ADJ
aiua-5550	140	4	configuration	configuration	NOUN
aiua-5550	140	5	of	of	ADP
aiua-5550	140	6	prostate	prostate	NOUN
aiua-5550	140	7	obtained	obtain	VERB
aiua-5550	140	8	by	by	ADP
aiua-5550	140	9	noninvasive	noninvasive	ADJ
aiua-5550	140	10	ultrasonography	ultrasonography	NOUN
aiua-5550	140	11	can	can	AUX
aiua-5550	140	12	predict	predict	VERB
aiua-5550	140	13	clinical	clinical	ADJ
aiua-5550	140	14	voiding	void	VERB
aiua-5550	140	15	parameters	parameter	NOUN
aiua-5550	140	16	for	for	ADP
aiua-5550	140	17	determining	determine	VERB
aiua-5550	140	18	boo	boo	NOUN
aiua-5550	140	19	in	in	ADP
aiua-5550	140	20	men	man	NOUN
aiua-5550	140	21	with	with	ADP
aiua-5550	140	22	luts	luts	PROPN
aiua-5550	140	23	.	.	PUNCT
aiua-5550	141	1	urology	urology	NOUN
aiua-5550	141	2	.	.	PUNCT
aiua-5550	142	1	2009	2009	NUM
aiua-5550	142	2	;	;	PUNCT
aiua-5550	142	3	73:232	73:232	NUM
aiua-5550	142	4	-	-	SYM
aiua-5550	142	5	236	236	NUM
aiua-5550	142	6	.	.	PUNCT
aiua-5550	142	7	10	10	NUM
aiua-5550	142	8	.	.	PUNCT
aiua-5550	143	1	cho	cho	PROPN
aiua-5550	143	2	ks	ks	PROPN
aiua-5550	143	3	,	,	PUNCT
aiua-5550	143	4	kim	kim	PROPN
aiua-5550	143	5	j	j	PROPN
aiua-5550	143	6	,	,	PUNCT
aiua-5550	143	7	choi	choi	PROPN
aiua-5550	143	8	yd	yd	PROPN
aiua-5550	143	9	,	,	PUNCT
aiua-5550	143	10	et	et	PROPN
aiua-5550	143	11	al	al	PROPN
aiua-5550	143	12	.	.	PUNCT
aiua-5550	144	1	the	the	DET
aiua-5550	144	2	overlooked	overlook	VERB
aiua-5550	144	3	cause	cause	NOUN
aiua-5550	144	4	of	of	ADP
aiua-5550	144	5	benign	benign	ADJ
aiua-5550	144	6	prostatic	prostatic	ADJ
aiua-5550	144	7	hyperplasia	hyperplasia	NOUN
aiua-5550	144	8	:	:	PUNCT
aiua-5550	144	9	prostatic	prostatic	ADJ
aiua-5550	144	10	urethral	urethral	ADJ
aiua-5550	144	11	angulation	angulation	NOUN
aiua-5550	144	12	.	.	PUNCT
aiua-5550	145	1	med	med	ADJ
aiua-5550	145	2	hypotheses	hypothesis	NOUN
aiua-5550	145	3	.	.	PUNCT
aiua-5550	145	4	2008	2008	NUM
aiua-5550	145	5	;	;	PUNCT
aiua-5550	145	6	70:532	70:532	NUM
aiua-5550	145	7	-	-	SYM
aiua-5550	145	8	535	535	NUM
aiua-5550	145	9	.	.	PUNCT
aiua-5550	146	1	11	11	NUM
aiua-5550	146	2	.	.	PUNCT
aiua-5550	147	1	cho	cho	PROPN
aiua-5550	147	2	ks	ks	PROPN
aiua-5550	147	3	,	,	PUNCT
aiua-5550	147	4	kim	kim	PROPN
aiua-5550	147	5	jh	jh	PROPN
aiua-5550	147	6	,	,	PUNCT
aiua-5550	147	7	kim	kim	PROPN
aiua-5550	147	8	dj	dj	PROPN
aiua-5550	147	9	,	,	PUNCT
aiua-5550	147	10	et	et	PROPN
aiua-5550	147	11	al	al	PROPN
aiua-5550	147	12	.	.	PROPN
aiua-5550	147	13	relationship	relationship	NOUN
aiua-5550	147	14	between	between	ADP
aiua-5550	147	15	prostatic	prostatic	ADJ
aiua-5550	147	16	urethral	urethral	ADJ
aiua-5550	147	17	angle	angle	NOUN
aiua-5550	147	18	and	and	CCONJ
aiua-5550	147	19	urinary	urinary	ADJ
aiua-5550	147	20	flow	flow	NOUN
aiua-5550	147	21	rate	rate	NOUN
aiua-5550	147	22	:	:	PUNCT
aiua-5550	147	23	its	its	PRON
aiua-5550	147	24	implication	implication	NOUN
aiua-5550	147	25	in	in	ADP
aiua-5550	147	26	benign	benign	ADJ
aiua-5550	147	27	prostatic	prostatic	ADJ
aiua-5550	147	28	hyperplasia	hyperplasia	NOUN
aiua-5550	147	29	pathogenesis	pathogenesis	NOUN
aiua-5550	147	30	.	.	PUNCT
aiua-5550	148	1	urology	urology	NOUN
aiua-5550	148	2	.	.	PUNCT
aiua-5550	148	3	2008	2008	NUM
aiua-5550	148	4	;	;	PUNCT
aiua-5550	148	5	71:858	71:858	NUM
aiua-5550	148	6	-	-	NUM
aiua-5550	148	7	862	862	NUM
aiua-5550	148	8	.	.	PUNCT
aiua-5550	149	1	12	12	NUM
aiua-5550	149	2	.	.	PUNCT
aiua-5550	150	1	ku	ku	PROPN
aiua-5550	150	2	jh	jh	PROPN
aiua-5550	150	3	,	,	PUNCT
aiua-5550	150	4	ko	ko	PROPN
aiua-5550	150	5	dw	dw	PROPN
aiua-5550	150	6	,	,	PUNCT
aiua-5550	150	7	cho	cho	PROPN
aiua-5550	150	8	jy	jy	PROPN
aiua-5550	150	9	,	,	PUNCT
aiua-5550	150	10	et	et	PROPN
aiua-5550	150	11	al	al	PROPN
aiua-5550	150	12	.	.	PROPN
aiua-5550	150	13	correlation	correlation	NOUN
aiua-5550	150	14	between	between	ADP
aiua-5550	150	15	prostatic	prostatic	ADJ
aiua-5550	150	16	urethral	urethral	ADJ
aiua-5550	150	17	angle	angle	NOUN
aiua-5550	150	18	and	and	CCONJ
aiua-5550	150	19	bladder	bladder	NOUN
aiua-5550	150	20	outlet	outlet	NOUN
aiua-5550	150	21	obstruction	obstruction	NOUN
aiua-5550	150	22	index	index	NOUN
aiua-5550	150	23	in	in	ADP
aiua-5550	150	24	patients	patient	NOUN
aiua-5550	150	25	with	with	ADP
aiua-5550	150	26	lower	low	ADJ
aiua-5550	150	27	urinary	urinary	ADJ
aiua-5550	150	28	tract	tract	NOUN
aiua-5550	150	29	symptoms	symptom	NOUN
aiua-5550	150	30	.	.	PUNCT
aiua-5550	151	1	urology	urology	NOUN
aiua-5550	151	2	.	.	PUNCT
aiua-5550	152	1	2010	2010	NUM
aiua-5550	152	2	;	;	PUNCT
aiua-5550	153	1	75:1467	75:1467	X
aiua-5550	153	2	-	-	NOUN
aiua-5550	153	3	1471	1471	NUM
aiua-5550	153	4	.	.	PUNCT
aiua-5550	154	1	13	13	NUM
aiua-5550	154	2	.	.	PUNCT
aiua-5550	154	3	park	park	PROPN
aiua-5550	154	4	yj	yj	PROPN
aiua-5550	154	5	,	,	PUNCT
aiua-5550	154	6	bae	bae	PROPN
aiua-5550	154	7	kh	kh	PROPN
aiua-5550	154	8	,	,	PUNCT
aiua-5550	154	9	jin	jin	PROPN
aiua-5550	154	10	bs	bs	PROPN
aiua-5550	154	11	,	,	PUNCT
aiua-5550	154	12	et	et	PROPN
aiua-5550	154	13	al	al	PROPN
aiua-5550	154	14	.	.	PROPN
aiua-5550	154	15	is	be	AUX
aiua-5550	154	16	increased	increase	VERB
aiua-5550	154	17	prostatic	prostatic	ADJ
aiua-5550	154	18	urethral	urethral	ADJ
aiua-5550	154	19	angle	angle	NOUN
aiua-5550	154	20	related	relate	VERB
aiua-5550	154	21	to	to	ADP
aiua-5550	154	22	lower	low	ADJ
aiua-5550	154	23	urinary	urinary	ADJ
aiua-5550	154	24	tract	tract	NOUN
aiua-5550	154	25	symptoms	symptom	NOUN
aiua-5550	154	26	in	in	ADP
aiua-5550	154	27	males	male	NOUN
aiua-5550	154	28	with	with	ADP
aiua-5550	154	29	benign	benign	ADJ
aiua-5550	154	30	prostatic	prostatic	ADJ
aiua-5550	154	31	hyperplasia	hyperplasia	NOUN
aiua-5550	154	32	/	/	SYM
aiua-5550	154	33	lower	low	ADJ
aiua-5550	154	34	urinary	urinary	ADJ
aiua-5550	154	35	tract	tract	NOUN
aiua-5550	154	36	symptoms	symptom	NOUN
aiua-5550	154	37	?	?	PUNCT
aiua-5550	155	1	korean	korean	PROPN
aiua-5550	155	2	j	j	PROPN
aiua-5550	155	3	urol	urol	PROPN
aiua-5550	155	4	.	.	PUNCT
aiua-5550	155	5	2012	2012	NUM
aiua-5550	155	6	;	;	PUNCT
aiua-5550	155	7	53:410	53:410	NUM
aiua-5550	155	8	-	-	SYM
aiua-5550	155	9	413	413	NUM
aiua-5550	155	10	.	.	PUNCT
aiua-5550	156	1	14	14	NUM
aiua-5550	156	2	.	.	PUNCT
aiua-5550	157	1	bang	bang	PROPN
aiua-5550	157	2	wj	wj	PROPN
aiua-5550	157	3	,	,	PUNCT
aiua-5550	157	4	kim	kim	PROPN
aiua-5550	157	5	hw	hw	PROPN
aiua-5550	157	6	,	,	PUNCT
aiua-5550	157	7	leec	leec	ADP
aiua-5550	157	8	jy	jy	PROPN
aiua-5550	157	9	,	,	PUNCT
aiua-5550	157	10	et	et	PROPN
aiua-5550	157	11	al	al	PROPN
aiua-5550	157	12	.	.	PUNCT
aiua-5550	158	1	prostatic	prostatic	ADJ
aiua-5550	158	2	urethral	urethral	ADJ
aiua-5550	158	3	angulation	angulation	NOUN
aiua-5550	158	4	associated	associate	VERB
aiua-5550	158	5	with	with	ADP
aiua-5550	158	6	urinary	urinary	ADJ
aiua-5550	158	7	flow	flow	NOUN
aiua-5550	158	8	rate	rate	NOUN
aiua-5550	158	9	and	and	CCONJ
aiua-5550	158	10	urinary	urinary	ADJ
aiua-5550	158	11	symptom	symptom	NOUN
aiua-5550	158	12	scores	score	NOUN
aiua-5550	158	13	in	in	ADP
aiua-5550	158	14	men	man	NOUN
aiua-5550	158	15	with	with	ADP
aiua-5550	158	16	lower	low	ADJ
aiua-5550	158	17	urinary	urinary	ADJ
aiua-5550	158	18	tract	tract	NOUN
aiua-5550	158	19	symptoms	symptom	NOUN
aiua-5550	158	20	.	.	PUNCT
aiua-5550	159	1	urology	urology	NOUN
aiua-5550	159	2	.	.	PUNCT
aiua-5550	160	1	2012	2012	NUM
aiua-5550	160	2	;	;	PUNCT
aiua-5550	160	3	80:1333	80:1333	NOUN
aiua-5550	160	4	-	-	SYM
aiua-5550	160	5	1337	1337	NUM
aiua-5550	160	6	.	.	PUNCT
aiua-5550	161	1	15	15	NUM
aiua-5550	161	2	.	.	PUNCT
aiua-5550	162	1	gravas	gravas	PROPN
aiua-5550	162	2	s	s	PROPN
aiua-5550	162	3	,	,	PUNCT
aiua-5550	162	4	bachmann	bachmann	PROPN
aiua-5550	162	5	a	a	PRON
aiua-5550	162	6	,	,	PUNCT
aiua-5550	162	7	descazeaud	descazeaud	VERB
aiua-5550	162	8	a	a	PRON
aiua-5550	162	9	,	,	PUNCT
aiua-5550	162	10	et	et	PROPN
aiua-5550	162	11	al	al	PROPN
aiua-5550	162	12	.	.	PUNCT
aiua-5550	162	13	guidelines	guideline	NOUN
aiua-5550	162	14	on	on	ADP
aiua-5550	162	15	the	the	DET
aiua-5550	162	16	treatment	treatment	NOUN
aiua-5550	162	17	of	of	ADP
aiua-5550	162	18	non	non	ADJ
aiua-5550	162	19	-	-	ADJ
aiua-5550	162	20	neurogenic	neurogenic	ADJ
aiua-5550	162	21	male	male	ADJ
aiua-5550	162	22	luts	lut	NOUN
aiua-5550	162	23	including	include	VERB
aiua-5550	162	24	benign	benign	ADJ
aiua-5550	162	25	prostatic	prostatic	ADJ
aiua-5550	162	26	obstruction	obstruction	NOUN
aiua-5550	162	27	.	.	PUNCT
aiua-5550	163	1	european	european	PROPN
aiua-5550	163	2	association	association	PROPN
aiua-5550	163	3	of	of	ADP
aiua-5550	163	4	urology	urology	NOUN
aiua-5550	163	5	,	,	PUNCT
aiua-5550	163	6	2014	2014	NUM
aiua-5550	163	7	.	.	PUNCT
aiua-5550	164	1	16	16	NUM
aiua-5550	164	2	.	.	PUNCT
aiua-5550	165	1	roehrborn	roehrborn	ADJ
aiua-5550	165	2	cg	cg	PROPN
aiua-5550	165	3	,	,	PUNCT
aiua-5550	165	4	barkin	barkin	PROPN
aiua-5550	165	5	j	j	PROPN
aiua-5550	165	6	,	,	PUNCT
aiua-5550	165	7	tubaro	tubaro	VERB
aiua-5550	165	8	a	a	PRON
aiua-5550	165	9	,	,	PUNCT
aiua-5550	166	1	et	et	PROPN
aiua-5550	166	2	al	al	PROPN
aiua-5550	166	3	.	.	PUNCT
aiua-5550	166	4	influence	influence	NOUN
aiua-5550	166	5	of	of	ADP
aiua-5550	166	6	baseline	baseline	NOUN
aiua-5550	166	7	variables	variable	NOUN
aiua-5550	166	8	on	on	ADP
aiua-5550	166	9	changes	change	NOUN
aiua-5550	166	10	in	in	ADP
aiua-5550	166	11	international	international	ADJ
aiua-5550	166	12	prostate	prostate	NOUN
aiua-5550	166	13	symptom	symptom	NOUN
aiua-5550	166	14	score	score	NOUN
aiua-5550	166	15	after	after	ADP
aiua-5550	166	16	combined	combine	VERB
aiua-5550	166	17	therapy	therapy	NOUN
aiua-5550	166	18	with	with	ADP
aiua-5550	166	19	dutasteride	dutasteride	NOUN
aiua-5550	166	20	plus	plus	CCONJ
aiua-5550	166	21	tamsulosin	tamsulosin	NOUN
aiua-5550	166	22	or	or	CCONJ
aiua-5550	166	23	either	either	DET
aiua-5550	166	24	monotherapy	monotherapy	NOUN
aiua-5550	166	25	in	in	ADP
aiua-5550	166	26	patients	patient	NOUN
aiua-5550	166	27	with	with	ADP
aiua-5550	166	28	benign	benign	ADJ
aiua-5550	166	29	prostatic	prostatic	ADJ
aiua-5550	166	30	hyperplasia	hyperplasia	NOUN
aiua-5550	166	31	and	and	CCONJ
aiua-5550	166	32	lower	low	ADJ
aiua-5550	166	33	urinary	urinary	ADJ
aiua-5550	166	34	tract	tract	NOUN
aiua-5550	166	35	symptoms	symptom	NOUN
aiua-5550	166	36	:	:	PUNCT
aiua-5550	166	37	4	4	NUM
aiua-5550	166	38	-	-	PUNCT
aiua-5550	166	39	year	year	NOUN
aiua-5550	166	40	results	result	NOUN
aiua-5550	166	41	of	of	ADP
aiua-5550	166	42	the	the	DET
aiua-5550	166	43	combat	combat	NOUN
aiua-5550	166	44	study	study	NOUN
aiua-5550	166	45	.	.	PUNCT
aiua-5550	167	1	bju	bju	PROPN
aiua-5550	167	2	int	int	PROPN
aiua-5550	167	3	.	.	PUNCT
aiua-5550	168	1	2014	2014	NUM
aiua-5550	168	2	;	;	PUNCT
aiua-5550	168	3	113:623	113:623	NUM
aiua-5550	168	4	-	-	PUNCT
aiua-5550	168	5	35	35	NUM
aiua-5550	168	6	.	.	PUNCT
aiua-5550	169	1	17	17	NUM
aiua-5550	169	2	.	.	PUNCT
aiua-5550	170	1	hou1	hou1	PROPN
aiua-5550	170	2	c	c	PROPN
aiua-5550	170	3	,	,	PUNCT
aiua-5550	170	4	chen	chen	PROPN
aiua-5550	170	5	l	l	PROPN
aiua-5550	170	6	,	,	PUNCT
aiua-5550	170	7	lin	lin	PROPN
aiua-5550	170	8	y	y	PROPN
aiua-5550	170	9	,	,	PUNCT
aiua-5550	170	10	et	et	PROPN
aiua-5550	170	11	al	al	PROPN
aiua-5550	170	12	.	.	PUNCT
aiua-5550	171	1	prostatic	prostatic	ADJ
aiua-5550	171	2	urethral	urethral	ADJ
aiua-5550	171	3	angle	angle	NOUN
aiua-5550	171	4	might	might	AUX
aiua-5550	171	5	be	be	AUX
aiua-5550	171	6	a	a	DET
aiua-5550	171	7	predictor	predictor	NOUN
aiua-5550	171	8	of	of	ADP
aiua-5550	171	9	treatment	treatment	NOUN
aiua-5550	171	10	efficacy	efficacy	NOUN
aiua-5550	171	11	of	of	ADP
aiua-5550	171	12	α	α	NOUN
aiua-5550	171	13	-	-	PUNCT
aiua-5550	171	14	blockers	blocker	NOUN
aiua-5550	171	15	in	in	ADP
aiua-5550	171	16	men	man	NOUN
aiua-5550	171	17	with	with	ADP
aiua-5550	171	18	lower	low	ADJ
aiua-5550	171	19	urinary	urinary	ADJ
aiua-5550	171	20	tract	tract	NOUN
aiua-5550	171	21	symptoms	symptom	NOUN
aiua-5550	171	22	.	.	PUNCT
aiua-5550	172	1	drug	drug	NOUN
aiua-5550	172	2	design	design	NOUN
aiua-5550	172	3	,	,	PUNCT
aiua-5550	172	4	development	development	NOUN
aiua-5550	172	5	and	and	CCONJ
aiua-5550	172	6	therapy	therapy	NOUN
aiua-5550	172	7	.	.	PUNCT
aiua-5550	173	1	2014:8	2014:8	NUM
aiua-5550	173	2	937	937	NUM
aiua-5550	173	3	-	-	SYM
aiua-5550	173	4	943	943	NUM
aiua-5550	173	5	.	.	PUNCT
aiua-5550	174	1	18	18	NUM
aiua-5550	174	2	.	.	PUNCT
aiua-5550	175	1	narayan	narayan	PROPN
aiua-5550	175	2	p	p	X
aiua-5550	175	3	,	,	PUNCT
aiua-5550	175	4	lepor	lepor	ADJ
aiua-5550	175	5	h.	h.	PROPN
aiua-5550	175	6	long	long	ADJ
aiua-5550	175	7	-	-	PUNCT
aiua-5550	175	8	term	term	NOUN
aiua-5550	175	9	,	,	PUNCT
aiua-5550	175	10	open	open	ADJ
aiua-5550	175	11	-	-	PUNCT
aiua-5550	175	12	label	label	NOUN
aiua-5550	175	13	,	,	PUNCT
aiua-5550	175	14	phase	phase	NOUN
aiua-5550	175	15	iii	iii	NUM
aiua-5550	175	16	multicenter	multicenter	NOUN
aiua-5550	175	17	study	study	NOUN
aiua-5550	175	18	of	of	ADP
aiua-5550	175	19	tamsulosin	tamsulosin	NOUN
aiua-5550	175	20	in	in	ADP
aiua-5550	175	21	benign	benign	ADJ
aiua-5550	175	22	prostatic	prostatic	ADJ
aiua-5550	175	23	hyperplasia	hyperplasia	NOUN
aiua-5550	175	24	.	.	PUNCT
aiua-5550	176	1	urology	urology	NOUN
aiua-5550	176	2	.	.	PUNCT
aiua-5550	177	1	2001	2001	NUM
aiua-5550	177	2	;	;	PUNCT
aiua-5550	177	3	57:466	57:466	NUM
aiua-5550	177	4	-	-	SYM
aiua-5550	177	5	470	470	NUM
aiua-5550	177	6	.	.	PUNCT
aiua-5550	178	1	19	19	NUM
aiua-5550	178	2	.	.	PUNCT
aiua-5550	178	3	yoshida	yoshida	PROPN
aiua-5550	178	4	m	m	PROPN
aiua-5550	178	5	,	,	PUNCT
aiua-5550	178	6	sugiyama	sugiyama	PROPN
aiua-5550	178	7	y	y	PROPN
aiua-5550	178	8	,	,	PUNCT
aiua-5550	178	9	masunaga	masunaga	NOUN
aiua-5550	178	10	k	k	PROPN
aiua-5550	178	11	,	,	PUNCT
aiua-5550	178	12	et	et	PROPN
aiua-5550	178	13	al	al	PROPN
aiua-5550	178	14	.	.	PROPN
aiua-5550	178	15	effect	effect	NOUN
aiua-5550	178	16	of	of	ADP
aiua-5550	178	17	tamsulosin	tamsulosin	NOUN
aiua-5550	178	18	hydrochloride	hydrochloride	NOUN
aiua-5550	178	19	on	on	ADP
aiua-5550	178	20	lower	low	ADJ
aiua-5550	178	21	urinary	urinary	ADJ
aiua-5550	178	22	tract	tract	NOUN
aiua-5550	178	23	symptoms	symptom	NOUN
aiua-5550	178	24	and	and	CCONJ
aiua-5550	178	25	quality	quality	NOUN
aiua-5550	178	26	of	of	ADP
aiua-5550	178	27	life	life	NOUN
aiua-5550	178	28	in	in	ADP
aiua-5550	178	29	patients	patient	NOUN
aiua-5550	178	30	with	with	ADP
aiua-5550	178	31	benign	benign	ADJ
aiua-5550	178	32	prostatic	prostatic	ADJ
aiua-5550	178	33	hyperplasia	hyperplasia	NOUN
aiua-5550	178	34	.	.	PUNCT
aiua-5550	179	1	evaluation	evaluation	NOUN
aiua-5550	179	2	using	use	VERB
aiua-5550	179	3	bother	bother	VERB
aiua-5550	179	4	score	score	NOUN
aiua-5550	179	5	.	.	PUNCT
aiua-5550	180	1	drugs	drug	NOUN
aiua-5550	180	2	today	today	NOUN
aiua-5550	180	3	.	.	PUNCT
aiua-5550	181	1	2007	2007	NUM
aiua-5550	181	2	;	;	PUNCT
aiua-5550	181	3	43:1	43:1	NUM
aiua-5550	181	4	-	-	SYM
aiua-5550	181	5	7	7	NUM
aiua-5550	181	6	.	.	NOUN
aiua-5550	181	7	20	20	NUM
aiua-5550	181	8	.	.	PUNCT
aiua-5550	182	1	mcneal	mcneal	PROPN
aiua-5550	182	2	je	je	PROPN
aiua-5550	182	3	.	.	PUNCT
aiua-5550	183	1	the	the	DET
aiua-5550	183	2	prostate	prostate	NOUN
aiua-5550	183	3	and	and	CCONJ
aiua-5550	183	4	prostatic	prostatic	ADJ
aiua-5550	183	5	urethra	urethra	NOUN
aiua-5550	183	6	:	:	PUNCT
aiua-5550	183	7	a	a	DET
aiua-5550	183	8	morphologic	morphologic	ADJ
aiua-5550	183	9	synthesis	synthesis	NOUN
aiua-5550	183	10	.	.	PUNCT
aiua-5550	184	1	j	j	PROPN
aiua-5550	184	2	urol	urol	PROPN
aiua-5550	184	3	.	.	PUNCT
aiua-5550	184	4	1972	1972	NUM
aiua-5550	184	5	;	;	PUNCT
aiua-5550	184	6	107:1008	107:1008	PROPN
aiua-5550	184	7	-	-	SYM
aiua-5550	184	8	1016	1016	NUM
aiua-5550	184	9	.	.	PUNCT
aiua-5550	185	1	21	21	NUM
aiua-5550	185	2	.	.	PUNCT
aiua-5550	186	1	keqin	keqin	PROPN
aiua-5550	186	2	z	z	PROPN
aiua-5550	186	3	,	,	PUNCT
aiua-5550	186	4	zhishun	zhishun	PROPN
aiua-5550	186	5	x	x	PRON
aiua-5550	186	6	,	,	PUNCT
aiua-5550	186	7	jing	je	VERB
aiua-5550	187	1	z	z	X
aiua-5550	187	2	,	,	PUNCT
aiua-5550	187	3	et	et	PROPN
aiua-5550	187	4	al	al	PROPN
aiua-5550	187	5	.	.	PROPN
aiua-5550	188	1	clinical	clinical	ADJ
aiua-5550	188	2	significance	significance	NOUN
aiua-5550	188	3	of	of	ADP
aiua-5550	188	4	intravesical	intravesical	ADJ
aiua-5550	188	5	prostatic	prostatic	ADJ
aiua-5550	188	6	protrusion	protrusion	NOUN
aiua-5550	188	7	in	in	ADP
aiua-5550	188	8	patients	patient	NOUN
aiua-5550	188	9	with	with	ADP
aiua-5550	188	10	benign	benign	ADJ
aiua-5550	188	11	prostatic	prostatic	ADJ
aiua-5550	188	12	enlargement	enlargement	NOUN
aiua-5550	188	13	.	.	PUNCT
aiua-5550	189	1	urology	urology	NOUN
aiua-5550	189	2	.	.	PUNCT
aiua-5550	190	1	2007	2007	NUM
aiua-5550	190	2	;	;	PUNCT
aiua-5550	190	3	70:1096	70:1096	X
aiua-5550	190	4	-	-	NOUN
aiua-5550	190	5	1099	1099	NUM
aiua-5550	190	6	.	.	PUNCT
aiua-5550	191	1	22	22	NUM
aiua-5550	191	2	.	.	PUNCT
aiua-5550	192	1	borth	borth	PROPN
aiua-5550	192	2	cs	cs	PROPN
aiua-5550	192	3	,	,	PUNCT
aiua-5550	192	4	beiko	beiko	ADJ
aiua-5550	192	5	dt	dt	PROPN
aiua-5550	192	6	,	,	PUNCT
aiua-5550	192	7	nickel	nickel	PROPN
aiua-5550	192	8	jc	jc	PROPN
aiua-5550	192	9	.	.	PROPN
aiua-5550	192	10	impact	impact	NOUN
aiua-5550	192	11	of	of	ADP
aiua-5550	192	12	medical	medical	ADJ
aiua-5550	192	13	therapy	therapy	NOUN
aiua-5550	192	14	on	on	ADP
aiua-5550	192	15	transurethral	transurethral	ADJ
aiua-5550	192	16	resection	resection	NOUN
aiua-5550	192	17	of	of	ADP
aiua-5550	192	18	the	the	DET
aiua-5550	192	19	prostate	prostate	NOUN
aiua-5550	192	20	:	:	PUNCT
aiua-5550	192	21	a	a	DET
aiua-5550	192	22	decade	decade	NOUN
aiua-5550	192	23	of	of	ADP
aiua-5550	192	24	change	change	NOUN
aiua-5550	192	25	.	.	PUNCT
aiua-5550	193	1	urology	urology	NOUN
aiua-5550	193	2	.	.	PUNCT
aiua-5550	194	1	2001	2001	NUM
aiua-5550	194	2	;	;	PUNCT
aiua-5550	194	3	57:1082	57:1082	NUM
aiua-5550	194	4	-	-	SYM
aiua-5550	194	5	5	5	NUM
aiua-5550	194	6	.	.	NOUN
aiua-5550	194	7	23	23	NUM
aiua-5550	194	8	.	.	PUNCT
aiua-5550	195	1	jepsen	jepsen	PROPN
aiua-5550	195	2	jv	jv	PROPN
aiua-5550	195	3	,	,	PUNCT
aiua-5550	195	4	bruskewitz	bruskewitz	PROPN
aiua-5550	195	5	rc	rc	PROPN
aiua-5550	195	6	.	.	PUNCT
aiua-5550	196	1	recent	recent	ADJ
aiua-5550	196	2	developments	development	NOUN
aiua-5550	196	3	in	in	ADP
aiua-5550	196	4	the	the	DET
aiua-5550	196	5	surgical	surgical	ADJ
aiua-5550	196	6	management	management	NOUN
aiua-5550	196	7	of	of	ADP
aiua-5550	196	8	benign	benign	ADJ
aiua-5550	196	9	prostatic	prostatic	ADJ
aiua-5550	196	10	hyperplasia	hyperplasia	NOUN
aiua-5550	196	11	..	..	PUNCT
aiua-5550	196	12	urology	urology	NOUN
aiua-5550	196	13	1998	1998	NUM
aiua-5550	196	14	;	;	PUNCT
aiua-5550	196	15	51:23	51:23	NUM
aiua-5550	196	16	-	-	SYM
aiua-5550	196	17	31	31	NUM
aiua-5550	196	18	.	.	PUNCT
aiua-5550	197	1	correspondence	correspondence	NOUN
aiua-5550	197	2	ali	ali	PROPN
aiua-5550	197	3	abdel	abdel	PROPN
aiua-5550	197	4	raheem	raheem	PROPN
aiua-5550	197	5	,	,	PUNCT
aiua-5550	197	6	md	md	PROPN
aiua-5550	197	7	(	(	PUNCT
aiua-5550	197	8	corresponding	correspond	VERB
aiua-5550	197	9	author	author	NOUN
aiua-5550	197	10	)	)	PUNCT
aiua-5550	198	1	aliraheem82@yahoo.com	aliraheem82@yahoo.com	X
aiua-5550	198	2	hassan	hassan	PROPN
aiua-5550	198	3	el	el	PROPN
aiua-5550	198	4	-	-	PROPN
aiua-5550	198	5	tatawy	tatawy	PROPN
aiua-5550	198	6	hassantat@yahoo.com	hassantat@yahoo.com	PROPN
aiua-5550	198	7	tarek	tarek	PROPN
aiua-5550	198	8	gameel	gameel	PROPN
aiua-5550	198	9	t_gameel@yahoo.com	t_gameel@yahoo.com	X
aiua-5550	198	10	mohammed	mohammed	PROPN
aiua-5550	198	11	abo	abo	PROPN
aiua-5550	198	12	el	el	PROPN
aiua-5550	198	13	-	-	PROPN
aiua-5550	198	14	enen	enen	PROPN
aiua-5550	198	15	m.aboelenen@yahoo.com	m.aboelenen@yahoo.com	PROPN
aiua-5550	198	16	ayman	ayman	PROPN
aiua-5550	198	17	hagras	hagras	PROPN
aiua-5550	198	18	aymanhagras@yahoo.com	aymanhagras@yahoo.com	PROPN
aiua-5550	198	19	ayman	ayman	PROPN
aiua-5550	198	20	mousa	mousa	PROPN
aiua-5550	198	21	hn.hn2020@yahoo.com	hn.hn2020@yahoo.com	PROPN
aiua-5550	198	22	abdel	abdel	PROPN
aiua-5550	198	23	hamid	hamid	PROPN
aiua-5550	198	24	el	el	PROPN
aiua-5550	198	25	-	-	PROPN
aiua-5550	198	26	bahnasy	bahnasy	PROPN
aiua-5550	198	27	mrabdo65@yahoo.com	mrabdo65@yahoo.com	PROPN
aiua-5550	198	28	urology	urology	PROPN
aiua-5550	198	29	department	department	PROPN
aiua-5550	198	30	,	,	PUNCT
aiua-5550	198	31	tanta	tanta	PROPN
aiua-5550	198	32	university	university	PROPN
aiua-5550	198	33	hospital	hospital	NOUN
aiua-5550	198	34	,	,	PUNCT
aiua-5550	198	35	egypt	egypt	PROPN
aiua-5550	198	36	khaled	khaled	PROPN
aiua-5550	198	37	abu	abu	PROPN
aiua-5550	198	38	-	-	PUNCT
aiua-5550	198	39	dewan	dewan	PROPN
aiua-5550	198	40	radiology	radiology	NOUN
aiua-5550	198	41	department	department	PROPN
aiua-5550	198	42	,	,	PUNCT
aiua-5550	198	43	tanta	tanta	PROPN
aiua-5550	198	44	university	university	PROPN
aiua-5550	198	45	hospital	hospital	NOUN
aiua-5550	198	46	,	,	PUNCT
aiua-5550	198	47	egypt	egypt	PROPN
aiua-5550	198	48	ali	ali	PROPN
aiua-5550	198	49	raheem_stesura	raheem_stesura	PROPN
aiua-5550	198	50	seveso	seveso	VERB
aiua-5550	199	1	30/09/15	30/09/15	PROPN
aiua-5550	199	2	09:39	09:39	NUM
aiua-5550	199	3	pagina	pagina	NOUN
aiua-5550	199	4	242	242	NUM